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Abstract  	
An estimated 12 million people worldwide are diagnosed with cancer every year, 
with around 17 million cancer-related deaths per year predicted by 2030 (Thun et 
al. 2010). Contemporary clinical treatments include surgery, chemotherapy and 
radiotherapy, however all vary in success and exhibit unpleasant side effects. 
Localised tumour hyperthermia is a moderately new cancer treatment envisaged 
by researchers, which exploits exclusive tumour vulnerabilities to specific 
temperature profiles (42-45°C) leading to cancer cell apoptosis, whilst normal 
tissue cells are relatively unaffected.  Hyperthermia is therefore proposed as an 
alternative potential therapy for cancer, by delivering localised treatment to cancer 
cells, without the severe side effects associated with traditional therapies.  
 
This project aimed to investigate potential hyperthermic treatment of cancer cells 
in vitro by adopting nanomedicine principles. Inorganic nanoparticles, such as gold 
or iron oxide, are both capable of generating heat when appropriately stimulated, 
therefore both have been suggested as candidates for inducing localised tumour 
heating following their internalisation into cells. In this project, both gold (GNPs) 
and magnetic (mNPs) were individually assessed for their potential to deliver toxic 
thermal energy to bone cancer cells (MG63) and breast cancer cells (MCF-7). 
Studies were carried out both in standard 2D monolayer and in 3D tumour 
spheroids.  
 
When considering use in vivo, it is essential that both GNPs and mNPs are 
biocompatible, therefore initial studies characterised the cell viability and metabolic 
activity following incubation with the NPs.  The NP internalisation was 
subsequently verified, prior to hyperthermic studies. Following hyperthermic 
treatment, both GNPs and mNPs were confirmed as inducing cancer cell death. 
Further studies were carried out using the GNPs, to identify the cell death 
pathways activated, where mitochondrial stress was evident following 2D culture 
tests.  Gene and protein expression analysis indicated that cell death occurred 
predominantly via several apoptotic pathways, through increased fold expression 
changes in apoptotic markers. Interestingly, cell protective mechanisms were 
simultaneously switched on, as cells were also observed to exhibit 
thermotolerance with a number of heat shock proteins (Hsps) being substantially 
increased during hyperthermic treatments.  
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1. General Introduction: 
 
1.1 Cancer  
 
Cancer is defined as a range of diseases, which originate from the unregulated 
proliferation of cells (Trosko 2009).	 The resultant cancerous tumours are 
malignant, which means they are able to spread, by invading neighbouring tissues, 
and/or distant tissues (via the bloodstream, or lymph system). The spread of the 
disease from one tissue or organ to another non-adjacent tissue or organ is 
referred to as metastasis, and it is this capability, which accounts for such high 
mortality rates in cancer patients (Geiger and Peeper 2009; Seyfried and 
Huysentruyt 2013).  Cancer-related deaths are projected to increase in the future, 
with the World Health Organization (WHO) estimating about 13.1 million cancer- 
related deaths by the year 2030. An estimated ten million people are diagnosed 
with the disease annually, with disease progression characterised by a multistep 
process involving various physiological systems, such as cell signalling and 
apoptosis, making it a highly complex disease (Misra et al. 2010). In humans, 
cancer refers to at least 100 versions of a disease capable of developing in almost 
any tissue in the body	 (Masoudi-Nejad et al. 2015). Although different cancers 
show various characteristics, all develop in a common system of progression, 
involving genetic and epigenetic incidences in addition to a complex network of 
interactions between cells and the extracellular matrix (Masoudi-Nejad et al. 
2015). Cancer arises as a result of alterations to DNA, enabling cells to avoid 
regulatory mechanisms that control normal cell growth and proliferation (Hyndman 
2016). In this state, cells display unique traits or ‘hallmarks’ – including genome 
instability; inhibition of apoptosis and growth suppression; proliferation and 
immortality; induction of angiogenesis and inflammation; invasion and metastasis 
(Hanahan and Weinberg 2000; Hyndman 2016).  
 
1.1.1 Carcinogenesis  
 
At its core, genomic instability is a characteristic feature of almost all human 
cancers (Negrini et al. 2010). DNA is vulnerable to a variety of stimuli, which can 
lead to DNA lesions and sites of damage. When referring to cancer, such stimuli 
are termed ‘carcinogens’, and include those in the environment such as UV 
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radiation, ionising radiation, drugs and dietary chemicals.  Carcinogens may also 
be present at the cellular level through metabolism, free radical production and gut 
microbiota (Roos et al. 2016). It is estimated that 95% of cancers occur through 
the interaction of environmental factors (such as tobacco smoke, dietary 
constituents, pollutants, drugs, radiation, and infectious agents) with genes, while 
the remaining 5% are attributed to hereditary mutations (Hyndman 2016). 
 
DNA lesions can cause significant structural and chemical alterations and eventual 
transcriptional mutagenesis (T. Gong et al. 2014). Damaged DNA can lead to cell 
death or survival based on DNA recognition repair mechanism and damage 
tolerance (Roos et al. 2016). Affected genes are broadly separated into proto-
oncogenes and tumour suppressor genes. Proto-oncogenes are a group of genes 
that usually encode for proteins involved in stimulating cell division and inhibiting 
differentiation and apoptosis. Oncogene activation can lead to replication stress 
and DNA double strand breaks as well as further genomic instability (Miron et al. 
2015). Onocogene activation and abnormal high expression can also cause the 
hyperactivation of signalling pathways that may be integral to control cell growth, 
proliferation, motility, and can have down stream implications of wider signalling 
networks that incite cancer progression, including the tumour microenvironment, 
angiogenesis, and inflammation (Sever and Brugge 2015).  
 
Tumour suppressor genes, meanwhile, generally encode for proteins involved in 
inhibiting cell proliferation and include proteins involved in cell cycle checkpoint 
controls, apoptosis, and DNA repair	(Velez and Howard 2015). If these genes are 
mutated, a loss-of-function occurs and an accumulation of genetic damage and 
double stranded breaks can arise (Broustas and Lieberman 2014; Sun and Yang 
2010; J. Zhang and Powell 2005). Also at this genomic level, continuous faulty 
DNA maintenance machinery and disruption to epigenetic modifiers can result in 
potentially thousands of sequence alterations and anomalies causing extreme 
difficulties in identifying global markers for various cancers	 (Du and Elemento 
2015).  
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1.1.2 Current Treatment Plans 
 
The need for early and effective detection, diagnosis and treatment is of upmost 
importance in treatment success. The most common cancer treatments to date are 
restricted to chemotherapy, radiation and surgery, however hyperthermia is 
emerging as a strong contender (Misra et al, 2010).  
 
1.1.2.1	Surgery	
 
Surgery is the oldest oncological discipline and involves the surgical removal of 
the primary tumour from the patient (Pagani et al. 2010; Wyld et al. 2015). In the 
case of breast cancer, the overall success of these procedures are debatable 
(Pagani et al. 2010). The removal of the primary tumour can inhibit the metastatic 
spread of cancer cells, while animal studies have shown the removal of tumours 
can restore immune function as primary tumours have been shown to compromise 
the immune system through release of immunosuppressive factors	(Gnerlich et al. 
2007; P. Sinha et al. 2005; Wood 2007).	 The removal of necrotic tumour tissue 
and overall reduction in cancer cells can also facilitate increased 
chemotherapeutic drug delivery within tumour sites (P. Sinha et al. 2005). Despite 
its relative success, major problems are associated with this treatment plan, 
including the fast-tracked relapse of the tumour, in response to its initial removal 
(Retsky et al. 2004). While the invasive nature of surgeries can lead to further 
complications such as infections and associated side effects of anaesthesia 
(Andreae and Andreae 2012; D. J. Jones et al. 2014). 
 
1.1.2.2	Chemotherapy		
 
Chemotherapy is a type of cancer treatment that uses specific drugs to kill cancer 
cells, by slowing the growth and proliferation of the rapidly dividing cells	 and is 
usually given in combination with surgery and/or radiotherapy (Pérez-Herrero and 
Fernández-Medarde 2015; Untch et al. 2014).  Chemotherapy is an aggressive 
form of treatment and due to its non-localised method of administration (e.g. by 
injection or oral tablet), has a global effect on the patient (Carr et al. 2014; Numico 
et al. 2015; Wissing 2015). The drugs used are toxic not only to cancerous cells 
but also to other rapidly proliferating normal cells, such as those of the bone 
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marrow, the intestinal epithelium and hair follicles, leading to severe side effects 
that can further hinder the recovery time and prognosis of the patient, as well as 
potentially leading to treatment failure (B. Yu et al. 2010). There are several 
different types of chemotherapeutics currently used in clinic, which are varied 
depending on the type of cancer, these are summarised in table 1-1.  
 
Table 1-1: A summary of the various types of chemotherapeutics available 
for cancer therapy. 
 
			
Drug Type Examples Mode of Action 
Alkylating 
agents 
Cisplatins; 
Mitomycin C  
Cell-cycle independent drugs. Typically, 
these chemotherapeutics alkylate (bind) 
DNA bases leading to the cross-linking of 
DNA strands and/or proteins, eventually 
leading to single and double stranded DNA 
breaks, leading to apoptosis	 (Puyo et al. 
2014).  
Antimetabolites Methotrexate; 
pemetrexed. 
Cell cycle dependent. Small molecules that 
closely resemble critical metabolites and are 
capable of interfering with the normal 
function of metabolic enzymes including 
those involved in DNA, RNA and protein 
synthesis	 (Bobrovnikova-Marjon and Hurov 
2014). 
Anti-microtubule 
agents 
Vinca alkaloids 
(vincristine, vinblastine 
etc); taxanes 
(paclitaxel, docetaxel). 
Cell cycle specific (s-phase). Inhibit 
microtubule function causing mitotic arrest 
and subsequent apoptosis	 (Klute et al. 
2014). 
Topisomerase 
inhibitors 
Irinoteacan/topotecan 
(I);etoposide, 
doxorubicin, 
mitoxantrone, 
novobiocin, aclarubicin 
(II). 
Cell cycle dependent. Inhibit enzymes 
(topoisomerase I and II) involved in DNA 
unwinding, therefore DNA replication and 
transcription; leading to apoptosis	 (Khadka 
and Cho 2013).  
Cytotoxic 
antibiotics 
actinomycin, 
doxorubicin,  
epirubicin, 
mitoxantrone. 
Cell cycle dependent. Generally act to 
interrupt cell division by intercalating with 
DNA and preventing the resealing of the 
DNA double helix, triggering the apoptotic 
pathway	(Tahover et al. 2015) 
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1.1.2.3	Radiotherapy	
 
Radiotherapy is a type of cancer treatment that utilises focused radiation in order 
to kill cancer cells. The exposure of radiation in tissue leads to the ionisation of 
molecules and eventually, DNA damage (Minniti et al. 2012). Radiation energy can 
be absorbed directly, in vital cellular components such as membranes, organelles, 
and importantly, DNA, while indirect radiation absorption through the ionisation of 
water and oxygen molecules leads to the formation of free radicals, further 
disrupting DNA integrity and eventually leading to apoptosis (Baskar et al. 2012; 
Willers et al. 2013). Radiotherapy is utilised ubiquitously in a wide variety of 
cancers with around 50% of cancer patients expected to receive radiotherapy as a 
form of cancer treatment (Baskar et al. 2012). As with chemotherapy, radiotherapy 
poorly discriminates between normal functional cells and cancerous cells, with 
both cell types susceptible to radiation therapy. However these effects have been 
somewhat alleviated, due to the efficiency of DNA repair in normal cells, upon 
radiation exposure, thus providing a small therapeutic window for successful 
treatment (Begg et al. 2011). Furthermore, due to variations in the tumour 
microenvironment, cancer cells are often characterised in oxygen deplete states 
(hypoxia)	 (J. M. Brown 2007). As radiotherapy primarily relies on the increased 
production of free radicals to kill cancer cells, a low concentration of oxygen 
molecules thus translates to a lower concentration of free radical production, thus 
lowering the impact of radiation therapy on cancer cells leading to the 
phenomenon of radioresistance (Willers et al. 2013). 
 
1.1.2.4	Malignant	Hyperthermia	
 
Hyperthermia is defined as a rise in temperature within the body. When 
considered as a cancer therapy, the increase in temperature is induced 
intentionally and results in cell death. The potential for localised treatments that 
will produce fewer side effects, yet accurately and effectively target cancerous 
cells for destruction, has led to the renewed interest in hyperthermia. The term 
‘hyperthermia’ in a cancer setting refers to a variety of techniques that utilise heat 
to treat cancer.	 It is considered that there is no intrinsic difference between the 
hyperthermia sensitivity of normal and cancerous cells, however it has been 
demonstrated that hyperthermia can lead to specific cancer cell apoptosis, while 
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normal tissues remain undamaged even after treatment for 1 hour at a 
temperature of up to 44°C (van der Zee 2002). Normal cells appear to exhibit 
thermotolerance and recovery upon hyperthermia exposure compared to cancer 
cells.  However the susceptibility of cancer cells to hyperthermia is likely due to the 
actual biophysical nature of tumours themselves, rather than inherent differences 
between normal cell and cancerous cells (Behrouzkia et al. 2016; Hegyi et al. 
2013).	 This includes the disorganised and compact vascular structure often 
presented during tumour development, which leads to difficulty in dissipating heat, 
while healthy tissues can more easily maintain a normal temperature (Hegyi et al. 
2013). Additionally, tumour environments are often hypoxic and exhibit a low pH 
that contribute to their sensitivity to hyperthermia (van der Zee 2002). 
 
“Those who cannot be cured by medicine can be cured by surgery. Those who 
cannot be cured by surgery can be cured by fire. Those who cannot be cured by 
fire, they are indeed incurable.”—Hippocrates (479–377 B.C.). 
 
The concept of treating cancer cells using hyperthermia dates back at least 5000 
years	 (K. Ahmed et al. 2015a). Before any knowledge of the molecular basis for 
cancer, there was an understanding that unexpected mass or growth lesions could 
be burned off as a form of treatment; this concept of using heat for cancer 
treatment is being revisited and explored more appropriately as hyperthermia 
(Glazer and Curley 2011). 
 
The effectiveness of the technique is predominantly dependent on the temperature 
range and exposure time (Raaphorst and Feeley 1990). However recent studies 
have also shown that the method of heat application to cells/tumours is also a 
significant variable in treatment success (Burke et al. 2012; Hegyi et al. 2013).	
Indeed, the recent resurgence in hyperthermic treatment is attributed to the rapid 
development of technology, with the delivery of controlled thermal energy to 
tumours and cancer sites in the body in a non-invasive fashion.  
 
At present, hyperthermia is used as an adjunct to traditional cancer therapies such 
as chemotherapy and radiotherapy, as it further renders cancer cells more 
vulnerable to such treatments, thus increasing their effectiveness (R. D. Issels 
2008; Jacoba van der Zee et al. 2000). In the case of chemotherapy, a 
temperature-dependent enhancement has been documented, including increased 
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cellular uptake of chemotherapeutic drugs upon exposure to hyperthermia (R. D. 
Issels 2008; Miyahara et al. 1993). The denaturation of proteins and inhibition of 
DNA repair by heat were also shown to increase the efficacy of certain 
chemotherapeutic drugs (Z. G. Cui et al. 2014d; DeNardo and DeNardo 2008). 
Hyperthermia also increases the local blood and interstitial fluid flow to facilitate 
chemotherapeutic delivery into tumour sites (L. Li et al. 2014). Although the exact 
mechanisms of action for the increased efficacy observed in 
chemotherapy/hyperthermia still remains unclear, it has been proposed that 
hyperthermia may affect sodium/potassium-ATPase activity, transmembrane 
conductivity, glutathione metabolism and P-gp activity (Hildebrandt et al. 2002; Y. 
Tang and McGoron 2013). Despite this lack of knowledge, clinical trials do support 
the use hyperthermia in conjunction to chemotherapy (Chicheł et al. 2007; 
Colombo et al. 2011; R. D. Issels 2008).  
 
For radiotherapy treatments, hyperthermia has radiosensitising properties that 
render cancer cells more susceptible to radiotherapy through multiple 
mechanisms, including cancer cells deemed resistant to radiotherapy effects	
(Datta et al. 2015; Horsman and Overgaard 2007). For example, hyperthermia 
affects cells in S phase - a phase where radiation is less effective – this also holds 
potential to increase treatment potency. As aforementioned, tumour cells have low 
oxygen concentration and therefore the effect of radiation and the production of 
reactive oxygen species that leads to the downstream effect of apoptosis are 
limited. The addition of hyperthermia counters this hypoxic effect by increasing 
blood flow and its clinical application has been greatly explored (E. L. Jones et al. 
2005; Kampinga and Dikomey 2001; Mallory et al. 2015; Zagar et al. 2010). 
However as explained previously, both chemotherapy and radiotherapy have 
challenging side effects for the patient and this has led to hyperthermia being 
evaluated as a sole mediator for cancer cell apoptosis, where it is being explored 
as a viable therapeutic alternative in its own right.  
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1.2 Hyperthermia at the Molecular Level  
 
A number of reviews have outlined the significant effects of hyperthermia on cells 
both in vitro and in vivo (M. Ahmed and Douek 2013; DeNardo and DeNardo 2008; 
Mallory et al. 2015). Broadly, hyperthermia has a variety of effects at both the 
cellular and molecular level as summarised in figure 1-1, which can inhibit cancer 
cell growth, function and ultimately viability, by promotion of apoptosis (Hildebrandt 
et al. 2002; C. H. Hou et al. 2014a).  
 
1.2.1 Apoptosis 
 
Apoptosis is an essential process and has multiple functions in ontogenetic 
development and tissue remodeling (Kerr et al. 1972). There are two major protein 
families that regulate apoptotic pathways; the caspase family and the Bcl-2 family. 
Once activated, these molecules determine the fate of the cell. Caspase proteins 
are a group of cysteine-aspartic proteases that either falls into the subcategories 
of pro inflammatory caspases (caspase -1, -4, 5 and 12), initiator caspases 
(caspase -2, -8, -9 and -10) and executioner caspases (caspase -3, -6 and -7) (D. 
R. McIlwain et al. 2013a; Perez-Hernandez et al. 2015). The caspase family thus 
provides critical links in cell regulatory networks and are integral components in 
supervising inflammation and cell death	(David R. McIlwain et al. 2013b). Caspase 
proteins are enzymes produced by cells as inactive zymogens	 (Shi 2004). The 
activation of caspase proteins are tightly controlled by the inactivation or activation 
of substrates and signalling events promoting their aggregation into dimers or 
macromolecular complexes, leading to their catalytic activation and the 
downstream	 demolition of cellular components and finally, apoptosis (David R. 
McIlwain et al. 2013b). 
 
The Bcl-2 proteins (B-cell lymphoma 2) are believed to negotiate whether the cell 
commits to apoptosis or aborts the process (Elmore 2007). It is thought that the 
main mechanism of action of the Bcl-2 family is the regulation of cytochrome c 
release from the mitochondria via alteration of mitochondrial membrane 
permeability. The Bcl-2 family therefore govern mitochondrial membrane 
permeability and can be either pro-apoptotic or antiapoptotic. Bcl-2 proteins thus 
regulate the permeabilisation of mitochondria, which leads to the activation of the 
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downstream caspase cascade events (J. H. Zheng et al. 2015). The Bcl-2 family is 
subdivided into pro-apoptotic proteins (e.g. Bak, Bax, Bid, Bim, Noxa, PUMA) and 
anti apoptotic proteins (e.g. Bcl-2, Mcl-1, Bcl-XL, etc) (Adams and Cory 2007). 
 
1.2.2 Mitochondrial Stress 
 
Hyperthermia has been shown to compromise the permeability of the 
mitochondrial membrane,	 although the exact mechanisms have not been fully 
realised (Z. G. Cui et al. 2014c). Caspase 2 has been shown to become active 
after hyperthemic exposure and once active can cleave and activate the pro-
apoptotic protein Bid	 (Bonzon et al. 2006).  The active Bid subsequently 
compromises mitochondrial permeability, leading to the release of a variety of 
proteins including cytochrome c into the cytosol, which disturbs the homeostasis of 
additional pro- and anti- apoptotic, Bcl-2 proteins (Bonzon et al. 2006; Saelens et 
al. 2004). Cytochrome c can also be released from the mitochondria via Bax 
activation in response to various death stimuli. Here, Bax undergoes a 
conformational change and consequently translocates to the mitochondria, leading 
to the eventual release of Cytochrome c (X. Yang et al. 2012a). Cytochrome c 
then interacts with the pro-caspase 9 on the scaffold protein, Apoptotic protease 
activating factor 1 (Apaf-1) and deoxyadenosine triphosphate (dATP) to form an 
apoptosome, leading to the activation of pro-caspase 9. This activation can initiate 
caspases that can then cleave and activate executioner caspases -3, -6 and -7. 
Executioner caspases are capable of cleaving critical proteins and leading the cell 
towards apoptosis (Adams and Cory 2007). Hyperthermia has also been reported 
to lead to the oligomerization of Bax and/or Bak. This conformational change leads 
to pore formation on the outer mitochondrial membrane and thus, the subsequent 
release of cytochrome c and the associated downstream effects (Pagliari et al. 
2005; Subburaj et al. 2015). 
 
1.2.3 Reactive Oxygen Species  
 
Apoptosis can also be induced by an increase in reactive oxygen species (ROS) 
(Chun et al. 2010; Slimen et al. 2014; Z. Wang et al. 2013c).	ROS are by-products 
generated during oxygen metabolism within mitochondria. An overproduction of 
ROS can stimulate oxidative stress and damage macromolecules, proteins, lipids 
and DNA (Ott et al. 2007). Antioxidant systems help neutralise ROS generation, 
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however a strong imbalance between antioxidants and elevated ROS 
concentration, upon hyperthermic exposure, can render the cell defenceless to the 
effects of oxidative stress (C.-H. Hou et al. 2014b; Mari et al. 2009).  Hyperthermia 
has been demonstrated to cause an increase in ROS in the form of hydrogen 
peroxide, superoxide anion and hydroxyl radical	 (Kikusato and Toyomizu 2013; 
Mujahid et al. 2006; Slimen et al. 2014).	 Hyperthermia has also been shown to 
decrease crucial antioxidant levels such as superoxide dismutase, thus promoting 
the cell into apoptosis (El-Orabi et al. 2011). 
 
1.2.4 Cellular Damage 
 
The morphological changes of mammalian cells exposed to hyperthermia have 
been well documented (Andocs et al. 2016; Luchetti et al. 2002; Villanueva et al. 
2010; Vlad et al. 2010; Vlad et al. 2013; Welch and Suhan 1985). Hyperthermia 
has been demonstrated to cause disruption and fragmentation of the Golgi 
complex – an essential organelle involved in lipid and protein intracellular and 
extracellular transport as well as lysosome formation in response to hyperthermic 
temperatures (Welch and Suhan 1985). The cytoskeleton microtubule 
polymerisation can also be directly altered by hyperthermia, compromising not 
only the integrity of the cell, but also cell proliferation through the lack of mitotic 
spindle structure, a crucial component to chromosome alignment during mitosis 
(S. H. Huang et al. 1999). 
 
Perhaps the most damaging cellular effect of hyperthermia is the resultant 
unfolding and aggregation of proteins (J. L. Roti Roti 2008a). Hyperthermia can 
denature proteins, leading to the exposure of hydrophobic regions in polypeptides 
that can engage non-specific intermolecular interactions with additional proteins, 
promoting the aggregation of various proteins. This not only inhibits their function 
but can also have a consequential effect on cell function and viability at a 
molecular level (Taipale et al. 2010).  
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Figure 1-1: Cellular damage initiated by hyperthermia (adapted from Rangel 
et al., 2013). 
 
 
1.3 Thermotolerance and Heat Shock Proteins 
 
The direct impact of hyperthermia on cells is dependent on temperature levels and 
exposure times.  However cells do maintain a form of thermotolerance, allowing 
the cell to resist heat stress and this is strongly associated with an increase in heat 
shock protein expression (Hsp)	 (H.-Y. Wang et al. 2013a). Hsps are a specific 
family of proteins produced by cells in response to stressful conditions that govern 
resistance to heat, as well as other environmental insults such as UV exposure 
and cold environments. Hsps both assist in the recovery of the cell and inhibit 
apoptosis (Yanting Cui et al. 2013; Kalmar and Greensmith 2009; Lanneau et al. 
2008b). Hsps are found in various locations in the cell, including the endoplasmic 
reticulum, lysosomes, and the mitochondria, but are predominantly concentrated in 
the cytosol and nucleus (Venojärvi et al. 2013). Although continually expressed at 
basal levels in cells, Hsps are induced and up regulated in response to cellular 
stress and have various functions in order to recreate a homeostatic environment 
and thus preserve the cell. 
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Hsps are highly conserved and ubiquitous in all organisms, from plants, bacteria 
and animals (Jolly and Morimoto 2000). In mammalian cells, five major Hsps exist; 
these highly conserved proteins are grouped accordingly based on their molecular 
weight and further subdivided to large ATP dependent Hsp110, Hsp90, Hsp70, 
Hsp60 and small ATP independent Hsps (15–30 kDa) including Hsp27. Hsps are 
also overexpressed in cells exposed to environmental insults such as oxidative 
stress (Y. Cui et al. 2014a), heavy metals (B. M. Kim et al. 2014) and inflammation 
(Batulan et al. 2016). The heat shock response was first demonstrated in 1962 
and since this original report, many groups have investigated Hsps for their 
function in normal cell viability, in particular, protein synthesis and management as 
well as associated pathologies (Adachi et al. 2009; Ou et al. 2014; Venojärvi et al. 
2013).  
 
Hsps have various roles but predominantly function as “molecular chaperones” 
aiding in the maintenance of protein homeostasis and protein quality control (C.-J. 
Park and Seo 2015). Hsps are capable of repairing and refolding denatured 
proteins, which have exposed hydrophobic residues that can lead to protein miss 
folding and aggregation with other proteins. Hsps are also fundamental for the 
destruction of misfolded/dysfunctional proteins, binding and guiding them for 
destruction via ubiquitination or lysosomal degradation (Bozaykut et al. 2014).  
 
Hsps are synthesised in response to cell stress, and are transcriptionally regulated 
to produce a rapid response, occurring within minutes of cell stress, such as 
elevated temperature exposure (Åkerfelt et al. 2010; K. J. Kelly et al. 2001). In 
response to hyperthermic stress, the inactive complex of Hsp and heat shock 
factor 1 (HSF1) dissociates, with the former able to bind to denatured proteins. 
HSF1 meanwhile can trimerise with other free HSF1 within the cytoplasm and 
translocate into the nucleus. Once in the nucleus the trimeric HSF1 complexes can 
bind to heat shock elements (HSE), which are specific DNA sequences in the heat 
shock gene promoters. Once bound to DNA, HSF1 becomes phosphorylated, 
thereby initiating the transcription and translation of Hsps, as shown in figure 1-2 
(Horowitz and Robinson 2007; Kalmar and Greensmith 2009; Stetler et al. 2010; 
Venojärvi et al. 2013).  
 
The response times of these events have been well documented with Boehm et al, 
2003 showing the rapid activation of Hsp70 in drosophila flies within minutes from 
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heat shock stimuli in vivo (Boehm et al. 2003).	As the synthesis of Hsps increases, 
Hsp70 localises to the nucleus and inactivates HSF1 leading to dissociation of 
trimmers back to their inert monomeric state, thereby repressing Hsp gene 
transcription	 (Santoro 2000). Of these Hsps, Hsp -90, -70, and -27 have been 
predominantly demonstrated to increase expression in response to hyperthermia	
(Sajjadi et al. 2013; Samali et al. 2001; Tedeschi et al. 2015). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-2: Activation of the heat shock response. Hyperthermia leads to the 
denaturation of proteins, and the dissociation of Hsp and HSF-1. Hsps begin 
refolding damaged proteins while free HSF-1 monomers, trimerise and 
become activated and translocate to the nucleus, binding to the heat shock 
element (HSE) located on the genes of Hsps. The activation of HSE mediates 
the upregulation of Hsps, orchestrating thermotolerance (personal image).  
 
1.3.1 Hsp90 
 
The importance of Hsp90 is apparent, due its highly ubiquitous and conserved 
nature within all kingdoms of life, with the exception of archaea (Taipale et al. 
2010). Hsp90 is a large dimeric protein found in almost every compartment of 
eukaryotic cells and has a range of functions including cell signalling, myelination 
of neuronal cells and predominantly, acting as chaperones for steroid and 
hormone receptors (Taipale et al. 2010; Tedeschi et al. 2015). Hsp90 relies on 
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ATP activity in order to fold proteins and is particularly aimed at a set pool of 
proteins involved in cell signalling, but in contrast to other Hsps, Hsp90 is 
responsible for maintaining proteins in a functional folded state rather than binding 
unfolded proteins and preventing aggregation (Karagoz and Rudiger 2015). Its 
chaperone activity has been shown to be dependent upon the interaction of a 
network of proteins or co-chaperones as well as an interaction with Hsp70, where 
Hsp70 members deliver protein substrates to the Hsp90 and co-chaperone 
complex (Richter et al. 2010). Although a comprehensive understanding of this 
process remains yet to be fully realised, several recent studies have demonstrated 
hyperthermia inducing Hsp90 expression	(Eng et al. 2014; Kalamida et al. 2015; T. 
Miyagawa et al. 2014a).	 
 
1.3.2 Hsp70  
 
The most widely understood heat shock family member, Hsp70 has been 
extensively studied in diabetes	 (Barbosa-Sampaio et al. 2015), chemo-resistance 
(Stope et al. 2016), radio-resistance	 (Lauber et al. 2015) as well as its possible 
role in the pathogenesis of various diseases such as inflammatory bowel disease	
(Samborski and Grzymislawski 2015). Hsp70 is highly conserved and ubiquitous in 
most prokaryotes and eukaryotes and has been heavily investigated for its role in 
cell thermotolerance for a number of years	 (Beckham et al. 2004; De Maio 2014; 
Jolesch et al. 2012; Manjari et al. 2015; Marquez et al. 1994; Sharma and Masison 
2009). The role of Hsp70 is clearly established under normal physiological 
conditions and involves the facilitation of protein synthesis, protein translocation, 
and protein homeostasis. During cellular stress Hsp70 is accountable for protein 
refolding and preventing protein aggregation,	thus protecting the cell against heat-
induced apoptosis (Bozaykut et al. 2014).  Hsp70 is possibly the most well known 
Hsp, known to be induced by minimum increases in temperature; a recent 
publication by Dangi et al (2014) demonstrated high Hsp70 protein expression 
compared to other Hsps in heat shocked barbari goats	(Dangi et al. 2015).  
 
The mechanistic chaperone activities of Hsp70 have been well characterised	
(Duncan et al. 2015). The ATP dependent chaperone is capable of binding to 
target proteins through its substrate-binding domain (SBD) while its affinity is 
grossly determined by the presence of either ATP (low substrate affinity) or ADP 
(high substrate affinity)	 (Clerico et al. 2015). The high versatility of Hsp70 allow it 
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to interact with nearly all proteins in their unfolded, misfolded, or aggregated states 
(Mayer 2013). Besides its protein homeostatic functions, Hsp70 has also been 
demonstrated to directly interact with members of the Bcl-2 family and can inhibit 
the activity of Bax proteins, resulting in the inhibition of apoptosis (X. Yang et al. 
2012a). Hsp70 has also been credited with the inhibition of the caspase pathway, 
the JNK stress signalling pathway, apoptosome formation and AIF (Apoptosis 
inducing factor) release, thus encouraging cell survival, as shown in figure 1-3 
(Evans et al. 2010).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-3: Pathways inhibited by Hsp70 to prevent apoptosis via 
hyperthermia. Hyperthermia leads to the activation of pro-apototic 
molecules orchestrated by the activation of the JNK pathway leading to the 
downstream release of cytochrome c and AIF. Hsp70 inhibits JNK activation, 
apoptosome formation and AIF activation, which are all integral components 
to the apoptosis pathway, thus preserving cell viability (personal image). 
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1.3.3 Hsp27  
 
Hsp27 is typically expressed at low basal levels within the cytosol of human cells	
and	 studies have shown that overexpression of Hsp27 protects cells from 
subsequent stress (Bechtold and Brown 2000; Rylander et al. 2010). Unlike the 
larger Hsps, Hsp27 is an ATP independent chaperone and has the capacity to be 
phosphorylated and oligomerise to form complexes up to 1000 kDa	 (Jego et al. 
2013; X. Wang et al. 2014b). The state of the oligomerisation appears to be 
significant to its cellular functions, with larger oligomers associated with anti-
oxidant properties by modulating ROS via the glutathione-dependent pathway and 
displaying potent chaperoning function (Rylander et al. 2010).  Smaller oligomers 
are known to play a role in favoring the ubiquitination and degradation of selected 
proteins under stress conditions as well as stabilising actin filaments (Jego et al. 
2013). Hsp27 has been shown to interact with and to inhibit key apoptotic proteins 
and is also involved in the negative regulation of cytochrome c (Bruey et al. 2000). 
A study by Bruey et al (2000) indicated that Hsp27 binds to cytochrome c released 
from damaged mitochondria and inhibit its interaction with Apaf-1 and procaspase-
9, thus preventing the formation of the apoptosome and the downstream activation 
of executor caspases (Samali et al. 2001). Hsp27 expression during hyperthermia 
has been evaluated both in vitro (Samali et al. 2001) and in vivo (Madersbacher et 
al. 1998) with Rylander et al (2010) observing the expression levels of Hsp27 
almost double that of Hsp70 at various hyperthermic profiles in prostate cells 
(Rylander et al. 2010). 
 
1.4 Nanomedicine  
 
Nanotechnology is the understanding and manipulation of matter at dimensions 
between approximately 1 and 100 nanometres. At these dimensions, materials 
produce unique phenomena that enable novel applications that have been 
fundamentally explored in areas of research and medicine. This exploaration has 
opened the relatively new field of nanomedicine, dealing with the detection, 
control, construction, repair, defence and improvement of all human biological 
systems (Boisseau and Loubaton 2011). The use of nanotechnology is not a new 
concept; indeed evidence suggests the use of nanocrystal-containing hair dyes by 
Egyptians, Greeks and Romans (Cole et al. 2011a). However it was not until 1959 
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when renowned physicist Richard Feynman presented his talk ‘There’s plenty 
room at the bottom’ where he discussed the possibilities and potential benefits of 
the manipulation of materials at the atomic level. This led to discussions with his 
peers about how we could begin ‘manipulating and controlling things on a small 
scale’. At its core, nanotechnology involves materials that have arrangements and 
structures of atoms at the nanoscale, whereby they display enhanced quantum 
level phenomena (Cherukuri et al. 2010). 
 
It has however, only been in the last three decades that researchers have begun 
to understand and subsequently exploit the unique properties materials 
demonstrate at the nanoscale (Sainz et al. 2015).	 In recent years, the field of 
nanotechnology has broadened to include expertise from material science, cell 
biology, chemistry, physics, engineering, computing, electronics energy, and 
biomedicine (Cherukuri et al. 2010).  
 
The application of nanotechnology within medicine has been termed 
‘nanomedicine’ (Rizzo et al. 2013), with a particular emphasis of nanosystems 
designed for therapeutics, diagnostics, and imaging (Boisseau and Loubaton 
2011; Langer and Weissleder 2015). Nanoscale particles, or nanoparticles (NPs), 
can be synthesised to a size compatible with biological molecules such as proteins 
and nucleic acids, as shown in figure 1-4, and can thus be appropriately 
developed for use as potential probes, delivery platforms, carriers and devices 
giving unique opportunities for improvements in disease detection, therapy and 
prevention (S. Tong et al. 2014). Furthermore, NPs can ultimately improve the 
pharmacokinetic and pharmacodynamic profiles of established and characterised 
therapeutics, making them very attractive vehicles for traditional anti-cancer 
compounds (Wicki et al. 2015). Indeed, nanomedicine has led to recent 
developments of nanoparticle-carriers for drug/gene delivery (W. Gao and Zhang 
2015; Look et al. 2015), imaging (Mu et al. 2016), and theranostics (diagnostics 
and therapeutics) (S. Tong et al. 2014).   
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Figure 1-4: Scale of materials in nanometer range Image adapted from 
WhichLab; http://www.wichlab.com/research). 
 
1.4.1 Nanoparticles  
 
Nanoparticles (NPs) are generally considered to be microscopic particles with at 
least one dimension less than 100 nm (Cole et al. 2011a).  NPs offer a unique 
advantage over traditional therapies as recent advances in nanotechnology allow 
researchers to synthesise NPs with dual modalities – integrating diagnostic as well 
as therapeutic capabilities within a single NP formulation (K. S. Kim et al. 2016b; 
Mieszawska et al. 2013; J. Park et al. 2015). Therefore, NPs hold great promise 
for theranostic purposes, and are considered to be highly applicable for 
personalising nanomedicine-based treatments. 
 
NPs are organic or inorganic in nature, with the latter often being implemented in 
nanotechnology, in particular nanomedicine as they offer unique inherent 
properties (Anselmo and Mitragotri 2015). Examples of both are shown in figure 1-
5. Inorganic NPs can be synthesised via bottom-up or top-down approaches, 
however bottom-up apporaches allow for a large degree of flexibility and control of 
size distributions (nm to µm scale), surface chemistry and physical properties the 
materials may infer; synthesis typically favours a co-precipitation technique, 
especially in the case of magnetic nanoparticle synthesis (Santhosh and Ulrih 
2013). The most popular method for gold nanoparticle synthesis involves the 
reduction of HAuCl4 (tetrachloroauric acid, TCCA) by reducing agents. This citrate 
reduction method was developed by Turkevich et al (1954) and later adapted by 
Fresn (1973) to produce comparatively monodisperse particles with a controlled 
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average equivolume diameter (Khlebtsov and Dykman 2010). Inorganic NPs, such 
as iron oxide and gold, are extensively investigated in both preclinical and clinical 
studies for the treatment, diagnosis, and detection of diseases (Anselmo and 
Mitragotri 2015).  
 
Figure 1-5. Examples of various types of inorganic and organic NPs that 
have been explored for their potential in nanomedicine (taken from (Xing et 
al. 2014)). 
 
Nanomedicine is a rapidly growing research field, involving the use of advanced 
NP design and functionalisation (Chang et al. 2015; Doane and Burda 2012). 
Currently, NPs are being explored as possible agents for drug	 (R. Singh and 
Lillard 2009), gene	 (G. Lin et al. 2015) and antibiotic	 (A. N. Brown et al. 2012) 
delivery due to their nano-scale size, and unique properties allowing for the 
capacity to cross natural barriers and interact with biomolecules in the blood, 
organs, tissues or cells	(Chang et al. 2015). The use of NPs as delivery agents is 
promising due to the multivalent properties NPs can exhibit, allowing NPs to 
deliver therapeutic payloads to target sites via ligand or antibody targeting	 (S. 
Kumar et al. 2008; R. Singh and Lillard 2009). NPs have also been explored as 
multifunctional agents with Hao and co-workers recently developing magnetic 
nanoparticles that were used as both contrasting agents for MRI and hyperthermia 
(R. Hao et al. 2013). More sophisticated NP synthesis have also been explored, 
producing multivalent NPs that express various ligands capable of interacting with 
specific receptors on targeted cells and increasing their internalisation into cells, 
compared to traditional NPs expressing a monovalent system	 (Avvakumova et al. 
2014). 
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1.4.2 Nanoparticles In Vivo 
 
When using NPs in vivo, as with any biomaterial, there are several immediate 
challenges, such as the host immune system. The immune system helps preserve 
and maintain tissue homeostasis by protecting the host from foreign environmental 
insults such as microbes and chemicals (Dobrovolskaia et al. 2016). NPs 
administered into the bloodstream are identified and subsequently coated by 
various components of the complement system, namely in the form of plasma 
proteins such as opsins, as indicated in figure 1-6 (Chaudhari et al. 2012). The 
NPs coated with these opsins are effectively ‘marked’ for recognition by the 
reticulo-endothelial system (RES). The RES is a diffusion system composed of 
phagocytic cells derived from the connective tissue framework of the liver, spleen 
and lymph nodes	(Berry 2005). Opsonisation aids the process of phagocytosis and 
thus the destruction of the NPs, it is therefore imperative for researchers to 
develop NP systems that can resist or avoid opsonisation and therefore avoid the 
cascade of events that can lead to the destruction of NPs although complete 
avoidance of the RES is still yet not possible. 
 
 
Figure 1-6: The fate of administrated NPs in vivo. NPs are coated by blood 
proteins (2) and sequestered by macrophages (3) upon opsonisation and are 
transported to the liver to be further metabolised and phagocytised (4). 
(Taken from (Jokerst et al. 2011)). 
 
There are two major routes for administration of NPs;  intravenously, where the 
blood circulation is used to transport the particles throughout the body, or directly 
injected into the tissue/organ of interest, where pressure gradients from blood 
vessels are assumed to aid diffusion to tissue spaces	(De Jong et al. 2008; Soni et 
al. 2014). First generation NPs aimed towards tumour therapy are designed 
without active targeting systems and instead rely on ‘passive targeting’ where 
systemically circulating NPs penetrate the leaky vasculature and poor tissue 
architecture often associated with tumours and accumulate due to slow clearance 
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from poor lymphatic drainage, a cumulative consequence termed the enhanced 
permeability and retention (EPR) effect	 (Cheng et al. 2015; Maeda et al. 2013; 
Ngoune et al. 2016; Soni et al. 2014).			
To maximise the EPR effect, NPs must be biocompatible within the bloodstream 
and must also avoid accumulation within the spleen and liver. The surface 
morphology, surface chemistry, charge and hydrophobicity are all important 
factors that influence NP pharmacokinetics, biodistribution and overall in vivo 
performance . For example, hydrophilic surfaces tend to resist opsonisation and 
are thus cleared slowly as opposed to hydrophobic surfaces, which are efficiently 
coated with plasma components and removed from the circulation at a faster rate 
(Shah et al. 2013). With regards to NP charge, negatively charged and neutral 
NPs are more biocompatible compared to their positively charged counterparts 
due to less protein binding in the blood (Duskey and Rice 2014).  NP size 
distribution and shape are also known to influence NP fate in terms of RES 
uptake, renal clearance and blood half-life with larger NPs (~100 nm) considered 
an optimal range for leveraging the EPR effect and minimising clearance in 
spherical NPs	 (Ernsting et al. 2013; S.-D. Li and Huang 2008). While more 
sophisticated geometries, such as rods and stars have shown to enhance 
circulation time compared to traditional spherical NPs	(Ernsting et al. 2013; Toy et 
al. 2014). 
 
In order to produce the optimum NP performance in vivo, the particles are 
sterically stabilised with either an inorganic or organic coating material, to increase 
their biocompatibility. The most commonly used coating materials to date are in 
the form of derivatives of polyethylene glycol (PEG)	 (Muhammad et al. 2016), 
dextran	(Peng et al. 2015), as well as amphiphilic molecules such as fatty acids or 
phospholipids (S. J. Soenen et al. 2009). PEG and dextran polymers in particular 
have been shown to prolong half-blood circulation times by inhibiting opsonisation 
(Inturi et al. 2015; Suk et al. 2016); coating NPs therefore effectively produces 
‘RES-evading’ particles.  
 
New generations of NPs have since been produced with ‘active targeting’ systems 
in the form of ligands	 (van der Meel et al. 2013), antibodies (M. Ahmed et al. 
2015c), peptides and polysaccharides, as well as specific cell surface receptors 
(Shah et al. 2013). Researchers therefore design NPs with increased blood half-
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life, which can avoid RES interaction and have a high specificity to target sites to 
increase particle accumulation.  
 
1.4.3 Nanoparticles in Cancer Hyperthermia 
 
Although hyperthermia is a highly regarded therapeutic alternative for cancer 
treatment, previous attempts before the intervention of NP-assisted hyperthermia, 
have produced partially satisfactory results	(K. Ahmed and Zaidi 2013). One of the 
crucial factors limiting the use of hyperthermia for clinical use is the means of heat 
delivery to tumours within patients. Traditional hyperthermia typically involves an 
external heating source that generates considerable temperature gradients from 
the external source to the tumour with the maximum heat dissipated on the body’s 
surface that dramatically decreases with distance from the heating source 
(outside-in hyperthermia) (Beik et al. 2016). Typically this traditional form of 
hyperthermia means the majority of energy is dissipated in the healthy tissues 
situated along the path of external radiation which can have toxic affects while also 
not providing adequate thermal energy within tumours to cause cell death (Beik et 
al. 2016). The use of NPs has helped alleviate these limitations as they act as the 
primary heating source and can be intravenously targeted into tumours, while also 
reversing the direction of heat loss, generating the necessary heating profiles (42-
45°C) within tumours and providing minimal damage to the surrounding tissue as 
the thermal energy dissipates from the tumour (inside-out hyperthermia) (Banobre-
Lopez et al. 2013; Beik et al. 2016).  
 
To be an effective candidate for NP-assisted cancer hyperthermia, NPs must 
exhibit low toxicity, ease of functionalisation, suitable biocompatibility and uptake 
into cells and importantly, able to generate efficient heating profiles upon exposure 
to an external non-invasive heating source (Banobre-Lopez et al. 2013; 
Ganeshlenin Kandasamy and Maity 2015b). Of the plethora of NPs that have been 
investigated for hyperthermia, both gold nanoparticles and magnetic nanoparticles 
have been proposed as the ideal candidates due to their low toxicity and inert 
nature in their inactive states, while their high conversion of energy into heat upon 
external laser exposure and external alternating magnetic field respectively, has 
placed them at the forefront for cancer hyperthermia (Chatterjee et al. 2011; 
Cherukuri et al. 2010; Curry et al. 2014; Giustini et al. 2010; Ingrid Hilger 2013). 
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1.5 Gold Nanoparticles  
 
The synthesis of Gold nanoparticles (GNPs) was first reported more than 150 
years ago however their resurgence in the last few decades has occurred due to 
the increased development, knowledge and functionalisation, thereby opening up 
opportunities to enhance and optimise their potential and breadth of their 
applicability (Alex and Tiwari 2015). In more recent years, GNPs have been 
investigated for use as drug/gene delivery carriers and diagnostics agents 
(Robinson et al. 2015). GNPs have also been investigated for cancer hyperthermia 
due to their unique optical properties when exposed to visible- near infrared (NIR) 
wavelengths (Wei et al. 2013), where they are capable of efficient conversion of 
light energy into heat, which is quickly dissipated into the environment. Over the 
past decade, researchers have concentrated on improving GNP design for 
hyperthermic treatments, focusing on varying particle shapes such as rods, cubes, 
stars, and prisms to promote GNP light absorption and thus heat generation	
(Dykman and Khlebtsov 2011). 
 
There have been several advances in GNP synthetic processes, in particular the 
ubiquitous and simple citrate reduction method, which allows controllable GNP 
sizes at high throughput and narrow size distributions (X. Huang and El-Sayed 
2010). The use of various coating agents to further increase the biocompatibility of 
an already deemed inert GNP core includes a variety of organic self-assembled 
monolayers (SAMs) (e.g. thiolates, dithiolates, amines, carboxylates, cyanides, 
isothiocyanates, phosphines, etc.) (Connor et al. 2005; Krpetic et al. 2010; Love et 
al. 2005; X. Wu et al. 2013). Other biomolecules have also been used to increase 
GNP biocompatibility including, transferrin, lipids, sugars such as dextran, and 
polymers such as PEG (Dickerson et al. 2008; I. H. El-Sayed et al. 2006; J. L. Li et 
al. 2009; Nikoobakht 2003; Beatriz Pelaz and del Pino 2012; Pissuwan et al. 2006; 
Vankayala et al. 2014). These molecules are capable of easily decorating GNPs 
due to their highly reactive surface chemistry. GNP surfaces can subsequently be 
further functionalised to allow for increased biocompatibility, targeting and uptake 
(Bastus et al. 2007; I. H. El-Sayed et al. 2006; Melancon et al. 2008; Pissuwan et 
al. 2006). 
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These physiochemical properties make them an attractive candidate for 
nanomedicine applications, however is it the increased understanding in the last 
decade of GNP tunable optical properties that has propelled them to the forefront 
of cancer hyperthermia as photothermal agents. Photothermal therapy is 
essentially the killing of cells by local hyperthermia, achieved by converting optical 
energy into thermal energy upon irradiation with light (P. M. Tiwari et al. 2015b). 
GNPs are efficient converters of light energy into heat, making them promising 
agents for targeted photothermal effects, while also offering real time diagnostics 
as imaging agents, therefore making them ideal agents for cancer hyperthermia 
(X. Huang and El-Sayed 2010, 2011; H. Liu et al. 2012; M. Singh et al. 2015).  
 
1.5.1 Photothermal Properties Of Gold Nanoparticles 
 
GNPs within the size range 10–100 nm, undergo a plasmon resonance with light 
exposure which leads to surface plasmon resonance (SPR) (Pissuwan et al. 
2006). SPR occurs when free electrons oscillating on the surface of the GNPs 
interact with electromagnetic fields in the form of photons at specific angular 
momentum and frequency, as shown in the simple schematic in figure 1-7 (Huang 
et al. 2009). This leads to a collective oscillation of electrons on the surface of the 
GNP, which greatly increases absorption, or scattering of the photons (Dreaden et 
al. 2011). Surface plasmon absorption occurs rapidly, dissipating absorbed energy 
into the environment via eventual phonon–phonon relaxation that results in highly 
localised heat generation (X. Huang and El-Sayed 2010). GNP size and shape are 
very important factors in determining the absorbance cross-sections and 
wavelength interaction. Smaller particle sizes (~30 nm) cause absorption at 
shorter wavelengths while larger particles shift absorption to longer wavelengths 
and increases the ratio of scattered versus absorbed light (K. L. Kelly et al. 2003; 
Link and El-Sayed 2003). 
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Figure 1-7: A simplified schematic depicting localized surface plasmon 
resonance (SPR) of gold nanoparticles due to collective oscillation of 
surface electrons with incident light at a specific wavelength (personal 
image). 
 
Researchers exploit this SPR phenomenon for cancer hyperthermia. By actively 
controlling GNP size, they are able to produce GNPs with peak optical absorption 
cross sections in the near infrared regions (NIR) (Khan et al. 2013; N. G. 
Khlebtsov and Dykman 2010; Kevin L. Shuford et al. 2005b). NIR spectrum 
between 750 and 1300 nm provides a ‘biological window’ for optical absorption 
through tissue (while shorter and longer wavelengths are attenuated by biological 
entities such as hemoglobin, pigments, and water) (R. Weissleder 2001a). NIR 
wavelengths allow for maximum tissue depth penetration without causing 
significant damage to normal cells (J. Park et al. 2015). The dispersion of heat 
energy may also be released through photoacoustic effects, if the rate of heat 
absorption is much faster than the relaxation rate. In this instance, GNP surfaces 
may exceed many hundreds of degrees leading to cavitation effects and the 
formation and collapse of microbubbles that can release mechanical shockwaves, 
which can rupture cell membranes as well as other acoustic associated damage 
(Lapotko et al. 2006; Wei et al. 2013). Several recent in vitro and in vivo studies 
have demonstrated the potential for GNP hyperthermia via laser irradiation with a 
plethora of GNP sizes, geometries and functionalisation	 (Y. Y. Bai et al. 2014b; 
Choi et al. 2011; Robinson et al. 2015). 
 
	27	
1.5.2 Gold Nanoparticle Size and Shape Influences Optical Properties  
 
The application of GNPs for photothermal therapy via laser irradiation does have 
several shortcomings. In order to synthesis GNPs that have optical absorption 
towards the NIR region, particles have to be synthesised at a fairly large size 
distribution, however the increase in size directly correlates to light scattering and 
absorption ratios. Therefore, GNPs over 40 nm begin to display light scattering 
characteristics while GNPs over 80 nm diameter the extinction is contributed by 
both absorption and scattering at similar ratios (X. Huang and El-Sayed 2010). 
More recently large GNPs (~80 nm) have been identified for use as strong 
contrast agents due to their high scattering efficiency	(P. K. Jain et al. 2006). Gold 
nanospheres in the size range commonly employed (40 nm) show absorption 
cross-section 5 orders higher than traditional dyes, while the magnitude of light 
scattering by 80 nm gold nanospheres is 5 fold higher than the light emission from 
fluorescing markers. The variation in the plasmon wavelength maximum of 
nanospheres, i.e., from 520 to 550 nm, is however too limited and reserved for 
more in vitro studies (Panchapakesan et al. 2011).  
 
For photothermal treatment to be fully realised, GNPs must be able to efficiently 
absorb light energy in the NIR region, however as described above, this involves 
increasing the size of GNPs. Increasing the size of GNPs has a negative impact 
on absorbance efficiency, with light energy predominantly scattered rather than 
absorbed, thus yielding a lower heating output that can not be effectively used for 
the purpose of hyperthermia	(Ivan H. El-Sayed et al. 2005; P. K. Jain et al. 2006). 
Due to the limitations of spherical GNPs, as described above, researchers began 
investigating the effects of GNP shape on light absorption and scattering, in order 
to synthesis GNPs that have optical light absorbance in the NIR region, suitable 
for laser therapy with low scattering and high absorbance to induce hyperthermia 
(Hua et al. 2015; Jihye et al. 2011). The more sophisticated geometries have 
included gold nanorods and gold nanoprisms, which have shown great potential as 
hyperthermic agents	(Mackey et al. 2014; J. E. Millstone et al. 2005; B. Pelaz et al. 
2012; Jing Wang et al. 2012a).	
 
 Nanorods are cylindrically shaped GNPs containing two distinct plasmon bands	
(Lakhani et al. 2015). This SPR spectrum split produces a stronger long-
wavelength band in the NIR region due to the longitudinal oscillation of electrons, 
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and a weaker short-wavelength band in the visible region around 520 nm due to 
the transverse electronic oscillation correlating to the length and width of the 
nanorods (X. Huang et al. 2008). The absorption spectrum of gold nanorods is 
dictated by the aspect ratio (length/width) of rods, a feature that can be 
manipulated by researchers to produce highly absorbing or scattering GNPs. By 
increasing the nanorod aspect ratio, the SPR absorption wavelength maximum of 
the longitudinal band significantly shifts toward the NIR region. This easily 
tuneable characteristic has made nanorods a suitable agent for cancer 
hyperthermia. Gold nanorods can therefore be synthesised to display the highest 
absorption peak in the NIR region that correlates well with laser wavelengths 
during photothermal irradiation both in vivo and in vitro and is seen as a key 
modulator for future GNP cancer hyperthermia therapies (A. M. Alkilany et al. 
2012; Dickerson et al. 2008; Tanya S. Hauck et al. 2008b; Qin et al. 2015). 
 
Gold nanoprisms represent a more complex nanoarchitecture, typically in the form 
of a triangular geometry	(Alfranca et al. 2016). Gold nanorpisms can be tailored by 
modifying their aspect ratio, tip sharpness, thickness and length, which can 
influence and promote enhanced optical properties as well as improve in vivo 
performance (Alfranca et al. 2016; Chenchen Bao et al. 2016). The optical 
properties of nanoprisms are not governed by diameter but instead are heavily 
influenced by their aspect ratio and symmetry (Jill E. Millstone, 2004). The aspect 
ratio is based on the thickness of the nanoprism and edge length, however the 
three tips of the nanoprisms are also crucial characteristics determining its optical 
properties (E. Hao et al. 2004; K. L. Shuford et al. 2005a).	 The absorption 
spectrum of gold nanoprisms in particular, often presents four frequency modes, 
which have been confirmed both theoretically and experimentally, namely in-plane 
and out of- plane modes, both of which in turn can be dipolar and quadrupolar (B. 
Pelaz et al. 2012; Perez-Hernandez et al. 2015). The major contribution to the UV-
vis-NIR spectrum of triangular gold nanoprisms (NPRs) is attributed to the in-plane 
dipolar mode located in the NIR range (B. Pelaz et al. 2012). The highly 
anisotropic shape of nanoprisims provides them with strong absorption in the NIR 
region and makes them highly suitable for biological applications including 
otpoacoustic imaging	 (C. Bao et al. 2013), bioesensing	 (Z. Guo et al. 2010a) and 
photothermal therapy (X. Ma et al. 2015). 
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1.6 Magnetic Nanoparticles 
 
In 1957, Gilchrist et al proposed the use of magnetic nanoparticles for cancer 
hyperthermia owing to their capacity to convert magnetic energy into thermal 
energy	 (C. S. Kumar and Mohammad 2011). Magnetic nanoparticles (mNPs) are 
composed of a magnetic metal core, very often in the form of magnetite, a potent 
magnetic material (Fe3O4), or its oxidised form, maghemite (Fe2O3), with an 
outer coating of a biocompatible material (e.g. dextran) (C. S. Kumar and 
Mohammad 2011). Synthesis is predominantly via a bottom up approach, allowing 
the generation of mNPs in the nanometre range that infer enhanced magnetic 
properties. In the presence of an alternating magnetic field, iron oxide mNPs 
generate heat and can induce hyperthermia. 
 
The current biomedical applications of mNPs have been outlined in several 
reviews (Catherine and Adam 2003; Gobbo et al. 2015; Yallapu et al. 2011), which 
detail the potential use of mNPs for cancer imaging, when used as contrast agents 
to enhance the contrast in magnetic resonance imaging (MRI) scans. A further 
potential use is with magnetic drug targeting, whereby the possibility of attaching 
various ligands (eg anti-cancer drugs) to the mNPs (figure 1-8) as well as the 
particles inherent magnetic properties are capitalised upon (Berry 2009).  Once 
inside the body, the mNPs can be attracted to external magnetic fields, allowing 
accumulation at specific sites where they can subsequently deliver their cancer 
therapeutic payloads. In 1996, the first clinical trial using magnetic drug targeting 
was performed in patients with advanced solid tumours	(Lubbe et al. 1996). 
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Figure 1-8: Schematic of a multifunctional mNP. MNPs can be functionalised 
with various biocompatible coatings including PEG and can also be further 
functionalised to act as a drug/gene chaperones or used as contrast agents 
with the addition of fluorescent molecules/dyes (personal image).  
 
Based on magnetic resonance tomographic techniques and histological detection, 
mNPs functionalised with epirubicin could be directed to tumours using magnetic 
fields localised outside the tumour surface. Magnetic nanoparticles are usually well 
physiologically tolerated within the body due to their external biocompatible 
coating with organic polymers (usually dextran), which have a very low toxicity 
index, while excess mNPs are cleared from the body via the aforementioned RES. 
Briefly, the RES, orchestrated mainly by the kuppfer cells within the liver, ingests 
the iron oxide mNPs via phagocytosis and the resultant products are stored within 
cellular compartments such as endosomes	 (Santhosh and Ulrih 2013).  The iron 
oxide is then metabolised into iron and oxygen with the former stored within 
storage proteins such as ferritin (Santhosh and Ulrih 2013). 
 
1.6.1 Magnetically-Mediated Hyperthermia  
 
Magnetic hyperthermia is dependent on two fundamental points (1) that the cancer 
cells uptake mNPs into the cell body, and (2) that the mNPs used are capable of 
generating heat when exposed to an alternating magnetic field. Gilchrist’s work 
was one of the first to utilise magnetic material for hyperthermia treatment, 
resulting in the heating of tissue samples using iron oxide nanoparticles ranging 
from 20-100 nm (1.2 MHz magnetic field exposure)(Gilcrest 1957). Since this 
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seminal report, many publications have been produced, with researchers 
attempting to use various metal NPs, including nickel, cobalt and zinc (C. S. 
Kumar and Mohammad 2011). However, whilst metals such as nickel and cobalt 
are also highly magnetic, they are also very toxic and can be easily oxidised within 
the body, causing cellular damage, thus iron oxide magnetic nanoparticles are 
reserved for biomedical application (S. Laurent et al. 2011). The effectiveness of 
mNP-hyperthermia relies on its inert, biocompatibility during inactivity and 
crucially, its ability to generate adequate heating profiles upon activation. The 
heating efficiency of mNPs is determined by the magnetic energy absorbed by 
mNPs and converted into thermal energy and is notably described as the specific 
absorbance rate (SAR). The SAR is expressed as an equation and is equal to the 
rate at which energy is absorbed per unit mass of the mNPs at a specific 
frequency, defined by the equation below	(Deatsch and Evans 2014; Guardia et al. 
2012; Arati G. Kolhatkar et al. 2013b). 
 
SAR, W/g = C (ΔT/ Δt) = (Area of hysteresis loop x (Frequency, f)) 
 
Where C is the specific heat capacity of water, and ΔT/Δt is the rate of change of 
temperature (A. G. Kolhatkar et al. 2013a). 
 
Although SAR is good indicator of heating potential, various groups have adopted 
different models, producing different degrees of consensus within the literature. 
For example Suto and co-workers emphasised the impact of the weight of mNPs 
and the frequency and strength of magnetic fields (Suto et al. 2009). Many groups 
that attempt to theoretically or experimentally estimate the SAR of mNP based 
heating highlight the significance of not just the mNP characteristics, but also the 
variation of the external alternating magnetic field, including field strength, 
frequency and duration (Deatsch and Evans 2014; C. S. Kumar and Mohammad 
2011; L. Yu et al. 2014). In general, the generation of heat produced by iron oxide 
magnetic nanoparticles is proportional to the square of the applied magnetic field 
amplitude, thus, as expected; an increase in magnetic field strength coincides with 
an increase heat generation within mNPs (Mehdaoui et al. 2010). The influence of 
magnetic field frequency is far more complex although at more physiologically 
appropriate boundaries, its impact becomes severely limited and is somewhat 
overlooked for hyperthermia investigations (Deatsch and Evans 2014). However 
the impact of field frequency itself does influence the size distribution of iron oxide 
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nanoparticles that can be used for hyperthermia experiments with studies showing 
the mNPs between 12 and 20 nm showing optimal magnetic field absorbance 
(Deatsch and Evans 2014). Physiological considerations have proved challenging 
for effective in vivo hyperthermia using mNPs as large amplitude, high frequency 
magnetic fields may induce uncontrolled local heating in tissues due to induced 
eddy currents	(Gunnar et al. 2006). Despite these limitations to the magnetic field 
variables, many groups have successfully used mNPs for hyperthermia 
experiments in vivo with promising results	 (I. Hilger et al. 2002; Thiesen and 
Jordan 2008). 
 	
Table 1-2: A list of clinical trials involving mNP based hyperthermia. 	
Clinical trials Key Features References  
Clinical hyperthermia 
of prostate cancer 
using magnetic 
nanoparticles: 
Presentation of a new 
interstitial technique  
Phase I study  
Concentration of ferrites in aqueous 
solution was 120 mg.ml-1   
15 nm and were coated with an amino                                                                                                                                         
silan-type shell in water  
Treatments were delivered in the first 
magnetic field applicator for use in 
humans (MFH300F, MagForceÕ 
Nanotechnologies GmbH, Berlin),  
alternating magnetic field with a 
frequency of 100 kHz and a variable field 
strength 
(0–18kAm-1).  
(M. Johannsen 
et al. 2005) 
Intracranial 
Thermotherapy using 
Magnetic 
Nanoparticles 
Combined with 
External Beam 
Radiotherapy: Results 
of a Feasibility Study 
on Patients with 
Glioblastoma 
Multiforme 
Phase I study  
 
Aminosilane coated iron oxide 
nanoparticles 
14 patients suffering with recurrent 
glioblastoma multiforme 
Used as an adjunct to radiotherapy  
(Maier-Hauff et 
al. 2007) 
mNP based 
hyperthermia 
combined with 
radiotherapy  
66 patients  
iron concentration of 112 mg.ml-1 
12 nm diameter with an aminosilane 
coating 
(Maier-Hauff et 
al. 2011) 
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1.6.2 Superparamagnetic Iron Oxide Nanoparticles (SPIONs) 
 
Superparamagnetic iron oxide NPs (SPIONs) are small particles (1-20 nm) 
containing an iron oxide magnetic core (Fe2O3 and Fe3O4) which exhibit 
superparamagnetic behaviour due to their small size and crucially, the subsequent 
switch from a multi domain structure to a single domain structure (S. Laurent et al. 
2011). Bulk magnetic material, such as iron are composed of multiple domains, 
each containing large numbers of atoms whose magnetic moments (orbital and 
spin motions of electrons within atoms) are parallel producing a net magnetic 
moment of the domains in random directions (Bashar Issa et al. 2013b). These 
randomly distributed domains within the material produce a zero net magnetic 
moment (Cindi L. Dennis and Ivkov 2013b). When ferromagnetic material are 
placed in a magnetic field, the magnetic moments of the domains align along the 
direction of the applied magnetic field forming a large net magnetic moment and a 
residual magnetic moment, allowing the material to retain its magnetism even after 
the magnetic field is removed (Bashar Issa et al. 2013b; Santhosh and Ulrih 2013).  
 
The change of SPIONs from a multiple domain structure to a single domain 
structure greatly alters their magnetic behaviour from ferromagnetic characteristics 
to superparamagnetic characteristics (B. Issa et al. 2013a; Wahajuddin and Arora 
2012b). In this single domain state the material can display either ferromagnetic or 
Combined treatment with radiotherapy 
showed more effective therapy 
 
Neo-adjuvant 
chemotherapy alone or 
with regional 
hyperthermia for 
localised high-risk soft-
tissue sarcoma: a 
randomised phase 3 
multicentre study 
 
Randomised phase 3 trial  
treatment for high-risk soft-tissue 
sarcoma (STS) in adults 
Patients received either neo-adjuvant 
chemotherapy consisting of etoposide, 
ifosfamide, and doxorubicin (EIA) alone, 
or combined with regional hyperthermia 
(EIA plus regional hyperthermia) in 
addition to local therapy. 
341 patients were enrolled, with 169 
randomly assigned to EIA plus regional 
hyperthermia and 172 to EIA alone. 
regional hyperthermia increases the 
benefit of chemotherapy 
(Rolf D. Issels 
et al. 2010) 
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paramagnetic characteristics depending on the presence or absence of an 
external magnetic field, respectively, leading to the phenomenon described as 
superparamagnetism (Amtenbrink et al, 2009).However unlike their larger, multi 
domain bulk, counterparts, single domain, superparamagnetic material do not 
retain their magnetism after the removal of an external magnetic field (Santhosh 
and Ulrih 2013). Thus, superparamagnetism is as a form of magnetism exhibited 
in small ferromagnetic NPs (Hervault and Thanh 2014). This form of magnetism 
relies on the presence of a magnetic field in order for particles to magnetise, 
therefore the loss or absence of a magnetic field leads to particles losing their 
magnetic potential and thus, magnetism and heating capacity (L. S. Wang et al. 
2012b). 
 
For biomedical applications, it is of paramount importance to have 
superparamagnetic behaviour at room temperature to prevent aggregation; 
aggregation is more common in SPIONs due to their smaller size, increased 
surface-to-volume ratio as well as magnetic attractive forces and weak Van Der 
Waals forces (Santhosh and Ulrih 2013). Superparamagnetic materials can flip the 
direction of their magnetisation under the influence of temperature and the time 
between these flips is termed the Neel relaxation time. In the absence of an 
external magnetic field, if the time used to measure the magnetisation of mNPs is 
longer than the Neel relaxation time, the magnetisation of the material is said to be 
approximately zero	(Arati G. Kolhatkar et al. 2013b).  
 
The Curie temperature is also an important parameter, which researchers can 
manipulate; the Curie temperature is the temperature at which a materials 
permanent magnetism changes, above these temperatures, materials lose their 
magnetism and effectively ‘turn off’	(Sharifi et al. 2012). This process inhibits their 
ability to heat, thus stopping them from over heating within the body (Rehman et 
al. 2002). The Curie temperature is therefore fundamental to hyperthermia 
therapies that can ‘turn off’ once the desired temperature is achieved	(Sharifi et al. 
2012).  					
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1.6.3 Mechanism Of Heat Generation In Magnetic Nanoparticles 
 
As described above, SPIONs have a size range of 1-20 nm. At this size it is 
considered that the SPIONs change from a multiple domain structure to a single 
domain structure and thus change from having ferromagnetic characteristics to 
superparamagnetic characteristics (Wahajuddin and Arora 2012a). Frenkel and 
Dorfman first studied single domain theory in 1930 with further studies, identifying 
the importance of a shift from multiple domain to a single domain in the creation of 
permanent magnets	(Ortega et al. 2010).  
 
When SPIONs are subjected to an alternating magnetic field (AMF) they generate 
heat by two main mechanisms; hysteresis loss and relaxation (Mamiya and 
Jeyadevan 2011; Ruta et al. 2015). Hysteresis occurs when an AMF is applied to 
the particles leading to the atomic dipoles within the particles aligning themselves 
accordingly with the AMF albeit at a delay and becoming magnetised in response 
(C. S. Kumar and Mohammad 2011). Single domain SPIONs respond by rotating 
during the presence of an external AMF and this can create currents within the 
SPION carrier fluid (usually in the form of a ferrofluid) (C. S. Kumar and 
Mohammad 2011). 
 
Heat is also produced via a delay in the relaxation processes in the form of 
Brownian and Neel relaxation mechanisms, again producing heat via friction	
causing thermal cytotoxicity to tumour cells (J. Pearce et al. 2013a). Both Neel and 
Brownian relaxation mechanisms lead to thermal loss via an applied MF but both 
are produced by different phenomenons, as shown in figure 1-9. Neel relaxation 
mechanism occurs due to the rapid changes in direction of magnetic moments 
within the particles thus leading to rotation within the particle itself leading to heat 
loss (J. Bai et al. 2014a). Brownian relaxation meanwhile relies on the actual 
physical rotation of the particle itself within the carrier media it is suspended in 
(e.g. ferrofluid) via an external AMF	 (S. Laurent et al. 2011). This mechanism 
therefore relies on the external environment - the carrier fluid, including density, 
viscosity and other external dynamic factors which could either inhibit, suppress or 
resist the particles spinning, thus affecting the generation of heat produced (L. Yu 
et al. 2014). 
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Both Neel and Brownian relaxation rely on particle diameter. When particles are 
exposed to an external AMF, the time of magnetic reversal is less than the 
magnetic relaxation times of the particles, and heat is dissipated via the delay in 
relaxation of magnetic moments within the particles (Vallejo-Fernandez et al. 
2013). By increasing the size of SPIONs it is possible to increase the heating 
efficacy of these particles, but this must be balanced with the requirement to 
maintain superparamagnetism (Sharifi et al. 2012).  
 
Other factors also affect SPIONs ability to generate heat, including their shape and 
crystal structure (linked to domain size). Furthermore, particle internalisation into 
cells can also cause a shift in heating potential, with mNPs likely to experience 
inhibition of particle spinning or movement, thus limiting heat to Neel relaxation 
only (Espinosa et al. 2016). All these parameters need to either be satisfied or at 
least accounted for in order to estimate the specific absorption rate of the SPIONs 
and thus their effectiveness in vivo. 
 
 
 
Figure 1-9: Néel rotation and Brownian rotation. (Top) Néel rotation: The 
magnetic moment rotates while the particle remains fixed. (Bottom) 
Brownian rotation: The magnetic moment leads to the physical rotation of 
the particle (personal image). 
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1.6.4 Clinical Application of Magnetic Nanoparticles  
 
Over the last two decades considerable improvements have been made to 
magnetically-mediated hyperthermia to enable clinical translation (Cole et al. 
2011a). A number of parameters are vital to the success of this application, 
including (1) the position of the tumour (superficial or deep seated), (2) the half-life 
of the NPs (avoiding opsonisation), (3) the specific targeting of cancer cells (e.g. 
by identifying specific molecular markers on cancer cells, such as antibodies), (4) 
the strength and exposure time of the magnetic field (high enough to excite mNPs, 
but low enough to not cause any potential localised damage), and (5) general 
safety considerations (eg. potential toxicity issues). All these factors have to be 
negotiated in order to produce a mNP that will be safe to use in vivo and able to 
efficiently produce heat when located in a cancer cell and exposed to an 
alternating magnetic field. 
 
The use of hyperthermia treatment to treat cancer patients was first highlighted in 
studies from Jordan et al 2001 and Johannsen et al 2005, with both studies 
focusing on the susceptibility of cancer cells to cell death/apoptosis or necrosis 
upon exposure to hyperthermia (M. Johannsen et al. 2005; A. Jordan et al. 2001). 
In 2001, Jordan and colleagues presented the proposals for the manufacturing of 
a new AC magnetic field therapy system for the clinical application of mNP 
hyperthermia. The first prototype of a clinical magetic fluid hyperthermia (MFH) 
therapy system that will be set up at the Charité Medical School, Campus Virchow-
Klinikum, Clinic of Radiation Oncology in Berlin. The system was produced to 
match the limitations given by non-specific eddy current heating in highly 
conductive tissue as well as monitoring other potential safety concerns. The 
system was expected to be used for global hyperthermic applications but primarily 
for regional hyperthermia (A. Jordan et al. 2001). Johannsen and co-workers 
(2005) conducted a pilot study to evaluate mNP hyperthermia for the treatment of 
prostate cancer. MNPs were injected transperineally into the prostate. Treatments 
were conducted in the first magnetic field applicator for human use (MFH300F, 
MagForceÕ Nanotechnologies GmbH, Berlin), with the system producing an 
alternating current magnetic field with a frequency of 100 kHz and variable field 
strength (0–18 kA m-1). Patients were subjected to treatments for 60 minutes for 
six weekly hyperthermia sessions. CT scans and invasive temperature 
measurements confirmed mNPs were retained in the prostate during the treatment 
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interval for six weeks with temperature reaching hyperthermic temperature profiles 
(42-45°). The study showcased the great potential of mNP hyperthermia 
highlighted by the low mNP toxicity and distribution within the tumour, however the 
group did note that a greater concentration of mNP was required than initially 
calculated in order to generate sufficient hyperthermic profiles while the field 
strength, even at more moderate conditions still appeared to cause pain and 
discomfort and was subsequently cut by more than half the original dose (<5kA m-
1) (M. Johannsen et al. 2005). In 2007, the same group conducted a prospective 
phase 1 study on ten prostate cancer patients using aminosilane-type shell 
SPIONs (MFL AS, MagForce® Nanotechnologies, Berlin, Germany). Not only did 
the group show more successful hyperthermic temperature profiles hyperthermic 
to thermoablative temperatures were achieved in the prostates at only 25% of the 
available magnetic field strength. The group also investigated a noninvasive 
thermometry method specific for this approach, which shows great potential for 
future development (Manfred Johannsen et al. 2007). 
 
There are two distinct approaches to magnetic hyperthermia used by research 
groups; conventional mNP hyperthermia and magnetic thermoblation (Stapf et al. 
2015). Conventional mNP hyperthermia typically involves temperature profiles of 
around 42-45°, and has shown to cause cancer cell death and the shrinkage of 
tumours in animal models	with minimal/no damage associated with normal cells 
(Elsherbini et al. 2011). Magnetic thermoblation meanwhile is similar in principle to 
magnetic hyperthermia, however higher temperatures are achieved, ranging from 
43-55°C. In this case the increase in temperature not only causes tumour cell 
death, but also has strong cytotoxic effects for neighbouring healthy cells (I. Hilger 
et al. 2002). The reason for utilising magnetic thermoblation as opposed to 
magnetic hyperthermia is that a higher rate of tumour regression is often noted 
with thermoablation	(I. Hilger et al. 2002). Although considered effective, magnetic 
thermoblation is used precariously as elevated temperatures >50°C is associated 
with necrosis (Cherukuri et al. 2010). At present, the clinical use of agnetic 
hyperthermia is being predominantly explored as an adjunct to existing cancer 
therapy treatments, such as chemotherapy and radiotherapy, particularly as cells 
show an increased susceptibility to both these treatments when magnetic 
hyperthermia is also used (Giustini et al. 2010). 
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1.7 Aims and Objectives  
 
The aim of this project was to assess the potential application of gold 
nanoparticles and magnetic nanoparticles as hyperthermic agents in vitro.  In 
order for any NP to be considered for future in vivo use and in clinical settings, 
they must exhibit low toxicity upon cell exposure, show good biocompatibility and 
subsequent cellular uptake (Charlton et al. 2016; Mahmoudi et al. 2011; A. Panariti 
et al. 2012a). Therefore, both NP species were assessed in terms of their 
biocompatibility. Two cancer cell lines were adopted for the in vitro studies 
representing both hard and soft tissue; bone cancer cells (MG63) and breast 
cancer cells (MCF-7).  The NPs were assessed in standard monolayer culture and 
3D tumour spheroid culture.  
 
To be considered as ideal candidates for hyperthermia, NPs must exhibit sufficient 
heating potential to achieve hyperthermic temperature profiles (42-45°C) when 
exposed to an appropriate stimulant, such as a NIR laser or an external alternating 
magnetic field, in the case of GNPs and mNPs, respectively (Hayashi et al. 2013; 
B. N. Khlebtsov et al. 2012). Following biocompatibility tests, both the NP species 
employed in this project were also characterised for their respective heating 
potential.  
 
In this final part of the project, I aim to identify the apoptosis pathways responsible 
for hyperthermia-induced cell death, as the molecular events of hyperthermia 
induced cell death have not been fully realised (Joseph L. Roti Roti 2008b). The 
discrimination between apoptosis and necrosis is often overlooked and the various 
apoptosis pathways which may be activated are poorly studied, making clinically 
applicable data untranslatable (Kodiha et al. 2014; Yin et al. 2014).  
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The following objectives were completed to achieve these aims; 
 
1. Gold & magnetic NPs - to assess the effectiveness of both NPs to induce 
hyperthermia within cancer cells (42-47°) when exposed to (i) an 
alternating electromagnetic field (AMF) or (ii) light.  	
2. Gold NPs – to adapt a laser system to allow for NP heating via plasmon 
excitation. 
 
3. Gold NPs - to study the mechanism events of cell death induced by 
hyperthermia and how this rate could be increased for cancerous cells as 
well as aiding non-cancerous cell survival. This may include use of targeted 
NPs (ie. targeting cancer cells). 
 
4. Magnetic NPs - to adapt a magnetherm device to allow testing of the 
parameters required to induced cancer hyperthermia in vitro. 																											
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2. Materials and Methods  
 
Table 2-1: A list of materials, reagents and suppliers used during 
experiments. (* Preparation methods of solutions are described in detail in 
section 2.1).  
Materials/Reagents Supplier(s)  
1. Cells 
Human breast adenocarcinoma (MCF-7 
Cells) 
Sigma Aldrich, UK 
Human osteosarcoma (MG63 Cells) Sigma Aldrich, UK 
2. Nanoparticles  
~11 nm Superparamagnetic Iron oxide 
nanoparticles (SPIONs) coated with dextran 
 
Synthesised by collaborators at the 
Aragón Materials Science Institute, 
Spain.  
 
Gold nanoprisms & nanorods coated with 
PEG 
Synthesised by collaborators in 
Zaragoza, Spain  
3. Cell Culture  
Dulbecco’s modified eagle medium (DMEM) Sigma-Aldrich, UK 
Ethylenediaminetetraacetic acid (EDTA) Sigma- Aldrich, UK  
Foetal bovine Serum (FBS)   Sigma- Aldrich, UK 
HEPES Fisher Scientific  
L- Glutamine 200 mM  Invitrogen, UK 
Media 199 Sigma- Aldrich, UK 
Penicillin-streptomycin  Sigma- Aldrich, UK 
Sodium Pyruvate mM Life Technologies  
Trypsin  Sigma-Aldrich 
Trypsin/Versene solution  In house  
Versene* 
  
 
In house (see section 2.1) 
 
4. Cell Viability  
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3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-
tetrazolium bromide (MTT) 
Sigma-Aldrich, UK  
Dimethyl sulfoxide Sigma-Aldrich, UK 
LIVE/DEAD® viability/Cytotoxicity kit Invitrogen, UK 
PBS Sigma-Aldrich, UK 
5. Cell Staining  
BSA Sigma-Aldrich, UK 
Formaldehyde (38%) Fisher Scientific, UK 
 
HEPES Fisher Scientific, UK 
Magnesium Chloride ((MgCl2) hexahydrate) VWR Chemicals, UK 
Primary antibodies Abcam, UK and Santa Cruz 
biotechnologies, UK 
Rhodamine-phalloidin Invitrogen, UK 
Secondary biotin conjugated antibodies Vector Laboratories, USA 
Sodium Chloride (NaCl) VWR Chemicals, UK 
Sucrose Fisher Scientific, UK 
Tertiary streptavidin- FITC Vector Laboratories, USA 
Triton X Sigma-Aldrich, UK 
Tween 20 Sigma-Aldrich, UK 
6. Electron Microscopy  
Aqueous uranyl acetate  Agar Scientific Ltd, UK 
Epon resin araldite (812 Kit E202)  TAAB Lab Equipment Ltd, UK  
Ethanol VWR Chemicals, UK 
Glutaraldehyde  (25% aq pure, EM Grade) Sigma-Aldrich, UK  
Methanol VWR Chemicals, UK 
Osmium tetroxide Agar Scientific Ltd, UK  
Propylene oxide VWR Chemicals, UK 
Reynolds lead citrate  Agar Scientific Ltd, UK  
Sodium cacodylate Agar Scientific Ltd, UK 
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2.1 Cell Culture Growth Media and Solutions  
 
Modified DMEM (standard growth media)  
MEM        400 mL 
Medium 199       100 mL 
FBS          50 mL 
Penicillin-streptomycin       10 mL  
Sodium pyruvate          5 mL  
 
 
Versene  
Water                  1000 mL 
NaCl         8 g 
KCl         0.4 g 
Glucose        1 g 
HEPES        2.38 g 
EDTA         0.2 g 
0.5% phenol Red       2 mL 
Adjusted to pH 7.5 
 
 
Trypsin/versene solution 
Versene (in house solution)       20 mL 
Trypsin         0.5 mL 
 
 
PBS Solution  
PBS          1 tablet 
Water          200 mL 
 
Cell Fixation buffer (fluorescent staining) 
PBS solution          90 mL 
Formaldehyde (38%)        10 mL 
Sucrose           2 g 
 
Cell Permeability buffer (fluorescent staining)     
PBS solution          100 mL 
Sucrose          10.3 g 
NaCl            0.292 g 
Thermanox Coverslip  ThermoScientific , UK 
Uranyl acetate  Sigma-Aldrich, UK  
7. Microscopes   
Axiovert 25 fluorescence Microscope  Zeiss, UK 
Jeol 6400 SEM Jeol Ltd, UK 
Leo 912AB TEM Zeiss, UK  
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MgCl2 hexahydrate             0.06 g 
HEPES           0.476 g 
Adjusted to pH 7.2           
Triton X           0.5 mL 
 
 
0.5% Tween 20 in PBS   
PBS solution          100 mL 
Tween 20            0.5 mL 
   
 
2.2 Monolayer Cell Culture  
 
The human osteosarcoma cell lines (MG63) and human breast adenocarcinoma 
cell line (MCF-7) were cultured in T75 flasks with Dulbecco’s modified Ealges 
medium (DMEM) supplemented with medium 199 (20%), foetal bovine serum 
(10%), antibiotics (2%) and sodium pyruvate (1%). Cells were incubated in an 
atmosphere of 5% CO2 at a temperature of 37ºC and cultured until 70% 
confluence. Once cells were confluent they were washed with HEPES solution and 
detached from the flask surface with 2 mL of trypsin/versene (5 minutes at 37ºC). 
Fresh media (~8 mL) was added to the cells to neutralise the trypsin/versene 
solution. The resultant cell suspension was centrifuged for 4 minutes at 1400 g, 
the supernatant was removed and the remaining cell pellet was re-suspended in 1 
mL of fresh media (unless otherwise stated). Cells were then counted using a 
hemocytometer and seeded into appropriate wells for experiments at a 
concentration of 1 x 104 per mL. 
 
2.3 Cell Viability  
 
Cells were analysed both for their metabolic activity using the MTT assay and also 
their viability, using a live/dead fluorescent stains.  	
2.3.1 MTT Assay  
 
The MTT assay is a colorimetric assay designed to assess cell metabolic activity 
(when challenged with nanoparticles). The assay relies on the ability of NADPH-
dependent cellular oxidoreductase found within mitochondria to reduce yellow 
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to purple 
formazan. Viable cells with an active metabolism will therefore produce a purple 
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colour at an absorbance near 570 nm. Measurements are recorded using a plate 
reader, with the concentration of purple (ie. formazan) proportional to the 
metabolic activity of the cells. The measurements are evaluated against control 
cell samples containing no nanoparticles (NPs), which are assumed to be 100%.  
 
MG63 and MCF-7 cells were seeded in 96 well plates at 1x104 per well and 
incubated for 24 hours. The media was then removed and replaced with fresh 
media containing the specific NPs at desired concentrations and the cells were 
incubated for a further 24, 48 and 72 hrs (5 replicates for each condition). 
Subsequently, 10 µL of yellow MTT dye solution (5 mg.mL-1 in phosphate buffer 
pH 7.4) was added to each well. The plates were wrapped in foil and placed into 
an incubator at 37°C for one hour. After one hour, the media was removed and 
any resultant formazan crystals were solubilised using 200 µL of DMSO per well. 
The absorbance of each well was read on a microplate reader (Dynatech MR7000 
instruments) at 550 nm.  
 
MTT data analysis: Percentage metabolic activity was calculated using the 
following equation:  
 
(Absorbance of NP-treated cells / Absorbance of control cells) x 100 = %) 
 
2.3.2 Live/Dead Fluorescent Staining   
 
The LIVE/DEAD® Viability/Cytotoxicity kit was also carried out, to determine cell 
viability. The assay is a two-colour fluorescence assay that allows simultaneous 
staining in both live and dead cells (via calcein AM and ethidium homodimer 
respectively). This allowed for the visualisation of cells exposed to NPs (as well as 
control group, containing no NPs). 
 
The kit contained two compounds, calcein AM and ethidium homodimer (EthD-1). 
MG63 and MCF-7 cells were seeded at 1 x 104 onto 13 mm diameter glass 
coverslips located in a 24 well plate and cultured for 24 hours to allow cell 
attachment. The media was then removed and replaced with fresh media 
containing the specific NPs at desired concentrations and the cells were incubated 
for a further 24, 48 and 72 hours (3 replicates for each condition). At the relevant 
time points, the media was removed from each sample, thoroughly washed in 
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warm PBS (3 times) and 1 mL of fresh media suspension containing 1 µL calcein 
AM and 1 µL ethidium homodimer was added to each sample. The well plates 
were foil wrapped and incubated for 1 hour (37°C, 5% CO2). After incubation, the 
media was removed and samples were washed twice in warm fresh media and 
stored in an incubator ready to be viewed. Samples were then imaged under an 
inverted fluorescence microscope; the excitation/emission wavelengths were 
485/515 nm for calcein AM and 525/590 for EthD-1 and were viewed with FITC 
and TRITC filters, respectively. 
 
2.4 Observation of Cell-NP Interaction and Internalisation 
 
2.4.1 Scanning Electron Microscopy  
 
Scanning electron microscopy (SEM) was used to visualise the interaction of the 
NPs with the cells.  The cells were seeded at 1 x 104 on 13 mm glass coverslips 
and cultured for 24 hours.  Samples were then incubated with the NPs diluted in 
fresh media at the desired concentrations (alongside control cells with no NPs). 
Two replicates were used for each condition.  
 
Samples were fixed 1 & 24 hours after NP introduction with 1.5% glutaraldehyde 
supplemented with 0.1 M cacodylate buffer at 4°C for 1 hour. Once samples were 
fixed, 1 mL of 1% osmium tetroxide in phosphate buffer was added to each 
sample for 1 hour followed by 0.5% uranyl acetate for 1 hour. Samples were then 
slowly dehydrated through a series of alcohol increments from 30-100%, before 
final dehydration with HMDS. The samples were then stored in a desiccator prior 
to gold sputter coating. 
 
2.4.2 Transmission Electron Microscopy  
 
Transmission electron microscopy (TEM) was used to observe NP internalisation 
into cells via analysis of a cross section of cells after NP culture. This allows us to 
verify internalisation and determine the intracellular localisation of the NPs.   
 
Cells were seeded at 1 x 105 cells per well on Thermanox coverslips in a 24 well 
plate for 24 hours prior to NP incubation. Cells were incubated with NPs at desired 
concentrations alongside control cells containing no NPs (two replicates were 
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used for each condition). Cell samples were then fixed, stained with 1% osmium 
tetroxide followed by 0.5% uranyl acetate and dehydrated through a series of 
alcohol increments from 30-100%, exactly as for SEM processing above.  
Following dehydration, cells were covered with a propylene oxide: Epon 812 resin 
araldite mix (1:1) overnight.  The samples were then placed in pure resin and 
cured in an oven at 60°C for 24 hours. Ultrathin sections were cut from the cured 
block and stained with 2% methanolic uranyl acetate and Reynolds lead citrate 
before being viewed under a LEOG12AB transmission electron microscope 
operating at 20−200 kV. 
 
Research Colleague Assistance Mrs. Margaret Mullin, Electron Microscopy 
Facility, University of Glasgow aided with the processing and imaging of SEM and 
TEM samples.   
 
2.4.3 Cell Fluorescence Staining  
 
Fluorescent staining was used to visualise F-actin and β-tubulin filaments within 
cells in order to determine if NP internalisation compromised the cell cytoskeleton 
structure. 
 
Cells were seeded at 1 x 104 onto glass coverslips within a 24 well plate and 
cultured for 24 hours before being incubated with NPs (two replicates per 
condition; control cells containing no NPs). The cells were cultured with the NPs 
for 24, 48 72 hours (unless otherwise stated). At the time points, cells were 
washed with warm PBS and samples were fixed with 1 mL 4% formaldehyde for 
15 minutes at 37°C. The fixative was removed, samples were washed in PBS and 
a permeabilising buffer was added to permeate the cell membrane (5 minutes at 
4oC). The permeabilising buffer was then removed and 1 mL of 1% BSA/PBS 
solution was added for a further 5 minutes at 37oC. Once removed, rhodamine 
phalloidin (1:100 in PBS/BSA) and anti-tubulin (1:100 in PBS/BSA) was added to 
each sample. The samples were then aluminium foil wrapped (to prevent loss of 
fluorescence) and incubated for 1 hour at 37oC. The solution was removed and the 
coverslips were washed three times in PBS/0.5% Tween. The relevant secondary 
biotin conjugated antibody (anti-mouse) was added (1:100 in PBS/BSA; 500 µL 
per coverslip) and samples were incubated a further hour at 37oC. After remove 
and washing (PBS/0.5% tween), FITC-streptavidin was added (500 µL per well; 
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1:100 PBS/BSA) for 30 minutes at 4oC. The cell samples were washed again in 
PBS/0.5% tween; the coverslips were mounted onto glass slides and finally 
stained with fluorescent DAPI. A 20x20 mm coverslip was subsequently placed on 
top and samples were viewed under a fluorescent microscope.  
 
2.5 Statistical Analysis  
 
One-way analysis of variance (ANOVA) was performed using GraphPad version 
6.01. The statistical significance of results was measured by calculating the 
probability of the null hypothesis being true using a predetermined limit  (p-value). 
If the level of confidence was less than 5% (p-value ≤0.05), the null hypothesis 
could be rejected and the results were considered statistically significant. Mean, 
standard error and standard deviation was calculated using the statistical analysis 
tool in Microsoft Office Suite (Excel) for each experiment. Studio R was used 
exclusively to analyse fluidigm data. 
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3. Gold Nanoparticles for Photothermal Therapy  
 
3.1 Introduction  
 
3.1.1 Gold Nanoparticles in Photothermal Therapy 
 
Gold nanoparticles (GNPs) exhibit unique properties, including surface plasmon 
resonance (SPR), which has been capitalised upon for the potential use of GNPs 
in photothermal therapy (hyperthermia).  As discussed in chapter 1, hyperthermia 
is known to induce apoptotic cancer cell death and also allows increased efficacy 
of chemotherapy and radiotherapy treatments (W. Li and Chen 2015). However its 
use as a cancer treatment is limited due to the overall lack of specificity for tumour 
tissues, the difficulty in heating tumours to therapeutic temperatures and 
thermolerance after treatment. GNPs are potential photothermic agents, which can 
be used to generate heat energy from electron excitation and relaxation (via SPR) 
when a laser of appropriate wavelength is applied. 
 
3.1.2 Gold Nanospheres and Nanoshells 	
To date, many studies have focused on gold nanoshells (eg. silica particles with a 
gold coating) (Hirsch et al. 2003; Mayle et al. 2016a; Stern et al. 2007; Vera and 
Bayazitoglu 2009). This is because gold nanoshells present a tunable SPR, which 
can be tuned to the near-infrared (NIR) region, thus optimising the potential for 
achieving tumour tissue penetration (X. Huang and El-Sayed 2010; Mayle et al. 
2016b; Prevo et al. 2008; G. Zhang et al. 2012; J. Zhao et al. 2014). However in 
recent years, advancements in nanoparticle synthesis have allowed for a variety of 
different GNP shapes and structures to be created. For example gold nanorods, 
whereby the aspect ratio can be altered to permit NIR benefits. When the shape of 
a GNP changes from spheres to rods, the SPR band is split into two bands; a 
strong band in the NIR region (corresponding to the long axis) and a weaker band 
in the visible spectrum (akin to gold nanospheres) (H. Kim et al. 2016a; Z. Zhang 
et al. 2013b). The NIR band can be tuned depending on the aspect ratio of the 
nanorod (ie. the length) thus increasing its heating efficacy at NIR wavelengths. 
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Photothermal therapy using GNPs can be achieved with pulsed or continuous 
wave lasers, with SRP absorption in the visible spectrum and thus suitable for 
near surface cancers (eg. skin). GNP photothermal therapy was first demonstrated 
in vitro and in vivo, by Hirsch et al (Hirsch et al. 2003). This report employed 
breast cancer cells incubated with PEGylated gold nanoshells. Cell death, via 
Calcein AM staining, was noted after 4 minutes exposure to a continuous wave 
NIR light (820 nm, 35 W/cm2). The corresponding in vivo study, where the GNPs 
were directly injected into a tumour, induced tissue damage and cell shrinkage.  
The following year they injected the PEGylated nanoshells into the bloodstream, 
rather than direct injection (mouse tail vein) and observed particles accumulation 
into the tumour via the enhanced permeability and retention effect (D. Patrick 
O'Neal et al. 2004b). 
A detailed study was also carried out in 2003 by Lin and co-workers, using a 
pulsed laser and gold nanospheres (Pitsillides et al. 2003). They targeted 
lymphocyte cells incubated with antibody-conjugated GNPs and a nanosecond 
pulsed laser (565 nm, 20 ns duration). Cell death was recorded with 100 laser 
pulses, with adjacent cells remaining viable and was attributed to micro-scale 
bubbles around the GNPs. Laser-induced bubbles were noted in subsequent 
studies using nanosecond laser pulses in vitro with breast and cervical cancer cell 
lines (Hleb et al. 2008; Zharov et al. 2003). However, the heating efficiency using 
nanosecond pulsed lasers is low, therefore continuous wave laser is often 
preferred to induce cell death in a larger area via hyperthermia, despite the lengthy 
time required (minutes as compared to seconds).  
Since these reports, an exponential number of studies have been conducted 
evaluating the use of GNPs for photothermal treatment.  The heating profiles of 
thermal treatments can be measured in real time (J. Park et al. 2015). While the 
biodistribution, accumulation within the liver and eventual clearance from the host 
without notably signs of toxicity has showcased GNPs as ideal candidates for 
clinical applications (Bednarski et al. 2015; Fraga et al. 2014). 
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3.1.3 Gold Nanorods and Nanoprisms 
In order to increase the proficiency of light to heat conversion, researchers have 
explored a range of GNP sizes (K. Jiang et al. 2013), shapes (Eustis and el-Sayed 
2006) and composition (hollow or solid GNPs) (Xie et al. 2013). To this end 
anisotropic GNPs, such as nanorods, have been extensively explored due to their 
strong optical properties they exhibit as discussed in section 1.5.2. Gold nanorods 
display an increased absorption cross-section and reduced light scattering in the 
NIR domain over traditional gold nanosphere shapes.  
As stated earlier, gold nanorods have gained particular attention over gold 
nanoshells and nanospheres due to their tuneable optical properties that can be 
tailored by changing the aspect ratio (rod length). Huang’s research group clearly 
demonstrated the capability of gold nanorods for use as both cancer cell imaging 
and photothermal therapy in the near- infrared region (X. Huang et al. 2006a). This 
study was the first to show photothermal therapy using gold nanorods in vitro, 
whereby ENT cancer cells incubated with gold nanorods were damaged following 
exposure to a continuous wave laser (4 minutes; 10W/cm2). Subsequent studies 
have demonstrated similar results, with cell death via apoptosis (Hironobu et al. 
2006; L. Tong and Cheng 2009). 
Alternative anisotropic GNPs have also been explored including nanoprisms, as 
previously discussed (chapter 1.5.2). The optical absorbance potential of 
nanoprisms is governed by a variety of parameters including length, thickness and 
the sharpness of the vertices (K. L. Kelly et al. 2003; K. L. Shuford et al. 2005a). 
The combination of these parameters produce nanoprisms that exhibit high aspect 
ratios and display stronger electromagnetic field enhancement - providing more 
distinct plasmon resonance in the near-infrared region in comparison to 
nanospheres and indeed, nanorods (Han et al. 2016b). The manipulation of gold 
nanoprism characteristics, ease of synthesis, functionalisation and 
characterisation has extended gold nanoprism use towards photodynamic therapy 
and imaging (You et al. 2016). An example of the versatility of gold nanoprisms 
was shown in a very recent study by Bao and co workers (2016). In this study, the 
group synthesised antibody functionalised gold nanoprisms for photoacoustic 
imaging, angiography, and photothermal therapy, allowing for the successful 
imaging and subsequent photothermal therapy treatment in situ, while 
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corresponding in vivo experiments led to a reduction in tumour size and improved 
survival rates within mice (Chenchen Bao et al. 2016). 
 
3.1.4 Successful GNPs Presentation In Vitro: Chapter Objectives 	
GNPs are evaluated based on their in vitro and in vivo performance in regards to 
toxicity. To qualify GNPs for potential biomedical applications, such as for 
hyperthermic treatments, they must demonstrate success across a variety of 
parameters including low toxicity, high cellular uptake, low cellular stress and 
successful intracellular heating. To this end, GNP candidates are typically 
assessed in cell culture. This chapter evaluates the biocompatibility of gold 
nanorods and gold nanoprisms and assesses their potential as hyperthermic 
agents in vitro.  
3.1.4.1	Cell	Lines	Employed	
Two cancer cell lines were employed in this study; a human bone osteosarcoma 
cell line (MG63) and a human breast cancer cell line (MCF-7). Both cell types 
represent cancer lineages from bone (hard tissue) and epithelia (soft tissue), 
therefore MG63 and MCF-7 cells were used as they offer insight into GNP 
interactions with different cell/tissue types. In addition, we focused on bone and 
breast cell lines as it is predicted that one-third of women with breast cancer will 
develop bone metastases, leading to secondary tumours (Koutsilieris et al. 1999).  
3.1.4.2	Cell	Culture	Models		
This chapter also diverges from the majority of the literature in this area by 
comparing the biocompatibility and photothermal capability of gold nanorods and 
nanoprisms both in standard monolayer culture and 3D tumour spheroid culture. 
The use of 3D multicellular spheroids aims to better replicate the in vivo tumour 
conditions, which are lost when culturing cells directly on stiff non-native 
substrates, such as cell-to-cell adhesion, synthesis and secretion of extracellular 
matrix proteins and structural cell changes. It is well known that 2D cultures are 
more sensitive to drug exposure producing data that lacks genuine clinical 
application. This was observed by Loessner et al, 2010, where they found ovarian 
cancer cell viability was reduced to 40-60% in 3D cultures after paclitaxel 
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treatment, however the same treatment in the 2D cell monolayer led to an 80% 
reduced cell viability (Loessner et al. 2010). It is therefore imperative for research 
groups to move towards 3D systems as a ubiquitous model especially for the 
evaluation of cancer therapy. This is particularly important for photothermal 
therapy, while technical issues of tissue penetration and depth of lasers to 
stimulate GNP heating  can also be evaluated (Dreaden et al. 2012).  
		
3.2 Chapter Aims and Objectives  
This chapter aims to evaluate the potential of both gold nanorods and nanoprisms 
as photothermal agents to induce hyperthermia in both MG63 and MCF-7 cells. 
Once successfully internalised into cells, the GNPs should be able to trigger cell 
death via SPR upon irradiation with a compatible NIR laser. All observations were 
carried out both in 2D monolayer and 3D multicellular spheroids in order to 
produce more clinically relevant data.  
These aims were achieved as follows:  
• Cells were incubated with a range of different GNP concentrations to 
determine the optimum dose for biocompatibility in terms of cell metabolic 
activity, viability and morphology.  
• GNP internalisation was determined and quantified. 
• Laser irradiation of GNPs localised within cells both in 2D and 3D culture 
models. 
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3.3 Materials and Methods  
 
3.3.1 Gold Nanorod and Nanoprism Synthesis, Functionalisation and 
Characterisation 
 
3.3.1.1	Gold	Nanorod	and	Nanoprism	Syntheses	and	Functionalisation		
 
GNPs in the form of nanorods and nanoprisms were synthesised by our 
collaborators at the Institute of Nanoscience in the University of Zaragoza, Spain.  
Our collaborators confirmed their hyperthermic potential within 1 minute of laser 
exposure at a concentration of 0.1 mg.mL-1 which was used as a benchmark for 
future experiments.  
 
Gold Nanorod Synthesis 
Gold nanorods were synthesised by preparing a seed stock solution of 1 M NaBH4 
(aq) dissolved in 1 M NaOH (aq), which was subsequently dissolved 1:100 in Milli-
Q water. Meanwhile, the surfactant, CTAB (aq) 0.2 M was dissolved to 
homogeneity in a water bath at 37ºC; 5 mL of 1 mM HAuCl4 (aq) and 5 mL of 
CTAB were prepared.	An aliquot	 of	 460 µL of the prepared NaBH4/NaOH stock 
solution was then added to this solution to produce gold nanoseeds. The growth 
solution was immediately prepared by mixing 50 mL of 0.2 M CTAB and 50 mL of 
1 mM HAuCl4 solution, followed by the addition of 700 µL 0.1 M AgNO3. Finally, 1 
mL 0.5 M hydroquinone was added to complete the growth solution. A 1.6 mL 
aliquot of the seed solution was added and was incubated for 5 hours at 26ºC in a 
water bath until reaching an LSPR of 1080 nm. Several centrifugation-washing 
steps were required after each reaction to clean nanorods from excess, toxic 
CTAB. 	
 
For the PEGylation of nanorods, 37 µL of a 1 mg.mL-1 NaBH4 (aq.) solution was 
mixed with 5 mg of heterobifunctional HS-PEG-COOH (5 kDa) diluted in 1 mL 
Milli-Q water at a ratio of 1:1 to produce a PEG solution. The previously prepared 
growth solution meanwhile was centrifuged at 15,000 G, 15 min, 30ºC, and pellets 
were re-suspended in 100 mL Milli-Q water. An aliquot of 1 mL of the prepared 
PEG solution was then added to the growth solution and the pH raised by the 
addition of 100 µL of 1M NaOH. The samples were then incubated for 20 hours at 
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room temperature, to inhibit CTAB crystallisation. After 20 hours, the PEGylation 
step was repeated and the sample centrifuged (15,000 G, 15 min, 30ºC) to 
remove excess PEG and CTAB. The resulting mixture was then sonicated for 15 
min at 60ºC and the repeat process of addition of PEG solution and consequently 
centrifugation was repeated two more times, with the last centrifugation step 
yielding pellets which were re-suspended in a final volume of 15 mL Milli-Q water. 
These excessive washing and centrifugation steps were necessary to remove 
toxic CTAB molecules from the solution. 
  
Gold Nanoprism Synthesis 
Gold nanoprisms meanwhile were synthesised using a novel wet-chemical 
synthetic route to produce nanoprisms functionalised with PEG chains to improve 
stability as described in previous published literature (B. Pelaz et al. 2012) with 
improved modifications. Briefly, 220 mL 0.5 mM Na2S2O3 (aq) was added to 60 µL 
0.1 M KI solution (12.2 µM final concentration). An aliquot of 110 mL of this 
solution was added slowly to 200 mL 2 mM HACl4(aq). A second addition of 110 
mL of KI and Na2S2O3 was prepared and an additional 70 mL Na2S2O3 was mixed. 
The solution was left for 1 hour at room temperature to produce gold nanoprisms.  
 
Nanoprisms were stabilised using heterobifunctional SH-PEG-COOH (5 kDa). 
PEG was added to GNPs at a 1:2 ratio (nanoprisms:PEG) of the total weight of 
gold used in the synthesis. PEG was diluted in 1 mL Milli-Q and a determined 
volume of a 10 mL, 0.1 mg.ml-1 stock solution of NaBH4 was then added to reach 
1:1 molar ratio of PEG:NaBH4. This solution was added to the nanoprism solution 
and attuned to pH 12 with 2 M NaOH. The solution was sonicated for 1 hour at 60 
ºC and centrifuged at 4,400 G for 15 min at room temperature. Pellets were 
resuspended in Milli-Q water and centrifuged three times at 4,400 G for 9 min at 
room temperature and aliquoted in 50 mL centrifuge tubes and allowed to rest at 
room temperature for several weeks. 	
3.3.1.2	Gold	Nanorod	and	Nanoprism	Characterisation	using	Transmisison	Electron	
Microscopy	
 
A 2 µL aliquot of gold nanoprisms and gold nanorods at 0.1 mg.ml-1 in miliQ H2O 
was dropped onto a carbon-coated grid and dried in air and observed using a 
LEOG12AB transmission electron microscope operating at 20−200 kV. 
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3.3.1.3	Gold	Nanorod	and	Nanoprism	UV-Visible	Absorbance	Spectra		
 
The GNP UV-visible absorbance was analysed by our collaborators in Zaragoza. 
The measurement protocol has been described (Alfranca et al. 2016). Briefly, GNP 
solutions were mixed with DMEM to a final volume of 300 µL per sample, at a 
concentration of 0.02 and 0.1 mg.ml-1.  Spectra were subsequently produced using 
a Cary 50 Probe® spectrophotometer from Varian.  
 
3.3.1.4	Gold	Nanorod	and	Nanoprism	Heating	Capacity			
 
The GNP heating capacity was assessed by our collaborators and was monitored 
using a temperature probe, placed into the GNP solutions during laser therapy, 
with the temperature recorded every 5 seconds as described (Alfranca et al. 
2016). Briefly, 300 µL per sample of GNPs at a concentration of 0.02 and 0.1 
mg.ml-1 were heated in a 96 WP using a 1 W, 1064 nm laser beam for 1 minute.  
 
3.3.2 Monolayer Cell Expansion and 3D Tumour Spheroid Culture  
 
MG63 and MCF-7 cells were cultured in T75 flasks with Dulbecco’s modified 
Eagles medium (DMEM) as described in section 2.2. Cells were seeded onto 
sterilised 13 mm coverslips within a 24 well plate at cell density of 1 x 104 per mL 
(for 2D monolayer culture) or 1 x 105 per mL (for 3D multicellular spheroid culture). 
Cells were grown for 24 hours prior to GNP exposure at 0.1 mg.ml-1 (unless 
otherwise stated).  
 
3.3.2.1	Tumour	Spheroid	Formation	via	Hanging	Drop		
 
A hanging drop ‘device’ to generate cell spheroids was created in-house using two 
6 cm petri dishes and nine 200 µL pipette tips. Briefly, an array of 3x3 dots (using 
24 WP format) was drawn on the base of a 6 cm dish and 2 mm holes were drilled 
into the corresponding dots. The holes were gently expanded to 3.5 mm while a 6 
mm drill was used to gently widen the opening of the hole. Nine 200 µL pipette tips 
were cut with the “head” completely removed and half an inch from the bottom 
removed to acts as “chambers”. The tips are then seated firmly onto the pre-drilled 
holes to create a suitable platform. This platform can be housed inside another 6 
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cm petri dish to form the lid and base of the device. Once prepared, the device 
was appropriately sterilised with 70% ethanol overnight, washed with sterile PBS 
(1x) and nitrogen dried. Cell concentrations with a maximum volume of 50 µL per 
chamber were gently pipetted into the chambers with the cell suspension forming 
a droplet at the bottom of the “chambers”/ pipette tips. The device was left in an 
incubator (37°C, 5% CO2) overnight for spheroids to form naturally within the 
droplet. 
 
3.3.2.2	Viability	of	3D	Tumour	Spheroids	Over	Time		
 
MG63 and MCF-7 cell viability during 3D spheroid culture was determined using 
the LIVE/DEAD® Viability/Cytotoxicity kit to verify the culture technique. Cells 
were expanded in flasks as described in section 2.2. MG63 and MCF-7 cells >90% 
confluence were trypsinised from flasks, centrifuged, counted and aliquots of cell 
suspensions at 1 x 104, 1 x 105 and 1 x 106 per 50 µL were prepared (n=5 for each 
cell density). The 50 µL cell solution was then gently pipetted into the chambers of 
the hanging drop device. The device was placed into an incubated humidified 
atmosphere with 5% CO2 in air at 37°C for 24, 48 and 72 hours. After this point, 5 
µL of fresh media was added to each chamber daily to accommodate for 
evaporation and availability of nutrients. 
At allocated time points (24, 48 and 72 hours) the droplets containing the 
spheroids were gently transferred into a new 24 well plate. This was achieved by 
first removing the base of the device and aligning the ‘chambers’ of the device 
over a fresh 24 well plate. The fresh 24 well plate contained 1 mL of pre-warmed 
sterile PBS in each well. The device was placed on top of the 24 well plate and the 
droplets, containing the spheroids were carefully dropped into the PBS by gently 
flooding the top of each chamber with ~250 µL of warm PBS. 
Spheroid viability was determined using the LIVE/DEAD® Viability/Cytotoxicity kit, 
as in section 2.3.2. Briefly, spheroids were washed gently in warm PBS three 
times. A media solution containing ethidium homodimer and calcein A/M (1 µL per 
mL) was then prepared and decanted into each well at 1 mL per spheroid. The 
well plate was foil wrapped and placed into an incubated humidified atmosphere 
with 5% CO2 in air at 37°C for 1 hour. Spheroids were then washed twice in fresh 
warm media and imaged under an inverted fluorescence microscope as described 
in section 2.3.2. The excitation/emission wavelengths are 485nm/515 nm for 
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calcein A/M and 525/590 for EthD-1 and is viewed with FITC and TRITC filters, 
respectively. 
 
3.3.3 GNP Labelled Monolayer and 3D Tumour Spheroid Biocompatibility 
 
3.3.3.1	Cytotoxicity	of	GNP	Labelled	Monolayer	and	3D	Tumour	Spheroids	via	the	MTT	
Assay		
 
The MTT assay, which measures cell metabolic activity, was used to determine 
the influence of GNP internalisation in MG63 and MCF-7 cells both in monolayer 
and 3D tumour spheroids. Control groups contained no GNPs. 
 
Monolayer MTT Assay 
MG63 and MCF-7 cells were seeded in 3 separate 96 well plates at 1x104 cells per 
well and incubated for 24 hours prior to GNP introduction as described in section 
2.3.1. Briefly, gold nanorods at concentrations of 0.01, 0.05 and 0.1 mg.ml-1 and 
nanoprisms at 0.1, 0.5 and 1.0 mg.ml-1were incubated with cells at 24, 48 and 72 
hours (n=5). An aliquot of 10 µL of MTT dye solution was added to each well and 
the plates were incubated at 37°C for one hour. The media was then removed and 
200 µL DMSO was used to solubilise the formazan crystals. The absorbance of 
each well was read on a microplate reader (Dynatech MR7000 instruments) at 550 
nm. 
 
3D Tumour Spheroids MTT Assay 
A similar method was conducted for the 3D tumour spheroids.  Cells were seeded 
at 1x105 per well in a 96 well plate, after 24 hours cells were incubated with 0.1 
mg.ml-1 of either gold nanorods or nanoprisms for 24 hours to allow successful 
internalisation of GNPs into cells. The cells were then trypsinised and 1x105 cells 
per spheroid were formed via a hanging drop method as described in 3.3.2.1, with 
the slight modification of spheroids dropped into a 96 well plate. The spheroids 
were then assayed at 24, 48 and 72 hours.  
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3.3.3.2	Cell	Viability	of	GNP	Labelled	Monolayer	and	Tumour	Spheroids		
 
The LIVE/DEAD® Viability/Cytotoxicity kit was used to visualise the number of 
viable and dead cells within a sample. Monolayers of MG63 and MCF-7 cells were 
cultured at 1 x 104 per well for 24, 48 and 72 hours after 0.1 mg.ml-1GNP 
incubation, as described in section 2.3.2. (n=3) 
 
The cell viability of MG63 and MCF-7 cells labelled with GNPs and cultured in 
monolayer and 3D tumour spheroids was determined qualitatively using a 
LIVE/DEAD® Viability/Cytotoxicity. MG63 and MCF-7 cells were seeded at a 
density of 1 x 105 per mL, in a 24 well plate for 24 hours. Both nanorods and 
nanoprism GNPs were introduced to the samples (0.1 mg.ml-1 in growth media; 
n=3) for a further 24 hours to allow for GNP uptake. After 24 hours, the media was 
removed and samples were washed twice in HEPES solution. An aliquot of 200 µL 
of trypsin/versene was added to each sample (5 minutes at 37ºC) until cell 
detachment, when 800 µL of media was decanted into each sample. Each 
replicate was pooled together and centrifuged for 4 minutes at 1400 rpm. Once 
centrifuged, the supernatant was removed and the cell pellet was re-suspended in 
500 µL media; cells were counted on a haemocytometer and a cell solution of 1 x 
105 per 50 µL was prepared. The 50 µL cell solution was was gently pipetted into 
the chambers of the hanging drop device. The device was then incubated at 37°C 
for 24 hrs. After 24 hours, spheroids were removed from the device and stained 
with ethidium homodimer and calcein A/M (1 µL per mL) and imaged as described 
previously (section 2.3.2) (n=5).  
 
3.3.3.3	Scanning	Electron	Microscopy	Analysis	of	GNP	/	Cell	Interaction			
To observe the interaction at the cell membrane level with the gold nanorods and 
nanoprisms, SEM was carried out. MG63 and MCF-7 monolayers were seeded at 
a cell density of 1 x 104 per mL onto 13 mm coverslips for 24 hours. GNPs at 0.1 
mg.ml-1 were then added to each sample, with samples fixed at both 1 and 24 
hours after exposure. Samples were then processed for SEM as detailed in 
section 2.4.1. 
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3.4 GNP Internalisation into MG63 and MCF-7 Cells 
 
3.4.1 Inductively Coupled Plasma Mass Spectroscopy Analysis of GNP 
Internalisation 
 
To quantitatively assess the uptake rate of GNPs into MG63 and MCF-7 cells ICP-
MS was performed. ICP-MS is a form of mass spectrometry capable of quantifying 
levels of elemental gold within samples, thus the technique was used to quantify 
the amount of GNPs internalised into both cell types at various GNP 
concentrations.  
 
MG63 and MCF-7 cells were seeded in a 96 WP at 1 x 104 per well for 24 hours. 
Gold nanorods at concentrations of 0.3, 0.2, and 0.1 mg.ml-1and gold nanoprisms 
at 0.02, 0.1 and 0.2 mg.ml-1 were added to cells (n=3). Cells containing no GNPs 
were used as control groups. After 24 hours, cells were washed in 1X PBS to 
remove extracellular GNPs.  An aliquot of 200 µL of RIPA buffer was added to 
each sample for 10 minutes at room temperature. The buffer was then removed 
and added to 50 mL centrifuge tubes. Each well was then washed with 100 µL of 
distilled water and subsequently added to each of the corresponding centrifuge 
tubes. An aliquot of 1 mL of AquaRegia (3:1 mix of HCL and 70% nitric acid) was 
added to each tube and heated in a water bath overnight at 70°C. The samples 
were then made up to 50 mL using distilled water and were prepared for ICP-MS 
analysis. The converted values for GNP uptake were averaged (n=3) and used for 
statistical analysis.  
 
3.4.2 Cell Cytoskeleton Staining  
 
The fluorescence staining of β-tubulin and F-actin filaments was completed as 
described in section 2.4.3. Briefly, MG63 and MCF-7 cells were seeded onto 13 
mm sterilised coverslips within a 24 well plate at a cell density of 1 x 104 for 24 
hours. GNPs (0.1 mg.ml-1) were then added to samples for 24 hours prior to 
fixation and processing (n=3). 
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3.4.3 Transmission Electron Microscopy Analysis of GNP Internalisation  	
To qualitatively assess gold nanorod and nanoprism internalisation by both cell 
types, TEM was carried out. MG63 and MCF-7 cells were incubated with the 
GNPs (0.1 mg.ml-1) in monolayer, prior to spheroid formation. The spheroids were 
subsequently fixed after 24 hours and processed for TEM as described in section 
2.4.2. 
3.4.4 Near Infrared Irradiation of GNP Labelled Monolayer and 3D Tumour 
Spheroids 
 
A Ventus 1 W unfocused continuous wave 1064 nm laser was used to irradiate 
GNPs that have been successfully internalised within cells in both monolayer and 
3D tumour spheroid culture. A viability stain was then used to visualise any 
resultant cell death after 1 minute laser irradiation (n=3). Control samples 
containing no GNPs were also irradiated and used to evaluate any potential effect 
of laser exposure on cells.  
 
3.4.4.1	Monolayer	Culture	Study	
 
For monolayer study, cells were cultured in a 24 well plate at a cell density of 
1x104 per sample. After 24 hours, cells were incubated with 0.1 mg.ml-1 GNPs for 
12 hours (to allow for GNP internalisation) and subsequently trypsinised and 
seeded onto 13 mm coverslips. The cells were cultured on the coverslips for a 
further 12 hours prior to irradiation. Cell samples were transferred to laser 
compatible culture chambers and positioned directly beneath the laser beam. 
Samples were then laser irradiated for 1 minute in triplicate, transferred back into 
the 24 WP and incubated for ~3 hours at 37°C, at which point cells were stained 
using the viability kit as described in section 2.3.2.  
 
3.4.4.2	3D	Tumour	Spheroid	Study	
 
Spheroids at 1x105 were prepared after monolayer incubation with GNPs (0.1 
mg.ml) and were treated exactly as the monolayer samples above. 
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3.4.5 Statistics  
 
Statistical analysis was performed in Graphpad using a one-way ANOVA. In all 
figures * = p<0.05, ** = p< 0.01, *** = p<0.001. Two tailed T-test were performed 
where mentioned.  
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3.5 Results  
 
3.5.1 Synthesis, Functionalisation & Characterisation of GNPs  
 
3.5.1.1	GNP	Size	and	Morphology	via	TEM		
 
Gold nanoprism and nanorod size, morphology, aggregation and purity were 
determined by TEM (figure 3-1). The images confirmed successful synthesis of 
both nanorods and nanoprism geometries. The nanoprisms were well dispersed, 
with varying sizes, with no indication of aggregation (figure 3-1 A,B). The 
nanoprism morphology indicated diversity not simply in size but also in the 
sharpness of the tips, which has been previously shown to affect absorbance (M. 
R. Jones et al. 2009; K. L. Kelly et al. 2003; K. L. Shuford et al. 2005a). Gold 
nanorods were also well dispersed and approximately 50 x 10 nm in size (average 
aspect ratio 7.2) (figure 3-1 C,D). Both GNP preparations did, however, present 
pseudo-spherical polyhedral particles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-1: TEM images of gold nanoprisms (A,B) and nanorods (C,D), 
obtained at 20-200kV. Polyhedral by-products were observed in both 
samples.  
D 
B A 
C 
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3.5.1.2	UV-Visible	Spectra	of	GNP	Absorbance	
 
UV-Vis spectroscopy results were performed by our collaborators in Zaragoza 
(figure 3-2). Both GNP preparations showed increased absorbance at longer 
wavelengths with peaks ~1064 nm (SPR) and thus heat generation when exposed 
to NIR wavelengths. While nanorods showed steep absorbance from ~900 nm 
until ~1064 nm and a subsequent decrease of absorbance at longer wavelengths 
thereafter, gold nanoprisms show a steady near-linear increase in absorbance 
from ~630 nm to ~1064 nm with an apparent increase in absorbance at longer 
wavelengths. Both GNPs also displayed a high absorbance peak at ~530 nm 
which may be due to a combination of GNPs transversal absorbance and pseudo-
spherical polyhedral gold nanoparticles within solutions which were also observed 
in TEM images above. 
 
 
Figure 3-2: The absorbance spectra for both gold nanorods and nanoprisms. 
Both GNPs present peak absorption values around 1064 nm wavelength 
(indicated by red dashed line).  
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3.5.1.3	GNP	Heating	Capacity	in	Response	to	Irradiation	
 
Following verification of the peak absorption at 1064 nm, the heating capacity of 
both GNPs was investigated following irradiation with a Ventus 1064 nm 
continuous wave laser. Both gold nanoprisms and nanorods demonstrated 
impressive heating capability at both 0.02 and 0.1 mg.ml-1, producing hyperthermic 
profiles within 60 seconds (figure 3-3). Gold nanorods achieved higher 
temperatures faster than their nanoprism counterparts; nanorods were able to 
reach hyperthermic profiles at ~30 seconds at 0.1 mg.ml-1 while nanoprisms at the 
same concentration required ~50 seconds. At 60 seconds, 0.1 mg.ml-1 
concentrations displayed temperatures above hyperthermic profiles, with gold 
nanorods in particular showing heating above 50°C. Blank samples containing 
DMEM were used to determine the heating effects of laser exposure alone, within 
a typical biological solution and a modest elevation of 3°C was noted after 60 
seconds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-3: The hyperthermic temperature profiles of both gold nanoprisms 
and nanorods at 0.02 and 0.1 mg.ml-1 concentration during 60 seconds of 
irradiation with a 1064 nm continuous wave 1 W laser. 
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3.5.2 Monolayer Cell Expansion and 3D Tumour Spheroid Culture  	
3.5.2.1	Tumour	Spheroid	Formation	via	Hanging	Drop		
 
MG63 and MCF-7 spheroids were formed via an in-house hanging drop device. 50 
µL of cell suspension was gently decanted into the nine 200 µL pipette tips, with 
spheroids forming naturally after ~24 hours incubation.  
 
 
Figure 3-4: In house, hanging drop device (A, C) and formation of MCF-7 
cells at a cell density of 1 x104 (B) and 1 x 105 (D) spheroids. Scale bar 
depicts 10 µm. 	
3.5.2.2		3D	Tumour	Spheroid	Viability		
 
Cell viability of 3D tumour spheroids was assessed using the viability staining kit. 
Figure 3-5 indicates the MG63 spheroids (A and B) and figure 3-6 for MCF-7 
spheroids (A and B) at different cell densities when cultured for 24, 48 and 72 
hours. Several observations were made; (1) cells were viable across the time 
points studied; (2) the increased cell density correlated with a larger spheroid 
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diameter; (3) cells appeared to proliferate over time, with a clear increase in 
spheroid diameter. Spheroid growth patterns were however inconsistent as 
indicated by the variability within samples (n=5). It was noted that at lowest, 1 x 
104 cell density at 24 hours, unified spheroids were not often formed and instead, 
micro-satellite clusters of cells were observed; this prevented the accurate 
recording of a single spheroid size per replicate. However, at the same cell density 
after 48 hours, the maturation of a single spheroid was observed in both cell types. 
Strikingly, the spheroids displayed very obvious growth in size in modest time 
frames, which has not been seen in the literature with studies using similar 
techniques. Due to the technical limitations of using a standard fluorescence 
microsocope, the focal plane was focussed on the peripheral reigons of the 
spheroid in order to guage the overal size of the spheroid. Thus, in some of these 
images, the out of focus plane often coincinded with a lack of observable 
fluorescence within the centre of the spheroid. This could be remedied using a 
confocal microscope to appropriately image spheroids, as shown by previous 
groups (Sirenko et al. 2015; Zanoni et al. 2016). 
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Figure 3-5: Cell viability staining, illustrating the spheroid diameter of MG63 
cells and the corresponding graphical representation of spheroids cultured 
for 24, 48 and 72 hours at a cell densities of 1 x 104, 1 x 105 and 1 x 106. Cells 
were stained with calcein AM (green) and ethidium homodimer (red) to 
observe live and dead cells respectively (A). Spheroid diameter 
measurements were taken; scale bars depict 100 µm (B) Error bars denote 
standard deviation (n=5). Two tailed T-test was performed * = p<0.05,            
** = p< 0.01, *** = p<0.001. 
B 
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Figure 3-6: Cell viability staining, illustrating the spheroid diameter of MCF-7 
cells and the corresponding graphical representation of spheroids cultured 
for 24, 48 and 72 hours at a cell densities of 1 x 104, 1 x 105 and 1 x 106. Cells 
were stained with calcein AM (green) and ethidium homodimer (red) to 
observe live and dead cells respectively (A). Spheroid diameter 
measurements were taken; scales bar depict = 100 µm (B) Error bars denote 
standard deviation  (n=5). Two tailed T-test was performed * = p<0.05,           
** = p< 0.01, *** = p<0.001.  
 
B 
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3.5.3 GNP Labelled Monolayer and 3D Tumour Spheroid Biocompatibility 
 
3.5.3.1	GNP	Labelled	Monolayer	and	3D	Tumour	Spheroid	MTT	Assay	
 
The debate over the biocompatibility of GNPs utilised in cell culture studies has 
been discussed extensively within the literature (Chuang et al. 2013; Connor et al. 
2005; Naha et al. 2015; H. K. Patra et al. 2007a),	 however only a modest 
consensus have suggested GNPs themselves may be inherently toxic (A. M. 
Alkilany and Murphy 2010; A. M. Alkilany et al. 2012). Therefore an MTT assay 
was performed to assess the potential toxicity, in terms of cell metabolic activity, of 
GNPs when cultured with MG63 and MCF-7 cells, both in 2D and 3D spheroid 
models. The MTT assay was performed on both MG63 and MCF-7 cells in 
monolayer at 24, 48 and 72 hrs after GNP incubation. Cells were exposed to gold 
nanoprisms at 0.1, 0.2, 0.5 and 1.0 mg.ml-1 and nanorods at 0.01, 0.05, 0.1 and 
0.2 mg.ml-1. A control group containing no GNPs was used as a benchmark at an 
assumed 100% metabolic activity.  
 
Monolayer MTT Study 
 
Gold nanoprisms did not appear to show any signs of toxicity, with consistent 
levels observed at all time points in both cell types, with MCF-7 cells actually 
indicating an increase in cell metabolic activity (figure 3-8, A). Meanwhile, whilst 
both MG63 and MCF-7 cells incubated with gold nanorods showed high levels of 
metabolic activity across the three time points at the lower concentrations, there 
was a clear drop in cell metabolic activity at the higher concentration at all time 
points (0.2 mg.ml-1; figure 3-7, B and figure 3-8, B). In particular with MCF-7 cells, 
where cell activity appeared compromised at 24 hours (75%), it did improve with 
time in culture, rising to 95% at 48 hours and 90% at 72 hours. These results were 
in agreement with the viability staining, which indicated several dead cells when 
exposed to gold nanorods. 
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Figure 3-7: MTT assay indicating GNP labelled cell metabolic activity over 
time in monolayer culture. MG63 cells were treated (A) with gold 
nanoprisms, and (B) gold nanorods. Values are presented as mean +/- SD 
(n=5). 
 
 
 
 
 
 
 
 
 
A  
B  
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Figure 3-8: MTT assay indicating GNP labelled cell metabolic activity over 
time in monolayer culture. MCF-7 cells were treated (A) with gold 
nanoprisms, and (B) gold nanorods. Values are presented as mean +/- SD 
(n=5). 
B  
A  
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3D Tumour Spheroid MTT Study 
 
The metabolic activity of GNP labelled spheroids was over 80% in all conditions, 
with no compromise in spheroid development over 72 hours, demonstrating the 
biocompatibility of GNPs in 3D systems (figure 3-9). Both cell types showed 
improved metabolic activity in a near time-dependent manner.  	
 
 
 
 
Figure 3-9: MTT assay indicating GNP labelled cell metabolic activity over 
time in 3D tumour spheroid culture. MG63 and MCF-7 cells were incubated 
with 0.1 mg.ml-1 of gold nanorods and nanoprisms prior to subsequent 
spheroid formation and culture up to 72 hours. Values are presented as 
mean +/- SD (n=5). 
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3.5.4. Viability of GNP Labelled Monolayer and 3D Tumour Spheroids  
 
The cell viability of both MG63 and MCF-7 cells following GNP labelling was 
determined in monolayer and 3D spheroid culture via live/dead staining.  
	
3.5.4.1.	Live/Dead	assay	of	MG63	and	MCF-7	Monolayers		 
 
The fluorescent viability assay was performed to assess the viability of MG63 and 
MCF-7 monolayer cultured cells incubated with both GNP preparations at 0.1 
mg.ml-1 for 24, 48 and 72 hours. Both cell types demonstrated a high quantity of 
viable cells across the time points, similar to control samples (containing no GNPs) 
(figure 3-10 A, B). In addition, the cell number increased over time in culture, 
suggesting that the presence of the GNPs did not affect cell proliferation. The gold 
nanoprisms in particular was coincided by an increase in cell density that was 
prevalent at all time points. Conversely, the gold nanorods did produce a few dead 
cells, although the overall cell culture did not appear negatively affected.  
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Figure 3-10: Fluorescent viability staining of (A) MG63 cells and (B) MCF-7 
cells, incubated with 0.1 mg.ml-1 gold nanoprisms or nanorods for 24, 48 and 
72 hours. Green fluorescence signals indicate viable cells and red indicates 
dead (control cells contain no GNPs). Scale bar depicts 100 µm. 
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3D Tumour Spheroid Viability Study 	
Figure 3-11 indicates the spheroid viability staining, where cell viability was  
maintained throughout and successful growth and maturation of spheroids was 
noted for both cell types in the presence of  0.1 mg.ml-1 GNPs.  
 
 
Figure 3-11: Cell viability staining of GNP labelled MG63 and MCF-7 
spheroids. MG63 spheroids were incubated with (A) no GNPs; (B) gold 
nanoprisms and (C) gold nanorods, whilst MCF-7 spheroids were incubated 
with (D) no GNPs; (E) gold nanoprisms and (F) gold nanorods. 
 
3.5.5. Observation of GNP/Cell Interaction Using SEM  
 
SEM was used to provide a magnified view of the cell morphology after incubation 
with the GNP preparations. Figure 3-12 and 3-13 show MG63 and MCF-7 cells, 
respectively. Both figures highlighted an increased number of cytoplasmic 
extensions in the form of filopodia in the presence of GNPs, while control groups 
(containing no GNPs) demonstrated a smooth cell surface.  GNP deposits were 
also observed around some of the cells and on the glass coverslip.                                                                                                                                                                                                          
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Figure 3-12: SEM images of MG63 cells incubated for 24 hours with (A) gold 
nanoprisms, and (B) gold nanorod, whilst (C) control cells were not 
incubated with GNPs. GNP deposits were observed both on the cell 
membrane and on the coverslip surface (black arrowheads), inducing a large 
number of filopodia compared to controls. Scale bar depicts 5 µm. 
 
 
Figure 3-13: SEM images of MCF-7 cells incubated for 24 hours with (A) gold 
nanoprisms, and (B) gold nanorods, whilst (C) control cells were not 
incubated with GNPs. GNP deposits were again observed on the cells (black 
arrowheads), producing more filopodia compared to controls. Scale bar 
depicts 5 µm. 
 		
	80	
3.5.6. GNP Internalisation into MG63 and MCF-7 Cells 
 
3.5.6.1	Quantitative	Analysis	of	GNP	Internalisation	into	Cells	in	Monolayer	by	
Inductively	Coupled	Mass	Spectrometry			
ICP-MS is an analytical technique used for the detection of elements in a sample. 
A quantitative assessment was required to analyse the GNP internalisation after 
24 hours to (1) verify cellular internalisation and (2) determine any difference in 
internalisation due to GNP type (morphology). 
 
Results clearly indicated that the gold nanoprisms were internalised far more 
efficiently than the nanorods (figure 3-14). The increase in GNP concentration 
correlated to an increased GNP internalisation for both cell types, but neither GNP 
types showed any difference in internalisation between the two cell lines. One 
point to note is that the gold nanoprisms are considerably larger than their nanorod 
counterparts and thus these results could be slightly misleading as even a low 
quantity of nanorprism internalisation could translate to a percieved higher 
internalisation rate compared to nanorods; TEM was therefore conducted to 
validate these reuslts within 3D multicellular spheroids. 
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Figure 3-14: ICP-MS analysis of MG63 and MCF-7 monolayer cells treated 
with various concentrations of GNPs at 24 hours (n=3, error bars denote 
SD). 
	
3.5.6.2	The	Influence	of	GNP	Internalisation	on	Cell	Cytoskeletal	Structure		
 
GNP internalisation is thought to be via endocytosis, which involves the cell 
cytoskeleton. The SEM images clearly indicate cell membrane extensions and 
filopodia in response to GNP incubation and internalisation; therefore components 
of the cytoskeleton, namely β-tubulin and F-actin microfilaments, were stained and 
observed. Disruption to the cytoskeleton can lead to inhibition of cell viability, cell 
proliferation and cell function	(Alice Panariti et al. 2012b).   
 
Figure 3-15 illustrates MG63 cytoskeletal staining following cell incubated with 
gold nanoprisms and gold nanorods at 0.1mg.ml-1 after 24 hours (control cells with 
no GNPs). Control cells are well spread, with distinct microtubules and actin 
filaments radiating throughout the cells. Conversely, the cells incubated with 
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nanoprisms exhibit a smaller, more elongated cell morphology, with tightly packed 
microtubules and filaments. This may reflect the high internalisation noted with 
ICP-MS and TEM data. The cell morphology of MG63 cells, when incubated with 
the nanorods was also notably different to control, with a high degree of actin 
polymerisation, a lack of actin stress fiber formation and ruffling at the cell 
periphery, most likely due to nanorod endocytosis.  
 
Figure 3-16 is identical, but illustrates MCF-7 cytoskeletal staining. In this case, 
the cells do not appear to react as strongly as the MG63 cells.  Generally, cells 
incubated with either prisms or rods are comparable with control cells in terms of 
size and shape, with visible tubulin integrity. F-actin staining suggested some actin 
remodeling in response to the GNPs but the cells maintained a well spread 
morphology where microfilaments formed stress fibers heterogeneously 
throughout the cell. Vacuoles, similar to that seen in MG63 treated gold nanorod 
samples, were also prevalent, indicating a similar up-take mechanism was 
adopted by both MG63 and MCF-7 cells, when internalising gold nanorods.
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Figure 3-15: R
epresentative fluorescence im
ages of M
G
63 cells, 24 hours after 0.1 m
g.m
l-1G
N
P incubation. Im
ages depict the F-
actin cytoskeleton (red), β-tubulin (green) and D
A
PI-stained nuclei (blue); scale bars: 50 µm
. 
 
	84	
 Figure 3-16: R
epresentative fluorescence im
ages of M
C
F-7 cells, 24 hours after 0.1 m
g.m
l-1 G
N
P incubation. Im
ages depict the F-
actin cytoskeleton (red), β-tubulin (green) and D
A
PI-stained nuclei (blue); scale bars: 50 µm
. 
	85	
3.5.6.3	GNP	Intracellular	Localisation	within	Spheroid	Cultures	Observed	using	TEM		
 
TEM images confirmed the successful internalisation by both cell lines and further 
indicated the intracellular localisation of both GNP types into endosome-like 
structures (Huefner et al. 2014) within the 3D tumour spheroids (figure 3-17). The 
TEM images appeared to support the ICP-MS data with a visible difference 
between the amount of nanoprisms and nanorods internalised into cells. The 
nanorods did not appear to be aggregated, however the nanoprisms did seem to 
aggregate within cell endosomes. No GNPs were observed free within the 
cytoplasm; suggesting GNP internalisation was via a form of endocytosis rather 
than passive diffusion.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-17:  TEM images of spheroid cross sections indicate MG63 cells 
after 24 hours incubation with 0.1 mg.ml nanorods (A)  and nanoprisms (B), 
and MCF-7 cells with nanorods (C) and (D) nanoprisms. 
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3.5.7 Near Infrared Irradiation of GNP Labelled Monolayer and 3D Tumour 
Spheroids 
 
Results from 3.5.1.3 (assessment of gold nanoprism and nanorod heating 
following irradiation) indicated that both types of GNP generated hyperthermic 
temperature profiles in under 60 seconds. Following confirmation of the 
biocompatibility of the GNPs and their successful internalisation into both cell 
lines, this study aimed to irradiate GNP labelled monolayer and 3D spheroid 
cultures to determine whether the temperatures profiles generated were sufficient 
to cause cancer cell death.  
 
Monolayer Study 
Figure 3-18 illustrates the cell viability staining of both GNP labelled MG63 and 
MCF-7 cells following irradiation (1064 nm; 1 minute; 1 W). Several observations 
can be made; (1) both control and GNP labelled cells which were not treated with 
the NIR laser were viable; (2) control cells treated with the NIR laser were viable 
and (3) GNP labelled cells treated with the NIR laser were dead.  It can therefore 
be confirmed that the cell death observed was produced from laser energy 
absorption via surface plasmon resonance of GNPs in the area of beam radius 
(and the immediate periphery) with cells outside this focal point remaining viable. 
For both cell types, the radius of cell death seems to be larger for gold 
nanoprisms, which may reflect the increased uptake and concentration of 
nanoprisms in cells.  This could lead to peripheral cells outside the immediate 
beam focus still absorbing enough laser radiation to lead to cell death, creating a 
larger “kill zone” than the nanorods.  
 
3D Tumour Spheroid Study 
The 3D tumour spheroids mirrored the monolayer results (figure 3-19). Control 
cells were not affected by laser irradiation, however spheroids incubated with 
GNPs were clearly affected by laser exposure at focused spots on spheroids. The 
irradiation of MCF-7 spheroids incubated with gold nanoprisms in particular, 
showed complete dissection of the spheroid indicating the extremely potent affect 
of gold nanoprisms, again, perhaps due to their high internalisation.    
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Figure 3-18: Fluorescencent cell viability staining of GNP labelled (A) MG63 
cells and (B) MCF-7 monolayer cultures following irradiation with a 1064 nm 
laser for 1 minute. Control cells contain no GNPs. Green fluorescence 
indicates viable cells and red indicates dead cells. Scale bar = 100 µm. Three 
independent biological repeats (n=3). 
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Figure  3-19: Fluorescencent cell viability staining of GNP labelled (A) MG63 
cells and (B) MCF-7 3D tumour spheroids following irradiation with a 1064 
nm laser for 1 minute. Control cells contain no GNPs. Green fluorescence 
indicates viable cells and red indicates dead cells. Scale bar = 200 µm. Three 
independent biological repeats (n=3). 
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3.6 Discussion  
 
3.6.1 GNP Synthesis: Size and Morphlogy  
 
Both the nanoprisms and nanorods used in this study were successfully 
synthesised, as observed by TEM. The size range varied depending on the type of 
particle being synthesised. The gold nanorods produced were controlled and 
uniform in size and aspect ratio, with rods of ~ 50 x 10 nm in size with an average 
aspect ratio of 7.2 which have been characterised by our collaborators in a 
previous study	(Alfranca et al. 2016).  
 
However the nanoprisms varied in size, with an average size of around 170 nm 
edge and 9 nm thickness. The synthesis of triangular nanoprisms tend to yield a 
small percentage of polyhedral GNPs, while other groups have observed similar 
tip-truncated nanoprisms or nanodisk by-products (J. E. Millstone et al. 2005; J.  E 
Millstone et al. 2006; Noda and Hayakawa 2016; B. Pelaz et al. 2012). Whilst the 
images confirmed the succesful synthesis of both geometries, smaller polyhedral 
GNPs were also observed in both samples. These were identified as a by-product 
of the synthesis process, which can be extremely difficult to remove	(Y. J. Shin et 
al. 2013). Any by-products are usually removed via electrophoresis, centrifugation 
and decantation however the process is not entirely efficient. However, the 
contribution of the polyhedral GNP by-products to the overall characteristics of 
both the gold nanoprisms and nanorods is minimal and did not affect the overall 
characteristic of the GNP solutions; producing gold nanoprisms with a low size 
distribution however still remains challenging using conventional wet-chemical 
synthetic routes with studies now showing lower size distributions using 
techniques such as biological (green) synthesis (Geng et al. 2016) modified seed-
mediated approach (Zhirui Guo et al. 2010b) and plasmon driven synthesis (Brus 
2016). 
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3.6.2 GNP Synthesis: Absorbance and Heating Potential 
 
Complementary UV-visible data provided by our collaborators indicated that the 
spectra do show both GNPs peak SPR bands finely tuned in the NIR region, at 
1064 nm for gold nanorods, corresponding to the longitudinal mode and 1100 nm 
for gold nanoprisms, corresponding to the in-plane dipolar band (Han et al. 
2016a). The fine-tuning of the SPR of these GNPs in the NIR region is integral to 
their function as biomedical agents	 (Cai et al. 2008). This is due to the ‘biological 
window’ for optical absorption through tissue at NIR regions, that can be 
capitalised on for non-invasive clinical application (Y. Liu et al. 2015). Interestingly, 
the presence of the polyhedral GNP by-products may explain the rise in 
absorbance that can be seen in both samples at ~530 nm (figure 3-2) (Han et al. 
2016a) but equally, this increased absorbance at ~530 nm may be in accordance 
to the transverse mode exhibited by both of these geometries (Jena and Raj 2007; 
Ye et al. 2016).  
 
The extremely efficient heating potential of both GNPs was observed in just 60 
seconds of laser irradiation, even at fairly modest concentrations (figure 3-3). Gold 
nanorods have been extensively researched and considered to be the most 
effective photothermal contrast agents, both in vitro and in vivo, with optimum 
nanorod sizes explored both theoretically and experimentally by Mackey and co-
workers (Mackey et al. 2014). It has been well documented that the surface 
plasmon resonance absorption characteristics are highly dependent on particle 
size and shape and in particular for gold nanorods, the maximum wavelength 
absorbance is directly proportional to the aspect ratio of the nanorods and thus 
increasing the aspect ratio, increases the maximum wavelength absorbance to the 
NIR regions	 (Castellana et al. 2010). The nanorods used in these experiments 
have an average size of ~50 x 10 nm. Although larger nanorod size are associated 
with maximum wavelength absorbance in the NIR regions, they are also often 
associated with an increase in scattering and thus a reduce heating potential. The 
high aspect ratio of the gold nanorods in this project - which is independent of size, 
seem to facilitate their excellent heating capacity while their long, thin morphology 
contribute to their maximum absorbance in the NIR range (P. K. Jain et al. 2006; 
Near et al. 2013).  
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Figure 3-20: Normalised extinction spectra of the gold nanorod solutions. 
The average sizes of the nanorods are, from left to right, 37 × 19 nm (aspect 
ratio 2 ± 1), 50 × 12 nm (aspect ratio 4.2 ± 1) and 50 × 8 nm (aspect ratio 6 ± 2) 
(Junxi et al. 2012). 
 
Gold nanoprisms, owing to their varied optical characteristics, which include 
triangular structure, high truncations, aspect ratio and three tips, are thought to 
have stronger electromagnetic field enhancements and provide a more distinct 
SPR in the NIR compared to their nanorod, nanocube or nanosphere counterparts 
(Huanjun Chen et al. 2008b; Han et al. 2016a; Xu et al. 2013; You et al. 2016).  
However, in this study the gold nanorods appeared to display a higher heating 
efficacy than the gold nanoprisms,	presumably due to their higher specific surface 
area leading to increased NIR absorption (Alfranca et al. 2016). 
 
3.6.3 Cell Lines and 3D Tumour Spheroid Culture  
 
Two cell lines were used in this study; a bone osteosarcoma cell line (MG63) and 
an epithelial breast cancer cell line (MCF-7). These two cell lines were selected as 
they represent tumour cells from a ‘hard’ tissue and a ‘soft’ tissue, and so may 
have intrinsic differences in their behaviour in terms of GNP internalisation and 
subsequent cellular response to intracellular heating. In addition, on a 
physiological note, epithelial cancers, in particular breast cancers, suffer from 
dormancy post metastasis, whereby the cancer cells migrate in the bloodstream 
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and relocate in the bone marrow (Valastyan and Weinberg 2011; van Zijl et al. 
2011). The cancer cells can lie undetected and dormant for many years, suddenly 
recurring to form secondary bone tumours, which have progressed beyond 
treatment (Brackstone et al. 2007; Ossowski and Aguirre-Ghiso 2010).  
 
Monolayer cell cultures, typically grown on plastic or glass substrates, are used as 
in vitro models to study tumour cell behaviour and assess anti-cancer therapies. 
However promising results at this stage are often not translated to animal studies 
or clinical trials (Edmondson et al. 2014).  This is because the extracellular 
environment, where the tumour cells live, is not reproduced. The use of 3D in vitro 
models has progressed along with advances in tissue and cell engineering, which 
provide an opportunity to bridge this gap (Edmondson et al. 2014). To this end, 3D 
multicellular tumour spheroids have been identified as useful tools, providing a 
more representative environment, featuring tumour characteristics such as 
dormancy, hypoxia and anti-apoptotic behaviour, whilst allowing for the strict 
analysis and control in vitro examination allow	 (Imamura et al. 2015; Weiswald et 
al. 2015).   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-21: A schematic comparison of a typical tumour in vivo and an in 
vitro tumour spheroid model (Phung et al. 2011). 
 
 
Early interest in tumour spheroid models began in the late 1970s, however its 
recent resurgence has coincided with our increased understanding of cancer cell 
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resistance to traditional therapies as well as the improved high throughput in vitro 
testing of tumour spheroids	 (Costa et al. 2016; Grimes et al. 2014). Spheroids 
often display more in vivo-like morphological and functional differentiation than 
their monolayer counterparts (Hornung et al. 2016), such as the notable diffusion 
limitation of spheroids, that has been suggested at around 100-150 µm for 
molecules such as oxygen, nutrients and metabolic waste	 (Curcio et al. 2007), 
while larger spheroids (~500 µm) usually display a hypoxic and necrotic core and 
an outer rim of quiescent cells and a peripheral layer of proliferating cells	(R. Z. Lin 
and Chang 2008). Tumour spheroid models also exhibit similar metabolic and 
signaling profiles, which are more closely related to in vivo conditions, compared 
to traditional monolayers and of particular interest for researchers is the 
aforementioned hypoxic environment that has been shown to lead to radiotherapy 
and chemotherapy resistance (Rey et al. 2016; Samanta et al. 2014). Thus, 
tumour spheroids help bridge the gap between standard two-dimensional and in 
vivo conditions and can further validate in vitro findings to better predict potential 
outcomes in in vivo models. 
 
Multicellular tumour spheroids were successfully produced and matured in this 
study, in the presence of GNPs, for 24 hours (figure 3-11).  Spheroids seeded at a 
lower initial cell density (1 x 104) often produced smaller ‘satellite’ aggregates of 
cells that were dispersed within the hanging drop solution, and therefore, did not 
readily form single uniform spheroids at the 24 hour time point. Meanwhile, 
spheroids seeded at the higher cell density (1 x 106) exhibited a number of dead 
cells within the spheroid structure with variability in the spheroid size (as noted by 
the higher standard deviations). Whilst characteristics such as a necrotic core 
would have been desirable, technical issues including the configuration and 
orientation of large spheroids for laser optics, and the resultant microscopy field of 
view prevented their use in this study (figure 3-5 and 3-6). Therefore, the middle 
cell density (1 x 105) was selected for photothermal therapy, due to its reliable 
production, relatively low variation in spheroid size and practicality; this was used 
for subsequent experiments.  
 
 
The presence of GNPs within the MG63 and MCF-7 spheroids did not affect their 
formation or development over 72 hours. Indeed, at the lower and middle cell 
densities the spheroids were noted to grow in diameter, suggesting cell 
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proliferation; the higher density did not appear to promote cell proliferation, with 
little/no significant change in diameter over time. 
 
3.6.4 GNP Biocompatibility 
 
The metabolic assay considered the ‘gold standard’ for cytotoxicity is the MTT 
assay	which is a colorimetric assay that measures the enzymatic activity of cellular 
mitochondria (Carnovale et al. 2016). If cells appropriately metabolise the MTT 
dye, the cell culture media will change colour, allowing for simple absorbance 
measurements to be used to quantify cellular activity (Marquis et al. 2009). The 
MTT assay, however does suffer from minor limitations (S. Wang et al. 2011a), so 
to supplement the quantitative data, the fluorescent viability staining was 
performed to visualise samples.  
 
Gold has long been considered to be chemically inert and therefore potentially 
safe in terms of biomedical applications, with gold-based compounds used in the 
clinic as anti-inflammatory agents to treat rheumatoid arthritis (Auranofin® and 
Tauredon®)(A. M. Alkilany and Murphy 2010). Due to the intricacy of nanoparticle 
toxicity, together with the lack of standardisation of experimental procedures, there 
is a discrepancy over the biocompatibility of GNPs in biological systems of 
increasing complexity (cell membrane, cells, tissues, organs and human body) 
(Fratoddi et al. 2015). The general consensus is that GNPs are well tolerated 
physiologically, as confirmed in a number of studies with both naked and 
decorated/functionalised GNPs in various cell lines (Arnida et al. 2010; Connor et 
al. 2005; J. H. Fan et al. 2009; Orlando et al. 2016). However some studies have 
also shown a potential toxicity of GNPs, particularly in relation to their size, where 
smaller GNPs (2-4 nm) can prove toxic (Hung-Jen Yen, 2009). This has been 
somewhat challenged with Mingfei Yao et al, (2015) who recently demonstrated 
that increasing particle diameter promoted the depolarisation of mitochondrial 
membrane potential, an early indicator of apoptosis.   
 
In addition to size, GNP shape has also been identified as being key in cytotoxicity 
studies, with more sophisticated geometries associated with a higher cytotoxic 
effect with gold nanorods often cited as a more toxic geometry as compared to 
nanospheres (Yinan Zhang et al, 2012). For example the in vitro cytotoxicity of 
gold nanorods in a human lung adenocarcinoma cell line was recently published 
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(Ying Tang, 2015). The study confirmed membrane damage within 4 hours of gold 
nanorod exposure while ROS production correlated to increased GNP 
concentration. Gold nanorods of varying aspect ratios were also evaluated for their 
cytotoxic potential across six different cell lines (Show-Mei Chuang, 2013). All 
three nanorods tested induced a dose-dependent suppression on cell growth to 
varying degrees, with ROS induced apopotosis and cell cycle inhibition the main 
route of GNP cytotoxicity. Bare/non-functionalised GNPs have been shown to lead 
to cell death in A549 cells (human hepatocellular liver carcinoma) in a dose 
dependent manner but not in HepG3 (human hepatocellular) and BHK21 (baby 
hamster kidney) (H. K. Patra et al. 2007a). The study confirmed cell death 
occurred through Poly ADP-ribose polymerase (PARP) activation. PARP is a 
protein which can be cleaved and leads to the downstream activation of caspases 
and cell death (H. K. Patra et al. 2007a) while oxidative stress and increased 
lactate dehydrogenase leakage was also induced in A549 cells, again in a dose 
dependent manner (Y. Tang et al. 2015).  
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The GNPs used in this study were functionalised with 5kDa PEG molecules which 
have been shown in a number of studies to improve the biocompatibility and 
stability of nanoparticles (T. Gong et al. 2014; Y. C. Park et al. 2014; Tlotleng et al. 
2016).  However, due to nanorod concerns highlighted above, it was important to 
evaluate the toxicity of both the nanoprisms and nanorods used in this study with a 
particular emphasis on the biocompatibility of the nanorods. The MTT assay 
indicated a slight reduction in cell metabolic activity for both cell lines with the 
nanorods at the highest concentration (figure 3-7 and 3-8), however, the values 
noted were not of concern and did not dip below 80% cell activity. 
 
The nanorods are synthesised in the presence of cetyltrimethylammonium 
bromide (CTAB), a cationic surfactant conventionally used by research groups 
(including our collaborators) to “grow” gold nanoseeds into nanorods. The 
surfactant CTAB is typically removed via purification or desorption techniques 
however these processes are often inadequate at removing all CTAB molecules 
and thus free CTAB molecules can remain within the nanorod solution	 (A. M. 
Alkilany and Murphy 2010). The synthesis process of gold nanorods, as described 
in section 3.3.1.1, detail the exhaustive processes used in order to remove the 
CTAB molecules from the GNP solutions.  CTAB has been argued as the main 
source of nanorod toxicity. Alkilany and Murphy (2009) validated this claim when 
they centrifuged GNP solutions, separating and analyzing the supernatant 
(containing free CTAB molecules), which was found to be cytotoxic (A. M. Alkilany 
and Murphy 2009). The potent cytotoxic effect of CTAB was also demonstrated 
well by Connor and co-workers in 2005, whereby using the MTT assay, they 
evaluated the toxicity of 18 nm GNPs to K562 cells (Connor et al. 2005). The GNP 
surface was modified with various ligands, including biotin, citrate, and CTAB. 
Both citrate- and biotin-modified particles were non-toxic when used up to a 
concentration of 250 mM, whereas CTAB-coated particles indicated toxicity at only 
0.05 mM. Once CTAB was cleared from the GNPs, the particle did not exhibit 
cytotoxic behaviour, highlighting GNPs themselves may not be toxic but rather, 
their precursors (Connor et al. 2005; N. Khlebtsov and Dykman 2011).   
 
The gold nanoprisms used in this study were synthesised without the use of the 
surfactant CTAB and thus avoided the potential cytotoxic issues encountered 
when synthesising the nanorods.  In fact, the MTT assay indicated an increase in 
cell activity in response to the nanoprisms, with consistently high cell viability.  
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One point to note is that the MTT assay may lead to an overestimation of cell 
activity. This is due to the technical processing of samples during a typical MTT 
assay. The GNPs are able to absorb and scatter light in the UV-visible range. The 
UV-visible spectra (figure 3-2) indicated an increased absorbance at around 530 
nm wavelength, while the absorbance wavelength used in by the microplate 
reader was set at 550 nm and can therefore, theoretically interfere with MTT 
results	(Kong et al. 2011).  Diaz et al (2008) assessed a variety of GNPs in media 
alone over 24, 48 and 72 hours, showing a general increase in absorbance with 
increased GNP concentration	 (Diaz et al. 2008), providing false positive results. 
The higher absorbance of nanorods at around 530 nm may account for the 
unexpectedly high viability of gold nanorods at the lower concentrations tested, 
particularly in MCF-7 cells, if they have not been adequately removed from the 
culture prior to being analysed in the plate reader (figure 3-8). Due to the nature of 
the MTT assay (the ability of mitochondrial dehydrogenase enzymes present in 
living cells capable of reducing MTT to purple formazan crystals), samples can 
display misleading false positive results. This is based on an increased metabolic 
rate  that may occur due the increased cellular activity and energy-consuming 
processes such as endocytosis, metabolism and exocytosis of the GNPs (van 
Tonder et al. 2015). This increase in cellular activity thus leads to the increased 
production of formazan, which can inaccurately be perceived as an increase in cell 
viability upon absorbance measurements.   
  
3.6.5 GNP Internalisation into the Cell Lines   
 
The SEM and TEM images (figures 3-12, 3-13 and 3-17) confirmed cell-GNP 
interaction and GNP internalisation. SEM images showed the increased number of 
cytoplasmic projections in the form of filododia in the presence of GNPs compared 
with control groups (containing no GNPs). Filopodia are cytoplasmic projections 
driven by actin polymerisation that extend beyond the leading edge of lamellipodia 
in migrating cells and are have crucial roles in and cell-cell interaction, migration 
and sensing	 (Mattila and Lappalainen 2008; S. Zhang et al. 2015). Hence an 
increase in filopodia is due to the close proximity of the GNPs to the cells.  
 
TEM imaging of GNP internalisation into MG63 and MCF-7 cells was observed by 
staining ultrathin cross sections of embedded spheroids (figure 3-17). The images 
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confirmed the GNP uptake into the cell body, the distribution and 
compartmentalisation of both GNP types into endosome-like structures (Huefner et 
al. 2014). This compartmentalisation into endosomes suggests GNP uptake was 
coordinated by a form of pinocytosis (Huefner et al. 2014), a form of energy-
dependent receptor-mediated endocytosis (RME) that is viewed as a dominant 
internalisation pathway, observed in a number of NP uptake studies (A. Albanese 
and Chan 2011a; Huefner et al. 2014; S. Jain et al. 2014). Furthermore, as 
Chithrani and Chan confirmed the influence of clathrin mediated uptake and its 
subsequent initiation of vesicle fomation in both nanorods and nanosphere 
internalisation, this suggests that a combination of uptake pathways are activated 
when cell lines are exposed to NPs (Chithrani and Chan 2007; McMahon and 
Boucrot 2011). 
 
The TEM images revealed large aggregated populations of gold nanoprisms in 
both cell types within lysosomes while a visibly lower quantity of nanorods were 
observed within similar endosome structures with little aggregation. The 
internalisation of GNPs via conventional routes such as receptor-mediated 
endocytosis follows an established pathway, including the formation of early 
endosomes, encapsulating GNPs, the maturation of the endosomes and fusion 
with lysosomes, all occurring in a spatial and temporal order	(Huotari and Helenius 
2011). The isolation of GNPs within the lysosomal system is believed to protect 
other important organelles from directly interacting with GNPs, with neither gold 
nanorods, nor nanoprisms observed in the nucleus, mitochondria, endoplasmic 
reticulum and Golgi body or free flowing within the cytosol in both cell types (W. 
Zhang et al. 2013a). It is important to note that GNPs were first introduced to cells 
whilst in a monolayer configuration (prior to spheroid formation) to allow for 
maximum GNP uptake however this may not accurately represent the 
internalisation and indeed the penetration capability of GNPs into spheroids.  
 
The GNP internalisation is dictated by the GNP geometry. This is highlighted in the 
ICP-MS results, where nanoprisms are internalised into cells far more efficiently 
than nanorods, in both cell types (figure 3-14). The striking variance between the 
two GNPs is due to their respective geometries, as NP shapes influences cell 
internalisation, as recently discussed (N. Ma et al. 2013; S. Salatin et al. 2015a).  
While relatively few studies have been dedicated to evaluating the uptake kinetics 
of nanoprisms, the debate over the proficiency of gold nanorods has been 
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reviewed, with disparity within the literature. For example, within human cervical 
cancer cells (HeLa cells), nanorods exhibit high internalisation, followed by 
spheres, cylinders, and cubes (N. Oh and Park 2014).  However it was noted in 
this study that gold nanorod internalisation was prominently decreased with a 
parallel increase in aspect ratio	(N. Oh and Park 2014). The nanorods used in this 
study have a larger than average aspect ratio and are not functionalised with 
additional ligands to assist uptake, which may account for their low uptake. 
 
It was also noted that nanorod exocytosis kinetics are faster when compared to 
spherical GNPs (N. Oh and Park 2014).  Zhang and co-workers observed the 
exocytosis of gold nanorods after just 30 minutes of incubation (W. Zhang et al. 
2013a). This may perhaps explain the lower amount of gold nanorods observed in 
this study, as samples were processed after 24 hours culture with GNPs.  
Although gold nanorods are capable of being re-internalised into cells, it may be 
the rate of exocytosis is considerably higher than the rate on endocytosis thus 
producing a low net concentration of gold nanorods within cells. 
 
3.6.6 The Cytoskeleton Post GNP Internalisation  
 
It has been reported that NPs produce sub-lethal damage to cells that may alter or 
inhibit cellular function, but are overlooked when assessing gross NP toxicity	
(Lanone et al. 2009). Therefore, although appearing viable, cells may incur 
intracellular stress following NP internalisation that is not picked up by assays 
such as the MTT assay, however such stresses are often indicated by alterations 
to the cytoskeletal network (Stefaan J. Soenen et al. 2012). Although these 
modifications to the cytoskeleton framework may simply be due to the 
internalisation process and subsequent endosomes/lysosome formation, 
disruption and reorganisation may also be indicative of additional cellular stress 
(Stefaan J. Soenen et al. 2011). 
 
Cytoskeletal staining was therefore applied to observe any alterations in 
cytoskeleton arrangement upon GNP internalisation, as reported by previous 
groups (Mironava et al. 2010; Noël et al. 2016; Tarantola et al. 2011).	F-Actin is a 
filamentous protein that facilitates the formation of microfilaments within the 
cytoskeleton; these microfilaments are integral for cell mobility and intracellular 
transport, cell-cell and cell-substrate interactions, and signal transduction	 (Calero 
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et al. 2014). Meanwhile, β-tubulin subunits are the major components of 
microtubules, which have cellular functions similar to those of microfilaments as 
well as involvement in endosome transport, apoptosis and the separation of 
chromosomes into daughter cells during interphase	 (Akhmanova and Steinmetz 
2015; Ogden et al. 2014). Potential damage to either of these components would 
suggest acute toxicity of NPs leading to inhibition of cell cycle, maturation, 
function, and of course viability.  
 
Our results suggest that, although both F-actin filaments and β-tubulin subunit 
formation were compromised to various degrees in the presence of GNPs (0.1 
mg.ml-1) after 24 hours. However, cytoskeletal reorganisation was not at the 
expense of cell attachment or viability. For MG63 cells exposed to gold 
nanoprisms the microtubule organising centre, located beside the nucleus, was 
intact, however disruption to the cytoplasmic microtubule network was noted and 
accompanied by large intercellular clefts (figure 3-15) (Tarantola et al. 2011).  TEM 
images (figure 3-17) confirmed the accumulation of GNPs enclosed within 
endosome vesicles. This increase in endosome size and number may actually, 
sterically hinder and deform the cytoskeletal architecture	 and thus explain the 
disruption and lack of dense microtubule networkat the perinuclear region	 and 
across the cell body (Alfranca et al. 2016; Estrela-Lopis et al. 2011; Hirak K. Patra 
et al. 2007b; Stefaan J. Soenen et al. 2012).  
 
Interestingly, actin filaments did not appear as affected within MG63 cells treated 
with nanoprisms, with a near homogenous distribution of filaments throughout the 
cell (figure 3-15). Conversely, MG63 cells treated with nanorods appeared to 
disrupt the microtubule network, again likely due to the formation and trafficking of 
endosomes (D. Choudhury et al. 2013a). With both nanorods and nanoprisms, a 
large concentration of actin filaments generating transverse protrusions, from the 
cell membrane were visible. These filamentous actin protrusions may be an 
indicator of cell internalisation mechanisms MG63 cells adopted, such as 
macropinocytosis;	 (Kuhn et al. 2014) an actin motivated process which is 
characterised by protrusions at the outer cell membrane, whilst a clathrin-mediated 
endocytosis	  is also dependent on actin involvement (Kaksonen et al. 2006). 
Soenen et al suggested NP-loaded endolysosomal structures located at the 
perinuclear region and near the microtubule organising centre begin to increase in 
size and lose their function due to the high influx of NPs into the cell. These large 
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structures may physically inhibit existing or newly forming cytoskeletal structures 
(Stefaan J. Soenen et al. 2012).  
 
MCF-7 cells exposed to GNPs were also evaluated in figure 3-16, with samples, 
containing no GNPs used as controls. The F-actin staining indicated that the 
majority of MCF-7 cells treated with GNPs did not exhibit an actin ring around the 
nucleus; a feature found in epithelial cells that featured in MCF-7 control samples 
although again this did not lead to any notable detrimental effects on the cell with 
β-tubulin largely remaining unaffected (Tarantola et al. 2011). 
 
 3.6.7 Photothermal Treatment of cells  
 
Due to their optical properties, both the gold nanorods and nanoprisms were 
capable of converting optical energy into thermal energy upon laser irradiation with 
a 1 W 1064 nm laser for 1 minute, as indicated in figures 3-3, 3-18 and 3-19 (P. M. 
Tiwari et al. 2015b). This NIR range would allow for maximum tissue depth 
penetration without causing notable injury to control cells (containing no GNPs) (J. 
Park et al. 2015), while longer wavelengths are attenuated by biological entities 
such as hemoglobin, pigments, and water (R. Weissleder 2001a). 
 
Following GNP internalisation, both monolayer and spheroids cell samples were 
treated with the 1 W 1064 nm laser for up to 1 minutes. All laser treated cells were 
rapidly killed with both nanorods and nanoprisms, as indicated by fluorescent 
viability staining. The absorption spectrum of the gold nanorods is dictated by their 
aspect ratio (length/width), a feature that can be manipulated by researchers to 
produce highly absorbing or scattering GNPs. By increasing the nanorod aspect 
ratio, the SPR absorption wavelength maximum of the longitudinal band 
significantly red-shifts toward the NIR regions. This easily tuneable characteristic 
has made nanorods a popular photothermal agent for cancer hyperthermia.  The 
nanorods displayed the highest absorption peak in the NIR region that correlates 
well with laser wavelengths during photothermal irradiation both in vivo and in vitro 
(Dickerson et al. 2008; T. S. Hauck et al. 2008a; Qin et al. 2015). Likewise, the 
gold nanorods used in this study indicated a strong absorbance in the NIR range 
due to their high aspect ratio of ~7.2, however the nanoprisms appeared to be 
more efficient at killing the cells, both in 2D and 3D.  
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Figure 3-22: (a) Normalised extinction spectra for gold nanorods with 
increasing aspect ratios showing a shift of wavelength to the right. The 
black, red, blue, magenta, and green spectra were taken for gold nanorods 
with aspect ratios 2.4, 2.7, 3.6, 4.4, and 6.1, respectively, with corresponding 
TEM images in (b) through (f) (Hinman et al. 2016). 
 
The aspect ratio of nanoprisms is based on the thickness of the nanoprism and 
edge length, however the three tips of the nanoprisms are also crucial 
characteristics determining its optical properties (E. Hao et al. 2004; Noda and 
Hayakawa 2016; K. L. Shuford et al. 2005a). The nanoprisms used here displayed 
excellent cell viability and but also strong heating capability upon laser excitation. 
The clear perimeter adjacent to the laser’s focal point indicates a large circular 
area with no cells present, and may be understood through the dispersion of heat 
energy that may also be released through photoacoustic effects. This occurs if the 
rate of heat absorption is much faster than the relaxation rate. In this instance, 
GNP surfaces may exceed a hundred degrees, leading to cavitation effects 
(Lapotko et al. 2006). The formation and collapse of microbubbles releases 
mechanical shockwaves, which can rupture cell membranes as well as other 
acoustic associated damage  forcing cells away from the laser focal point (Wei et 
al. 2013). Although laser treatment with both 2D and 3D models were succesful, 
technical challenges were present with 3D spheroids suspended in media. This 
included the movement of the spheroid during laser treatment; either through 
rotation or lateral motion of spheroids during treatment. This created difficulties in 
isolating the laser bean to specific regions on spheroids, although this was 
somewhat remedied by gently draining the excess media surrounding spheroid 
samples prior to treatment in order to restrict their motion.  
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3.7 Summary  
The aim of this chapter was to i) evaluate the biocompatibility of GNPs in both 2D 
and 3D and ii) assess their effectiveness as photothermal agents upon laser 
irradiation, leading to cell death  
As previously highlighted within this chapter, the debate over the biocompatibility 
of GNPs is controversial while further investigations into the shape of GNPs, in 
particular gold nanorods, influencing toxicity has been explored (Qiu et al. 2010; 
Shuguang Wang et al. 2008). The results in this study demonstrate the low toxicity 
of both gold nanoprisms and gold nanorods in MG63 and MCF-7 cells both in 
monolayer and 3D multicellular tumour spheroids, over 24, 48 and 72 hours. The 
results were particularly encouraging in the case of gold nanorods, which were 
synthesised in the presence of CTAB, which is believed to be the main culprit of 
gold nanorod associated toxicity (Wan et al. 2015).  Our results also further 
validates our collaborators removal process of CTAB during nanorod synthesis 
(Alfranca et al. 2016).  
Further investigations into the biocompatibility of the GNPs included the 
interaction, internalisation, compartmentalisation and quantification of GNPs into 
cells. Both GNPs successfully internalised within MG63 and MCF-7 cells both in 
monolayer and spheroids with TEM imaging suggesting GNP entry is 
predominantly governed by receptor mediated endocytosis and clathrin-mediated 
endocytosis.  
ICP-Mass spectroscopy revealed the large discrepancy between the two 
geometries, with nanoprisms appearing the more successfully internalised GNP in 
both cell types, over a range of concentrations. Upon internalisation into cells, 
GNPs appeared to affect the network of actin and tubulin filaments, although 
without deleterious consequences and did not appear to greatly impact cell 
viability. The remodelling of the cytoskeleton may be attributed to the increased 
quantity and volume of endosomes as a consequence of GNP uptake that can 
impair cytoskeleton integrity rather than GNPs themselves directly disrupting 
tubulin and actin formation.  
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Finally, GNPs were assessed for their photothermal efficiency via irradiation, using 
a 1 W 1064 nm unfocussed laser for 1 minute. Both GNPs displayed proficient 
heating upon NIR laser exposure as characterised by our collaborators 
experimentally within a GNP solution. In this project we evaluated photothermal 
capacity in vitro and verified its capability to lead to cell death across a large radius 
in monolayer. Within multicellular tumour models, the photothermal treatment 
demonstrated its potential for depth penetration and focus to lead to cell death on 
isolated regions within the spheroid.  
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Chapter 4 
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4 Identifying the Underlying Mechanisms of Photothermal 
Hyperthermia  
 
4.1 Introduction  
 
4.1.1 Hyperthermia and Cancer Cells  
 
Hyperthermia is the process of raising the temperature, either locally or globally in 
a patient for medicinal purposes. As previously described in section 1.2. 
Hyperthermia (42-45°C) can lead to cellular and molecular events that promote 
cancer cells to undergo apoptosis and also render cancer cells more susceptible 
to treatments from chemotherapy and radiotherapy. For example, elevating the 
temperature within the tumour tissue leads to alterations in the vascular 
permeability, increasing blood flow and tumour oxygenation that can further 
intensify the cytotoxic effect of radiation or chemotherapy (Beik et al. 2016). 
Indeed, many clinical studies have confirmed that the use of hyperthermia 
alongside radiotherapy or chemotherapy significantly improves tumour control and 
patient survival rates in breast, cervix, bladder, brain, head and neck tumours 
(Beik et al. 2016).  
 
Generally, there are no intrinsic differences between normal and tumour cell 
sensitivity upon hyperthermia, however in vivo and in vitro studies have shown that 
a selective tumour cell killing effect is achieved at temperatures between 40 and 
44°C (Behrouzkia et al. 2016; van der Zee 2002). This has been attributed to the 
tumour tissue environment, where the disorganised and compact vascular 
structure of tumourss does not promote heat dissipation, leading to retention of 
high temperatures for longer periods, subsequently leading to cancer cell 
apoptosis, while normal vascular architecture facilitates heat dissipation (Hegyi et 
al. 2013). Cancer cells characteristically survive in a hypoxic environment, with low 
oxygen, alongside acidic (low pH) conditions, due to insufficient blood perfusion 
(van der Zee 2002). Interestingly, it has been recently noted that due to their high 
metabolic demands, constant anabolic and catabolic reactions may also lead to 
the production of sub-lethal intensities of heat (Hegyi et al. 2013; Keibler et al. 
2016). The use of additional hyperthermic treatments could therefore confer 
additional thermal energy to the cells, which takes them over a toxic threshold, 
		109	
inducing the cancer cell to commit to apoptosis. The effectiveness of the technique 
is dependent on exposure time and temperature profiles achieved during 
treatment	 while considerations of cell and tissue type may determine these 
parameters (R. Haghniaz et al. 2015a; Hegyi et al. 2013). 
 
4.1.2 Apoptosis and Necrosis 
 
Apoptosis is integral to homeostatic processes and is involved in various 
physiological responses during normal development and morphogenesis, while 
also being activated during cell stress or damage (Nikoletopoulou et al. 2013). The 
morphological assessments of apoptotic features include; alterations in membrane 
composition, budding of plasma membrane without loss of integrity, mitochondrial 
permeability, shrinking of cytoplasm, condensation of nucleus, development of 
membrane bound vesicles, and fragmentation of cell into smaller bodies (apoptotic 
bodies) (Elmore 2007). 
 
However at higher temperatures (>47°C) complete thermal ablation of tissue can 
occur, this frank necrosis is often indiscriminate, effecting both healthy and 
cancerous cells. Necrosis is an acute and severe response leading to the 
premature death of cells consequently damaging nearby cells. Major hallmarks of 
necrosis include loss of membrane integrity, swelling of cytoplasm, mitochondrial 
disruption and calcification, fragmentation of organelles, and cell lysis leading to 
the release of intracellular components of the cell into the microenvironment, 
which is capable of eliciting an inflammatory response, damaging peripheral cells 
(Y. S. Cho 2014; X. Wang et al. 2014b).  
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Figure 4-1: Schematic depicting the intrinsic and extrinsic apoptotic 
pathway, previously described (Vucic et al. 2011). 
 
4.1.3 The Role of Mitochondria and Reactive Oxygen Species (ROS) in 
Apoptosis 
 
One of the major triggers to stimulate apoptosis is the ‘Intrinsic pathway’ and the 
‘Extrinsic pathway’ (as shown in figure 4-1). While the major catalyst for the 
intrinsic pathway is mitochondrial damage and subsequent release of pro-
apoptotic proteins, the extrinsic pathway is capable directly activating effector 
caspases but can also cross talk with the intrinsic pathway leading to 
mitochondrial disruption, ultimately leading to the formation of the apoptosome and 
activation of caspases, leading to apoptosis	(Yağmur Kiraz et al. 2016b; Winter et 
al. 2014). Mitochondrial stability is therefore vital for cell viability, with disruption of 
mitochondria recently been associated with an increase in ROS production 
(Leadsham et al. 2013; Ricci et al. 2004). The increased concentration of ROS in 
cells can cause damage to lipids, organelles, membranes and in particular, 
proteins and nucleic acids, further potentiating apoptosis	 (Redza-Dutordoir and 
Averill-Bates 2016). Increased ROS production has also been observed during 
heat stress with increased ROS concentration associated with increased apoptosis 
within samples (C.-H. Hou et al. 2014b; Katschinski et al. 2000; Z. Wang et al. 
2013c). 
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4.2 Chapter Aims and Objectives  
 
Chapter 3 assessed the potential use of gold nanorods and gold nanoprisms to 
induce hyperthermic cell death in bone (MG63) and breast (MCF-7) cancer cell 
lines. Both nanoparticle types were stable in biological solutions, biocompatible in 
both monolayer and 3D spheroid cell cultures and exhibited sufficient heating upon 
irradiation with a NIR laser to lead to cell death. This chapter will focus on 
assessing the gene and protein expression of key apoptotic candidates to identify 
the dominant process that occurs during the photothermal cell death induced by 
gold nanorods and nanoprisms.  
 
At the molecular level, apoptotic cells reveal key molecular players that have been 
previously discussed in chapter 1 (section 1.2.1), these include pro inflammatory-, 
initiator- and executioner caspases. Bcl-2 family members are also integral for 
regulating cell survival or apoptosis. To the best of our knowledge, studies 
involving nanoparticle-invoked hyperthermia have only screened for very small 
clusters of apoptotic markers (Espinosa et al. 2016; R. Haghniaz et al. 2015a; L. 
Mocan et al. 2015a; Shetake et al. 2015; S. Y. Yan et al. 2014; D. Yoo et al. 2013). 
While other groups determined apoptosis via morphological changes such as 
phospholipid phosphatidylserine (PS) translocation (Y. Oh et al. 2016) and 
membrane damage (Blanco-Andujar et al. 2016). 
 
This chapter will assess some of the integral molecules that belong to various 
families (e.g. Bcl-2, Hsps and caspases) that either influence cells to undergo 
apoptosis or attempt to preserve the viability of cells (in terms of thermotolerance, 
as described in chapter 1, section 1.3), with a view to identifying the mechanisms 
of gold nanoparticle induced hyperthermia.  Both cells types were assessed in 
monolayer and 3D tumour spheroid culture. All candidates were evaluated at both 
the gene and protein level. 
 
Gene expression levels were analysed using a Fluidigm Biomark HD system, 
which is a fluid dynamic high-throughput real-time automated PCR system that 
can simultaneously assess up to 96 RNA targets within a dynamic array.  Primers 
were selected based on their association with the intrinsic and extrinsic apoptotic 
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pathways; this includes members from the Hsp family, caspase family, Bcl-2 
family, cathepsins family as well as other notable apoptosis inducing molecules. 
 
Protein expression was measured using a human apoptosis antibody array, which 
allowed for the targeting of 43 apoptotic targets, including the primary members of 
the Bcl-2 family, caspase 3 and 8, Hsp -27, -60 and -70. 
 
For both RNA analysis, the cells that have undergone laser treatment were 
compared to non-laser treated cells. The conditions assessed were: 
 
• MG63 / MCF-7 monolayer; gold nanoprisms; +/- laser treated 
• MG63 / MCF-7 monolayer; gold nanorods; +/- laser treated 
• MG63 / MCF7 monolayer; no GNPs; +/- laser treated 
 
• MG63 / MCF-7 spheroids; gold nanoprisms; +/- laser treated 
• MG63 / MCF-7 spheroids; gold nanorods; +/- laser treated 
• MG63 / MCF-7 spheroids; no GNPs; +/- laser treated 
 
For protein analysis, only the monolayer cell samples were analysed, as the 
protocol uses cell lysates. 	
Both techniques produced a snap shot of the selected RNA transcripts and 
selected protein levels after GNP laser treatment in both/either 2D and 3D models 
in MG63 and MCF-7 cells.  Figure 4-2 details the molecules assessed, indicating 
any overlap where some molecules were assessed by both techniques.
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Figure 4-2: Venn diagram representing both the RNA and the protein 
targets that were assessed as potential apoptotic markers. Protein 
targets were exclusively investigated in monolayer only. 
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4.3 Materials and Methods  
 
4.3.1 Laser treatment of Monolayer and 3D Spheroid Culture Models   
 
Both MG63 and MCF-7 cells were seeded at 1 x 104 onto 13 mm coverslips and 
cultured for 24 hours prior to GNP incubation at 0.1 mg.ml-1 (section 3.3.2). 
Meanwhile, MG63 and MCF-7 spheroids were prepared at 1 x105 cells following 
incubation with 0.1 mg.ml-1 GNP concentration (as section 3.3.2.1). Once 
prepared, cell samples were subjected to laser treatment, using the Ventus 1 W 
unfocused continuous wave 1064 nm wavelength laser for 1 minute (as section 
3.3.5). Control samples either contained no GNPs or were not subjected to laser 
treatment (n=3). 
 
4.3.2 RNA Extraction and Isolation 
 
Following laser treatment, samples were further incubated for 3 hours (37ºC, 5% 
CO2). Subsequently, the MG63 and MCF-7 monolayers were washed in HEPES, 
detached with versene/trypsin, resuspended in fresh growth media and centrifuged 
(3000 x g, 10 minutes) to cell pellets. For spheroid samples, cell spheroids were 
washed with HEPES saline, centrifuged (1000 x g, 5 minutes).  All pellets were re-
suspended in 1 mL PBS and prepared for RNA extraction and isolation using 
PicoPuretm RNA Isolation Kit (thermofisher KIT0202). 
 
Samples were then processed as per the manufacturers instruction. Briefly, the 
supernatant was gently removed from each sample and re-suspended in 1 ml per 
sample of suspension media (0.9 mL of 1 x PBS/10%BSA; 0.1 mL of 0.5 M 
EDTA). Samples were then centrifuged (3000 x g for 5 minutes) and the 
supernatant removed. Cells were then extracted using 100 µL  of extraction buffer 
(XB) while the cell pellet was gently re-suspended by pipetting; samples were then 
incubated at 42°C for 30 minutes and centrifuged (3000 x g for 2 minutes). The 
extracted RNA supernatant was then transferred into a fresh microcentrifuge tube.  
 
Meanwhile, RNA purification columns were pre-conditioned by pipetting 250 µL of 
condition buffer (CB) on the purification column filter membrane for 5 minutes at 
room temperature. The purification columns were then placed into corresponding 
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collection tubes and centrifuged at 16000 x g for 1 minute. Ethanol (10 µL of 70%) 
was added to the previously extracted RNA solution and the final RNA 
extract/ethanol mixture was transferred to the pre-conditioned purification column. 
To bind RNA, the samples were centrifuged for 2 minutes at 100 x g and then 
immediately centrifuged at 16000 x g for 30 seconds, to remove flowthrough. 
Subsequently, wash buffer (100 µL) was then added to the purification columns, 
which were again centrifuged at 8000 x g for 1 minute. Following centrifugation, 
100 µL of wash buffer II was then added into the purification column with 
centrifugation at 8000 x g for 1 minute. Wash buffer II was again added to the 
purification columns and centrifuged at 16000 x g for 1 minute. After centrifugation, 
the purification column was transferred to a fresh 0.5 mL microcentrifuge tube. 
Finally 10 µL  of elution buffer was added to each purification column and 
incubated for 1 minute at room temperature. The columns were then centrifuged at 
1000 x g for 1 minute in order to distribute elution buffer in the column and then re-
centrifuged at 16000 x g to elute RNA. The isolated RNA was then immediately 
stored at -80ºC for fluidigm processing. 
 
4.3.3 Fluidigm Analysis 
 
The isolated RNA samples were subjected to reverse transcription using a 
SuperScript III Reverse Transcriptase (Invitrogen). An aliquot of 11 µL of each 
sample was added to 1 µL of oligo (dT) and 1 µL dNTPmix, followed by heating at 
65ºC for 5 minutes. A solution containing 4 µL 5X First Strand buffer, 1 µL 0.1 M 
DTT, 1 µL RNaseOUT Recombinant RNase inhibitor, 0.5 µL SuperScript III RT 
and 0.5 µL water was prepared and added to samples for 5 minutes at 4ºC and 
then incubated at 50ºC for 30 minutes, and subsequently at 70ºC for 15 minutes to 
produce cDNA. All 48 primers were pooled together (1 µL) from each primer set 
pooled and 152 µL of DNA suspension buffer. A fresh solution containing 1.25 µL 
cDNA from each sample, 2.5 µL 2x TaqMan PreAmp Master Mix, 0.5 µL pooled 
primer mix and 0.75 µL of water was prepared. Samples were then vortexed, 
centrifuged and underwent 22 thermal cycles from the following programme.  
 
 
 
 
 
		116	
Table 4-1: Thermal cycles of samples prior to fluidigm analysis  
	
 
After the cycles were completed a solution comprised of 1.4 µL water, 0.2 µL 
Exonuclease I reaction Buffer and 0.4 µL Exonuclease were added to each 
sample buffer being vortexed, centrifuged and incubated at 37ºC for 30 minutes 
followed by incubation for 15 minutes at 80ºC.  Once completed, 18 µL of TE 
buffer was added to each sample. The Exonuclease I treated sample (2.7 µL) was 
added to 3 µL of 2x SsoFast EvaGreen Supermix and 0.3 µL of 20x DNA Binding 
Dye sample loading reagent. Finally, samples were vortexed and centrifuged upon 
loading onto a 96.96 array chip. Furthermore, 0.3 µL of each individual primer set, 
as detailed in table 4-2, was added to 3 µL 2X assay loading reagent and 2.7 µL 
1x DNA suspension buffer was vortexed and centrifuged before being loaded onto 
the 96.96 array chip. 
 
Table 4-2: Fluidigm primers designed for human apoptotic targets.  
 
Primer Sequence  
Caspase 3 Forward:	5’	TGTGGAAGAACTTAGGCATC	3’	(20nt)	Reverse:	5’	TTTGCTCACACTTTCTCTCA	3’	(20nt)	
 
Caspase 7 Forward:	5’-TCTTTTGTGCTGCTTCTTTG-3’	(20nt)	Reverse:	5’-CCCACTCCTATCTTACTCCA-3’	(20nt)	
 
Caspase 8  Forward:	5’-	CTGGTCCCTGCTAACATTTG-3’	(20nt)	Reverse:	5’-	CGCATAGTGACGAATGATG-3’	(19nt)	
 
Caspase 9  Forward:	5’-	CCTGGAGTCTTAGTTGGCT-3’	(19nt)	Reverse:	5’-	TCATATGGGGCCTGAACA-3’	(18nt)		 	
 
Hsp60 Forward:	5’-	AGTGGAAATCAGGAGAGGTA-3’	(20nt)	Reverse:	5’-	AGAGGAGGAATGAGAGAAGG-3’	(20nt)	
 
Hsp70  Forward:	5’-	ATGCCATGTACTTCTCTTGG-3’	(20nt)	
Condition Hold 22 cycles Hold 
Temperature 95℃ 95℃ 60℃ 4℃ 
Time 10minutes 15 seconds 4 minutes  
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Reverse:	5’-	ATACAGAACATCTCCCACCT-3’	(20nt)	
 
Hsp90  Forward:	5’-	CACCACCCCAAATATCTTCT-3’	(20nt)	Reverse:	5’-‘TAGCTCCTCACAGTTATCCA-3’(20nt)	
 
 
 
Once completed, a qPCR heat map was created of the CT values: 
 
((CT(target,untreated)-CT(ref, untreated))-(CT(target, treated)-CT(ref,treated))  
Samples were normalised to multiple housekeeping genes, representing the 
increase/decrease in gene expression.  
 
4.3.4 Protein Expression in Monolayer Cell Samples Following Photothermal 
Therapy using Human Apoptosis Antibody Arrays 
 
Following laser treatment, both MG63 and MCF-7 monolayers were quantitatively 
assessed for apoptotic markers using the Human Apoptosis Antibody Array 
Membrane (Abcam, UK) as per the manufacturers protocol. Briefly, samples were 
laser treated as previously described and incubated for 24 hours to allow for 
optimal protein expression	(Graner et al. 2016; Moussa et al. 2016; A. S. Song et 
al. 2014; D. Tang et al. 2005; Sihong Wang et al. 2004; K.-L. Yang et al. 2016). 
Samples were washed twice in cold PBS and lysed with a protease inhibitor 
cocktail containing 1X lysis buffer and 100X Protease Inhibitor Cocktail 
Concentrate. Samples were incubated for 30 minutes at 4°C. The total protein 
lysate was then analysed via Thermo Scientific NanoDrop 2000c 
Spectrophotometer and normalised to 2.5 ug/µL per sample. Samples were 
transferred to microfuge tubes and centrifuged at 14000 x g for 10 minutes. The 
supernatant was removed from each lysate and transferred into fresh microfuges. 
Meanwhile, 2 mL of 1X blocking buffer was added to each membrane at room 
temperature (RT) for 30 minutes with gentle rocking. After 30 minutes, the blocking 
buffer was removed from membranes and sample lysates were added to 
membranes overnight at 4°C with gentle rocking. Sample lysate was aspirated 
from membranes and washed 3 x 5 minutes with 2 mL wash buffer I at room 
temperature RT and subsequently washed 2 x 5 minutes with 2 mL of 1X Wash 
Buffer II at RT. Once thoroughly washed, 1 mL of 1 X Biotin-conjugated Anti 
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Cytokines was added to each membrane with further incubation at 4°C (gentle 
rocking). Anti-cytokine reagent was aspirated from membranes and washed with 2 
mL wash buffer I at 3 x 5 minutes at RT and 2 mL 2 x 5 minutes with 1X Wash 
Buffer II at RT per membrane. Membranes were then incubated at room 
temperature (RT) for 2 hours with 1.5 mL of 1X Streptavidin-HRP. After 2 hours, 
samples were washed with wash buffer I and II as previously described and 
incubated overnight at 4°C. A solution containing detection Buffer C and detection 
Buffer D (250 µL of each buffer per membrane) was added to each membrane and 
plastic film was placed over the membranes. Samples were incubated for 2 
minutes at RT. The chemiluminescence of the samples was imaged using myECL 
Imager (thermofisher). Quantitative comparison of array images was produced via 
densitometry analysis using imageJ software. 
 
Many of these targets increase during apoptosis, and are induced during 
thermotolerance or change in response to environmental insults leading to 
dynamic genomic changes. While the majority of these targets have other primary 
functions within cells, the Bcl-2 family members, caspase members and Hsps are 
of particular interest as their main function within cells appears instrumental 
between cell survival and cell death. Other proteins such as cytochrome c, XIAP, 
livin, p53, SMAC, survivin, TRAILR -1, -2, -3, -4 and XIAP were also evaluated due 
to their direct/indirect effect on cell survival or death.   
 
4.3.5 Reactive Oxygen Species (ROS) Production Following Photothermal 
Treatment  
 
Following laser treatment of monolayer cell cultures, the cells were further 
incubated for 1 hour (37ºC, 5% CO2) and washed in HEPES saline. MitoSOX Red 
mitochondrial superoxide indicator (Molecular Probes, Invitrogen, USA) was pre-
treated according to manufacturer's instructions and added to samples at 1 mL per 
sample at 5 µM, final concentration in media. In the same media solution, 
MitoTracker® Green FM (molecular probes, Invitrogen, USA), at 100nM final 
concentration, was added. Samples were then incubated for an additional 30 
minutes (37ºC, 5% CO2) prior to washing in PBS and observation using a Axiovert 
200m fluorescence microscope (the excitation/emission wavelengths are 510/580 
nm for MitoSox Red and 490/516 for MitoTracker® Green). Images were acquired 
with ImagePro Plus Version 6.01 software (Media Cybernetics) and a sideport 
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Evolution QEi Monochrome CCD camera (Media Cybernetics). Images were 
processed using imageJ software (https://imagej.nih.gov). The 
immunofluorescence images were merged, with the co-localisation of the 
mitochondria and ROS, producing a representative fluorescence yellow image. 
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4.4 Results 
 
4.4.1 Apoptotic Marker Analysis via Fluidigm  
 
Following laser induced hyperthermia, the gene expression levels of apoptosis 
targets in MG63 and MCF-7 cells in both monolayer and 3D spheroid cultures 
were verified by fluidigm analysis. The 42 apoptotic gene markers assessed 
included members of the caspase family, Hsp family members, Bcl-2 only family 
members and cathepsin members as indicated in table 4-3  
 
APAF-1, ATP5B, B2M, BAD, BAK, BAX, BBC3, Bcl-2, BCL2L15,  
BCL2L2, BCL-XL, BID, BIK, BIM, BMF, BOK, Caspase 3, Caspase 7, Caspase 8,  
Caspase 9, Cathepsin B, Cathepsin D, Cathepsin G, Cathepsin K, Cathepsin L,  
Cathepsin S, CFLAR, CyC1, Cytochrome C, DIABLO, ENOX2, FAS, FAS-L, 
GNB2L7, Hsp60, Hsp70, Hsp90, MCL-1, PARP, PMAIP, Serpin B 10, Serpin B 3, 
Serpin B4, Survivin, TNFSF10, TYW1, UBE2D2, XIAP 
 
Table 4-3: RNA targets for human apoptotic pathways.  
 
Target Pathway 
APAF-1 Predominantly intrinsic pathway but also linked to extrinsic 
pathway  
ATP5B Housekeeping gene 
B2M Housekeeping gene 
BAD Intrinsic Pathway  
BAK Predominantly intrinsic pathway but also linked to extrinsic 
pathway  
BAX Predominantly intrinsic pathway but also linked to extrinsic 
pathway  
BBC3/PUMA Predominantly intrinsic pathway but also linked to extrinsic 
pathway  
Bcl-2 Predominantly intrinsic pathway but also linked to extrinsic 
pathway  
BCL2L15 Predominantly intrinsic pathway but also linked to extrinsic 
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pathway  
BCL2L2 Intrinsic pathway  
BCL-XL Intrinsic pathway and ROS induced-apoptosis pathway 
BID Extrinsic and intrinsic pathway  
BIK Intrinsic pathway  
BIM Intrinsic pathway  
BMF Intrinsic pathway  
BOK Intrinsic pathway  
CASPASE 3 Intrinsic and extrinsic pathway  
CASPASE 7 Intrinsic and extrinsic pathway  
CASPASE 8 Extrinsic pathway  
CASPASE 9 Intrinsic pathway  
Cathepsin B  Lysosome-mediated apoptosis  
Cathepsin D Lysosome-mediated apoptosis  
Cathepsin G Lysosome-mediated apoptosis  
Cathepsin K Lysosome-mediated apoptosis  
Cathepsin L Lysosome-mediated apoptosis  
Cathepsin S Lysosome-mediated apoptosis  
CFLAR/C-FLIP Extrinsic pathway 
CyC1 Intrinsic pathway  
Cytochrome c Intrinsic pathway  
DIABLO/SMAC Intrinsic pathway  
ENOX2 House keeping gene 
FAS Extrinsic pathway 
FAS-L Extrinsic pathway 
GNB2L7 House keeping genes  
Hsp60 Expressed in response to heat stress  
Hsp70 Expressed in response to heat stress  
Hsp90 Expressed in response to heat stress  
MCL-1 Extrinsic pathway (TRAIL mediated apoptosis) 
PARP Intrinsic, extrinsic pathway and lysosome activation 
PMAIP/NOXA Oxidative stress-triggered p53-mediated apoptosis 
Serpin B3 TNF-α induce apoptosis  
Serpin B4 TNF-α induce apoptosis 
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Serpin B 10 TNF-α induce apoptosis 
Survivin Intrinsic pathway  
TNFSF10 Extrinsic pathway 
TYW1 House keeping gene 
UBE2D2 House keeping gene 
XIAP Caspase-dependent pathway and lysosome activation 
 
 
The following figures depict the screening of apoptotic genes using a 96x96 
Fluidigm Biomark HD system. In an attempt to visually plot and compare the 
considerable differences identified, the average fold change was transformed to 
log2 to graphically depict all the results within a modest range. The graphs 
therefore all show the log2 gene fold changes based on CT calculations using 
average values from 6-housekeeping genes and then comparing laser to non laser 
samples.  
 
4.4.1.1	MG63	and	MCF-7	Monolayer	Control	Cultures	(no	GNPs)	
 
The fold change in apoptotic genes of MG63 control monolayers containing no 
GNPs when comparing laser treated to non-laser treated is shown in figure 4-3. 
There were little/no changes to the majority of apoptotic genes in the presence of 
laser treatment, indicated by the relatively low fold change expression in the 
majority of targets. Targets that show >2 fold change will be discussed in further 
detail and include the pro-apoptotic associated genes such as BID, BOK, FAS-L, 
caspase 3, BIM, BIK but also the anti-apoptotic gene Bcl-2. Although these pro-
apoptotic markers increased >2 fold, suggesting cellular stress upon laser 
exposure, these molecular events did not translate to cell death within the culture, 
as inferred in previous results from viability staining post-laser treatment (chapter 
3, section 3.4.7). 
The fold change in MFC-7 cells is shown in figure 4-4. Again, minimal fold change 
expression was detected, indicating that laser treatment did not drive cells towards 
apoptosis.  The increased expression of cytochrome c, an early apoptotic indicator 
did show a 5-fold increase	 (Chandra et al. 2002), however this did not activate 
caspase 9 or further downstream apoptotic markers, resulting in viable cells 
(chapter 3, section 3.4.7). 
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       Figure 4-3: Fold change in apoptotic gene expression in m
onolayer control M
G
63.  C
ells contained no G
N
Ps, laser treated sam
ples 
are norm
alised against non-laser treated sam
ples (n=3).  
        Figure 4-4: Fold change in apoptotic gene expression in m
onolayer control M
C
F-7. C
ells contained no G
N
Ps, laser treated sam
ples 
are norm
alised against non-laser treated sam
ples (n=3). 
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4.4.1.2	MG63	and	MCF-7	Spheroid	Control	Cultures	(no	GNPs)	
 
The fold change in apoptotic genes of MG63 control spheroids is shown in figure 4-5. 
Results indicate a greater fold change expression when compared to the 
corresponding monolayer results, with >2 fold in the majority of markers. Of these 
targets, Hsp90, Cytochrome c, BCL2L15, BID, and caspase 3, showed >4 fold 
change expression. This suggests that spheroid cultured MG63 cells induce a larger 
cellular stress in response to laser exposure than monolayer cells, however it should 
again be noted that little/no cell death was evident in viability staining (section 3.4.7). 
 
The fold change for MCF-7 cells is shown in figure 4-6. As with its monolayer 
counterpart, laser exposure did not appear to lead to any notable changes in 
apoptotic marker expression. 
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       Figure 4-5: Fold change in apoptotic gene expression in control spheroid M
G
63 cells.  C
ells contained no G
N
Ps, laser treated 
sam
ples are norm
alised against non-laser treated sam
ples (n=3). 
        Figure 4-6: Fold change in apoptotic gene expression in control spheroid M
C
F-7 cells.  C
ells contained no G
N
Ps, laser treated 
sam
ples are norm
alised against non-laser treated sam
ples (n=3). 
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4.4.1.3	MG63	and	MCF-7	Monolayer	Cultures	Labelled	with	Gold	Nanoprisms	
 
The fold change in apoptotic genes of MG63 monolayers labelled with gold 
nanoprisms and laser treated is shown in figure 4-7. Large increases were observed 
in almost all markers, in agreement with the cell death observed following laser 
treatment in chapter 3 (section 3.4.7). The majority of cell death occurred via the 
intrinsic pathway, with >10 fold change in the expression of markers associated with 
this pathway, such as, BID, BAK, BAD, DIABLO/SMAC, BCL-XL, and caspase 3, 7 
and 9 (Elmore 2007; M. Tiwari et al. 2015a; C. Wang and Youle 2009; Zhou et al. 
2011). Hsp70 and Hsp90 showed pronounced expression changes, >15 and >20 fold 
respectively, indicative of hyperthermia induced thermotolerance (Tomoyuki 
Miyagawa et al. 2014b). 
 
The fold change for MCF-7 cells is shown in figure 4-8. The majority of these markers 
showed >2 fold increase in expression with a particular increase in   APAF-1, BMF, 
Hsp70, DIABLO/SMAC, XIAP, caspase 9 and BID. Caspase 8 in particular showed a 
fold change of >21.  
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       Figure 4-7: Fold change in apoptotic gene expression in m
onolayer M
G
63 cells labelled w
ith gold nanoprism
s. Laser treated 
sam
ples are norm
alised against non-laser treated sam
ples (n=3). 
        Figure 4-8: Fold change in apoptotic gene expression in m
onolayer M
C
F-7 cells labelled w
ith gold nanoprism
s. Laser treated 
sam
ples are norm
alised against non-laser treated sam
ples (n=3). 
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4.4.1.4	MG63	and	MCF-7	Spheroid	Cultures	Labelled	with	Gold	Nanoprisms	
 
The fold change in apoptotic genes of MG63 spheroids labelled with gold nanoprisms 
is shown in figure 4-9. As with the corresponding monolayer cultures (figure 4-7), 
results showed an increased expression of almost all markers, with a particular 
increase in caspase 3, cathepsin S, MCL-1, caspase 8 and 9, APAF-1, BAX, BID, 
cathepsin –B, –K, -S, FAS, SERPIN B3, Cytochrome c and BAD. These results 
support activation of both the intrinsic and extrinsic pathways. Hsp70 and Hsp90 
were again expressed at high levels to induce thermotolerance and preserve cell 
viability	(Behrouzkia et al. 2016; X. Wang et al. 2014b). 
 
The fold change for MCF-7 spheroid is shown in figure 4-10.  Large increases in 
apoptotic markers were observed; CFLAR (also referred to as, C-FLIP), cytochrome 
c, caspase 9, Bcl-2, BAK, caspase 8 and BAX demonstrated high expression 
changes (>10 fold change) as well as >20 fold change in BID, indicating the intrinsic 
pathway is predominantly responsible for cells undergoing apoptosis, while the 
increased expression of Hsp90 was noted. 
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       Figure 4-9: Fold change in apoptotic gene expression in spheroid M
G
63 cells labelled w
ith gold nanoprism
s. Laser treated sam
ples 
are norm
alised against non-laser treated sam
ples (n=3). 
        Figure 4-10: Fold change in apoptotic gene expression in spheroid M
C
F-7 cells labelled w
ith gold nanoprism
s. Laser treated 
sam
ples are norm
alised against non-laser treated sam
ples (n=3). 
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4.4.1.5	MG63	and	MCF-7	Monolayer	Cultures	Labelled	with	Gold	Nanorods	
 
The fold change in apoptotic genes of MG63 monolayers labelled with gold nanorods 
and laser treated is shown in figure 4-11. Changes were noted in most markers.  
Whilst large fold changes (>10) were observed in markers associated with the 
intrinsic pathway (BID, capasase 9, caspase 7, BAK), increased levels of 
SERPINB10, FAS-L and BBC3 also suggested an alternative route of cell death to 
the more commonly associated hyperthermia-induced apoptosis involving the 
traditional intrinsic and/or extrinsic pathway.  
 
The fold change for MCF-7 monolayers is shown in figure 4-12. Although a fold 
change >2 is seen in most markers, the changes themselves appear more subtle 
than MCF-7 samples incubated with gold nanoprisms, with >10 fold increase 
observed in XIAP, Hsp90 and Hsp70. However a >5 fold increase was observed in 
BMF, CLFAR, Cathepsin K, BIM, Cathepsin S, Cathepsin B, BAK, SERPIN B10, 
caspase 9, cytochrome c, BID and caspase 7. These results suggest a combination 
of both the intrinsic and extrinisic (TNF) apoptosis pathways.  
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        Figure 4-11: Fold change in apoptotic gene expression in m
onolayer M
G
63 cells labelled w
ith gold nanorods. Laser treated sam
ples 
are norm
alised against non-laser treated sam
ples (n=3). 
          Figure 4-12: Fold change in apoptotic gene expression in m
onolayer M
C
F-7 cells labelled w
ith gold nanorods. Laser treated sam
ples 
are norm
alised against non-laser treated sam
ples (n=3). 
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4.4.1.6	MG63	and	MCF-7	Spheroid	Cultures	Labelled	with	Gold	Nanorods	
 
The fold change in apoptotic genes of MG63 spheroids labelled with gold nanorods is 
shown in figure 4-13.  High fold changes (>10) were noted for many apoptotic 
markers, with cytochrome c and caspase 8 indicating fold changes of >30 and >27, 
respectively. Again, heat shock proteins were induced, with Hsp70 and Hsp90 
increased >14 and >18 respectively. 
 
Differences in gene expression levels were noted with MCF-7 cells (figure 4-14) but 
the pattern was different to MG63 cells. A large increase was observed with many 
markers showing a fold change of >3. Of these markers, Bcl-2, PARP, cathepsin S, 
BIK, caspase 8, BAK, and cytochrome c show fold changes >10.  
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        Figure 4-13: Fold change in apoptotic gene expression in spheroid M
G
63 cells labelled w
ith gold nanorods.  Laser treated sam
ples 
are norm
alised against non-laser treated sam
ples (n=3). 
         Figure 4-14: Fold change in apoptotic gene expression in spheroid M
C
F-7 cells labelled w
ith gold nanorods.  Laser treated sam
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4.4.2 Apoptotic Protein Marker Analysis    
 
Antibody arrays were used to quantify the expression and fold change of 43 
apoptotic proteins within monolayer MG63 and MCF-7 cells labelled with gold 
nanorods or nanoprisms following photothermal laser treatment. Whilst the RNA 
levels have been identified, mRNA molecules are transient and often shortly after 
synthesis are degraded, therefore not all mRNAs will be used as templates to 
generate proteins.  For example, in mammalian cells, on average two copies of a 
given mRNA are synthesised per hour, however cells are capable of producing 
dozens of copies of the corresponding protein per mRNA per hour and, while the 
half-life of mRNA is short (2.6–7 hours), proteins exist for longer time periods (46 
hours); thus can also impact on the perceived fold change expression of samples 
(Vogel and Marcotte 2012b). By profiling the expression of genes and proteins 
from samples it was possible to evaluate the effects of hyperthermia on cells at 
both the genomic and proteomic level.  
 
Table 4-4: The array contained a membrane substrate enclosing 43 
antibodies of known apoptotic markers; 
Target Pathway 
Bad Intrinsic Pathway  
Bax Predominantly intrinsic pathway but also 
linked to extrinsic pathway  
Bcl-2 Predominantly intrinsic pathway but also 
linked to extrinsic pathway  
Bcl-w/bcl2l2 Intrinsic pathway  
BID Extrinsic and intrinsic pathway  
BIM Intrinsic pathway  
Caspase3 Intrinsic and extrinsic pathway  
Caspase 8 Extrinsic pathway 
CD40 (TNFR) family 
member)  
JNK/AP-1 pathway 
CD40L JNK/AP-1 pathway 
cIAP-2 (Inhibitor of apoptosis 
family)  
Extrinsic pathway 
Cytochrome c Intrinsic pathway  
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DR6 (death receptor family) Intrinsic pathway  
Fas Extrinsic pathway 
FasL Extrinsic pathway 
Hsp27 Expressed in response to heat stress 
Hsp60 Expressed in response to heat stress  
Hsp70 Expressed in response to heat stress  
HTRA (member of the serine 
protease)  
Intrinsic pathway  
IGF-I (insulin-like growth 
factor member) 
Inhibits apoptosis  
IGF-II Inhibits apoptosis 
IGFBP-1 (Insulin-like growth 
factor-binding protein 
Inhibits apoptosis (forms a proapoptotic 
p53/BAK complex to promote cell survival) 
IGFBP-2 Inhibits apoptosis  
IGFBP-3 Promotes apoptosis (p53-induced apoptosis) 
IGFBP-4 Promotes apoptosis via intrinsic pathway  
IGFBP-5 Promotes apoptosis (caspase-dependent 
apoptosis) 
IGFBP-6  Promotes apoptosis (p53-induced apoptosis) 
IGF-1sR Blocks apoptosis by inhibiting BAD activation  
livin Blocks apoptosis by inhibiting members of the 
intrinsic pathway  
p21 (The cyclin-dependent 
kinase inhibitor p21) 
Inhibitor of apoptosis  
p27 Inhibits apoptosis  
p53 Promotes apoptosis  
DIABLO/SMAC Intrinsic pathway  
Survivin (member of the 
inhibitor of apoptosis family) 
Inhibits apoptosis  
sTNF-R1 (soluble TNF 
receptors) 
Activates extrinsic pathway  
sTNF-R2 Promotes extrinsic pathway  
TNF-alpha (tumour necrosis 
factor)  
Activates extrinsic pathway 
TNF-beta Activation of the JNK pathway and intrinsic 
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pathway  
TRAILR-1 (TNF related 
apoptosis inducing ligand 
receptor 1)  
Activate extrinsic pathway linked to lysosomal 
apoptosis  
TRAILR-2 Activate extrinsic pathway linked to lysosomal 
apoptosis 
TRAILR-3 Inhibits apoptosis via TRAILR-1 and -2 
inhibition 
TRAILR-4 Inhibits apoptosis via TRAIL inhibition 
XIAP Caspase-dependent pathway  
 
These targets have been shown in a variety of studies to increase in response to 
cells either undergoing apoptosis or responding to environmental insults leading to 
dynamic proteomic changes within cells	 (K. Ahmed et al. 2015a; Hassan et al. 
2014; Moulin and Arrigo 2008). While Hsps, caspases and Bcl-2 members have 
been discussed, proteins such as cytochrome c, XIAP, livin, p53, DIABLO/SMAC, 
survivin, TRAILR -1, -2, -3, -4 and XIAP will also been evaluated due to their 
direct/indirect effect on the survival or death of cells.  An example of a stained 
antibody array is shown in figure 4-15, imaged by myECL Imager (ThermoFisher). 
Differences in protein levels were quantified by comparison of array images 
produced via densitometry analysis using imageJ software. 
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Figure 4-15: Example of a human apoptosis antibody array membrane, 
targeting 43 apoptotic markers expressed by MCF-7 cells incubated with 
gold nanoprisms and laser treated. Positive controls are indicated by bright 
spots, whilst negative controls are blank areas on the membrane. 
	
4.4.2.1	MG63	and	MCF-7	Monolayer	Control	Cultures	(no	GNPs)	
 
The protein expression of pro-apoptotic and anti-apoptotic markers in control 
monolayer MG63 cells, that were either exposed to laser treatment or not, is 
shown in figure 4-16. A basal level of almost all markers was recorded, with an 
increase in several markers in response to laser treatment, indicating cellular 
stress, however previous results noted that cell viability was not compromised 
during laser treatment alone (chapter 3, section 3.4.7).  
 
Similarly, the protein expression of apoptosis markers in control monolayer MCF-7 
cells also demonstrated an increase in several markers in response to laser 
treatment, as shown in figure 4-17.  In particular, an increase of ~1.5 fold was 
observed in Hsp27 and caspase 8, which have been previously demonstrated to 
interact with each other (Y. Guo et al. 2015). While Hsp60, a potent anti-apoptotic 
chaperon, showed increased expression.  These results do, therefore, confirm that 
laser irradiation does cause mild stress to cells, but these molecular events do not 
lead to cell death. 
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4.4.2.2	MG63	and	MCF-7	Monolayer	Cultures	Labelled	with	Gold	Nanoprisms	
 
The protein expression of apoptosis markers in monolayer MG63 cells labelled with 
gold nanoprisms, and either exposed to the laser or not is shown in figure  4-18. 
There was a significant increase in all markers for laser treated cells when compared 
to non-laser treated, demonstrating that the gold nanoprisms facilitate cellular heating 
and subsequent stimulation of apoptotic markers.   The nanoprism labelled cells 
which were not exposed to the laser (i.e. the darker bars in figure 4-18) exhibited 
higher values across almost all markers when compared the corresponding non-laser 
treated cells in figure 4-16, suggesting that the internalisation of the gold nanoprisms 
causes cellular stress. This was expected, as previous studies have shown an 
increase in cellular stress markers upon NP internalisation (Xifei Yang et al. 2010). 
However this internalisation was assessed in chapter 3 and did not compromise cell 
viability.  
 
The protein expression pattern was similar for the gold nanoprism labelled MCF-7 
cells, as shown in figure 4-19. The nanoprism labelled cells exposed to laser 
treatment consistently showed higher levels of apoptosis markers. Furthermore, the 
non-irradiated samples again showed higher levels of marker expression than the 
control MCF-7 cells (figure 4-17), indicating that nanoprism internalisation caused 
cellular stress.   
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4.4.2.3	MG63	and	MCF-7	Monolayer	Cultures	Labelled	with	Gold	Nanorods	
 
Figure 4-20 and figure 4-21 shows the protein marker expression in MG63 and MCF-
7 monolayer cells labelled with gold nanorods respectively. In both cell types, a large 
increase in apoptotic markers is noted following laser treatment.  
 
As with the nanoprisms, there was an increase in protein expression for non-
irradiated cell samples (when compared to corresponding control monolayers in 
figure 4-16 and figure 4-17 for MG63 and MCF-7 samples, respectively), however as 
stated, the internalisation, metabolism and downstream effects of GNPs could lead to 
minor cellular stress (Petrache Voicu et al. 2015).  
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4.4.3 Reactive Oxygen Species (ROS) production Following Photothermal 
Treatment  
 
Results from the previous fluidigm and protein expression analysis appeared to 
show the importance of ROS generation in stimulating apoptosis within cells via 
the increased expression of cathepsin members as well as p53, XIAP and TRAIL	
(Aits and Jäättelä 2013; Werneburg et al. 2012). Therefore, a mitochondrial and 
ROS fluorescence stain was used to visualise the mitochondria and ROS 
accumulation in MG63 cells, both laser treated and non-laser treated, labelled with 
gold nanoprisms and nanorods, or controls (containing no GNPs), shown in figure 
4-22. The non-laser treated results showed no cellular stress in control cells, with 
some minor co-localised staining evident in GNP labelled cells (upper panel figure 
4-22). However, a mass accumulation of ROS was observed in laser treated GNP 
labelled cells, as indicated by the overlay of both Mitotracker (green; mitochondria) 
and MitoSox (red; ROS). The staining confirmed an increase in cellular stress 
evident following photothermal treatment, which is linked to the mitochondria.
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Figure 4-22: Representative immunofluorescence showing MitoTracker 
staining (green fluorescence) and MitoSox staining (red fluorescence) in 
MG63 cells in laser treated and non-laser treated samples, labelled with 
gold nanoprisms, gold nanorods, or controls (containing no GNPs).  Co-
localisation is indicated by yellow; scale bar represents 50 µm.
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4.5 Discussion  
 
Gold nanoparticles (GNPs) are excellent potential candidates for photothermal 
therapy. In the previous chapter, gold nanoprisms and nanorods were assessed in 
terms of their biocompatibility in bone and breast cancer cell lines and their ability 
to generate toxic heat levels in cells following irradiation.  The resultant cell death, 
both in monolayer and 3D tumour spheroid cultures, was verified using a 
fluorescence viability stain. 
 
In this chapter, I aimed to confirm cell death via apoptosis and identify the 
pathways responsible, by using both gene and protein analysis. Most cancer 
treatments, including radiotherapy and chemotherapy, involve the activation of 
apoptosis in cancer cells, via the intrinsic and/or extrinsic pathway. It is believed 
that understanding the molecular events involved in apoptosis activation in 
response to photothermal therapy will contribute towards the development of a 
rational approach to combating cancer (S. Fulda and Debatin 2006). 
 
4.5.1 Activation of Apoptosis via the Extrinsic and Intrinsic Pathway 
 
Apoptosis is initiated through two main routes involving the plasma membrane by 
activating death receptors (the extrinsic pathway) or the mitochondria (the intrinsic 
pathway). The main molecules that have been identified and extensively studied to 
date are highlighted in figure 4-23. Both pathways converge to induce the 
activation of caspases as the terminal molecules that effect cell death (although it 
is noted that caspase-independent apoptosis pathways have been identified). 
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Figure 4-23: Schematic depicting the extrinsic and intrinsic apoptosis 
pathways with key molecules involved in initiating cell death. Note that the 
extrinsic pathway utilise membrane-bound death receptors, whilst the 
intrinsic relies on external stimuli to influence the mitochondria (Mariño et 
al. 2014). 
 
4.5.1.1	The	Intrinsic	Pathway	
 
The intrinsic, mitochondrial, pathway is initiated by stress signals such as 
radiation, hypoxia, free radicals and hyperthermia (Elmore 2007). These stimuli 
can directly affect the inner mitochondrial membrane, resulting in the mitochondrial 
permeability transition (MPT) pore, loss of the mitochondrial transmembrane 
potential and DNA damage. This in turn causes the release of apoptotogenic 
factors such as cytochrome c, apoptosis inducing factor (AIF) or Smac/DIABLO 
from the mitochondrial intermembrane space into the cytosol and activation of p53 
(Nikoletopoulou et al. 2013). P53 is a potent tumour suppressor gene and upon 
activation during DNA damage or intrinsic/extrinsic signalling, acts a transcription 
factor to activate the transcription of target genes such as BAX, NOXA and PUMA, 
all key pro-apoptotic proteins involved in the disruption of the mitochondrial 
membrane and thus, the intrinsic pathway	(Yağmur Kiraz et al. 2016b). 
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As indicated in figure 4-23, once cytochrome c has been released into the cytosol, 
it is capable of activating caspase 9 by interacting with the cytoplasmic protein, 
Apaf-1 and procaspase-9 to form the active multiprotein apoptosome. Activating 
caspase 9 in turn stimulates effector caspases 3, 6 and 7, resulting in degradation 
of cellular components and apoptosis	(Ilmarinen et al. 2014; K. Sinha et al. 2013). 
Meanwhile, SMAC/DIABLO, along with HtrA2/Om, also released from the 
mitochondria are capable of interacting with, and impeding IAPs (inhibitors of 
apoptosis proteins), including XIAP (X-linked inhibitor of apoptosis protein), c-IAP1 
(Apoptosis Inhibitor 1) and c-IAP2 Apoptosis Inhibitor 2) (Du and Elemento 2015; 
Gustavo Martinez-Ruiz et al. 2008b; Q.-H. Yang and Du 2004). 
 
In addition, activation of BAX/BAK also occurs at the mitochondrial outer 
membrane (MOM)	 (Nikoletopoulou et al. 2013). Upon activation, BAK and BAX 
undergo conformational changes to form homo-oligomers and translocate to the 
mitochondrial membrane, disrupting mitochondrial potential and the subsequent 
release of important pro-apoptotic molecules such as cytochrome c and 
DIABLO/SMAC	 (Ren et al. 2010). Though the exact mechanism of BAK/BAX 
initiation is still unknown, it has been proposed that the pro-apoptotic protein, 
PUMA can activate BAX and BAK-dependent permeabilization of the MOM	
(Nakano and Vousden 2001). Although Willis et al also observed BAX/BAK 
activation occurring naturally once BH-3 only proteins inhibit pro-survival proteins 
such as Bcl-2, Bcl-xL, and Mcl-1 (Willis et al. 2007).  
 
The mitochondrial outer membrane (MOM) permeability is a vital catalyst to 
activating the intrinsic pathway, with Blc-2 members responsible for regulating its 
permeability	 (Gillies and Kuwana 2014). Disruption to the MOM can occur via 
truncated BID (tBID); the conformational change of BID to tBID is actually 
orchestrated by caspase-2 in response to various stimuli including an increase in 
ROS concentration (Bonzon et al. 2006; S. Kumar 2009). The activation of tBID 
leads to the  oligomerisation of  Bak and/or Bax at the MOM, again leading to the 
disruption of mitochondrial outer membrane potential and the subsequent release 
of cytochrome c and SMAC/DIABLO into the cytosol	 (S. Fulda and Debatin 2006; 
Kantari and Walczak 2011; Ren et al. 2010).  The convergence between the 
intrinsic and extrinsic pathway is observed in this initiation as BID is also activated 
by caspase 8, which has been previously shown to be an active member of both 
the extrinsic and intrinsic pathways (Kantari and Walczak 2011).  
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4.5.1.2	The	Extrinsic	Pathway	
 
In apoptosis initiated by death receptor signalling, the extrinsic pathway, 
mitochondrial damage is not required in most cells as caspase 8 can directly 
activate downstream caspases	 (Westphal et al. 2011). The cell surface death 
receptors, include Fas (CD95/APO1), TRAIL-R (TNF related apoptosis receptor), 
death receptor 5 (DR5; also known as TNFRSF10B) receptors and TNFα (tumour 
necrosis factor-α) receptors (Nikoletopoulou et al. 2013). These receptors can be 
activated by their respective ligands, such as CD95 ligand, TNFα as well as TRAIL 
(Simone Fulda 2015). Once activated, corresponding receptors begin to activate 
and the recruitment of adaptor proteins such as adaptor FADD (FAS-associated 
DEATH domain protein), or in the case of TNFR1 the adaptor TRADD (TNFR1-
associated DEATH domain protein), begin to complex with inactive caspase 8, 
leading to the formation of DISC (death-inducing signaling complex) (Simone 
Fulda 2015; Vucic et al. 2011).  DISC can activate caspase 8, this active caspase 
8 is then capable of cleaving BID to tBID, thus leading to the downstream 
activation of BAX/BAK, and the intrinsic apoptosis pathway, although it can also 
activate caspase 3 and 7 independently, thus bypassing the intrinsic pathway	 (Y. 
Kiraz et al. 2016a).  
 
4.5.1.3	Lysosome-mediated	apoptosis		
 
For many years, caspases have been regarded as the chief instigators of 
apoptotic signaling however fairly recent studies have begun to show the 
significance of proteases from the endosomal/lysosomal systems (Ivanova et al. 
2008). Lysosomes are cytoplasmic membrane-enclosed organelles containing a 
plethora of hydrolytic enzymes, including proteases such as cathepsin members 
(cathepsin -B,-D, -L)  which are capable of activating pro-apoptotic effectors such 
as caspase 2, BID, BAX/BAK and can even directly influence the MOMP, 
prompting the intrinsic pathway (Boya and Kroemer 2008b). For cathepsins (and 
other hydrolytic enzymes) to escape the lysosome and become active within the 
cytosol, the lysosome membrane must first be permeabilised, this lysosomal 
membrane permeabilisation (LMP) can occur via various stimuli, including an 
increase in ROS concentration, upstream protease activation, p53 activation/DNA 
damage and pro-apoptotic Bcl-2 members (Aits and Jäättelä 2013). LMP has also 
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been shown to be involved in processes such as necrosis, necrotoposis, 
autophagy as well as apoptosis (Repnik et al. 2013). It is thought that a 
quantitative relationship exists between the amounts of LMP within a cell and the 
pathway of cell death with more moderate stimuli triggering a modest LMP 
reaction leading towards more of an apoptotic pathway while more rigorous insults 
leading to an increased LMP response and a complete release of lysosomal 
contents, favouring a more necrotic pathway (Kroemer and Jaattela 2005; Repnik 
et al. 2013; B. Turk and Turk 2009). 
 
4.5.2 Changes in Apoptotic Gene Expression  
 
4.5.2.1	Laser	Treatment	Alone	Induces	Mild	Cell	Stress	
 
The results in this chapter indicate that laser treatment of unlabelled cells (i.e. 
control cells) causes mild cellular stress but does not affect cell viability.  The 
results indicating which genes were increased in both monolayer and 3D cultured 
cells are summarised in table 4-5. 
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Table 4-5. A table indicating the genes expressed and the related apoptosis 
pathway following laser treatment of unlabelled control MG63 (bone) and 
MCF-7 (breast) cancer cell lines in 2D and 3D culture. 
 
 
With MG63 monolayer cells, the main increases noted were in BOK, BID, FAS-L, 
Bcl-2 and caspase 3. BOK is a pro-apoptotic Bcl-2 family member that has been 
shown to lead to BAX/BAK activation and thus the intrinsic pathway (Echeverry et 
al. 2013), while the overexpression of BID is also linked to BAX/BAK activation 
and the subsequent release of pro-apoptotic proteins from mitochondria.  The 
elevated Bcl-2 expression may have reduced capsase 9 and thus caspase 3 
activation through inhibition of cytochrome c release (Elmore 2007), however 
caspase 3 expression was elevated, suggesting involvement of the extrinsic 
pathway involving FAS-L (although subsequent activation of FAS and caspase 8 
would be required, which was not shown here). It may therefore appear that 
caspase 3 was activated by a novel ROS activated pathway (C.-H. Hou et al. 
2014b). The mitochondrial / ROS fluorescent staining in figure 4-22 did indicate 
Cell 
Type 
Culture Increased Genes 
Expressed 
Apoptosis 
Pathway 
Thermotolerance 
MG63  monolayer BID, BOK, BIK 
 
FAS-L,  
Caspase 3  
(>2 fold change) 
Intrinsic 
 
Extrinsic 
 
MCF-7  monolayer PMAIP 1 
Cytochrome c 
(>2 fold change) 
Intrinsic 
 
Hsp90 
MG63  spheroid BAX  
 
Caspase 7 
 
PARP 
(>5 fold change) 
Intrinsic  
 
Intrinsic/extrinsic 
 
DNA damage, 
oxidative stress 
Hsp90 
MCF-7 spheroid Caspase 8 
 
 
Cytochrome c, 
Survivin 
(>2 fold change) 
Extrinisic pathway 
 
Intrinsic pathway 
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the presence of ROS in some cells while the generation of ROS in cells upon 
continuous wave laser exposure has been previously confirmed (Mohanty et al. 
2006).  
 
Interestingly the breast cancer cell line, MCF-7, whilst also indicating signs of 
cellular stress, showed very small variations in markers, although a fold change >2 
was observed in Hsp70, PMAIP 1 and >4 fold change in cytochrome c. These 
markers have previously been noted in response to an increase in ROS 
accumulation within cells, an occurrence that has been linked to NIR exposure 
(Eno et al. 2013). Oxidative stress within cells can also lead to the downstream 
release of cytochrome c from mitochondria, which may account for its increase 
expression (C.-H. Hou et al. 2014b).  
 
When cells were cultured in 3D spheroids, MG63 cells showed a greater level of 
cell stress as an increase in the majority of apoptotic markers were observed with 
BAX, caspase 7, PARP and Hsp90 showing >5 fold increase. Caspase 7 can be 
directly activated by capsase 9 and as our results suggest, this intrinsic activation 
may be responsible for its increased expression (Brentnall et al. 2013). PARP-1 
plays key roles in DNA repair, chromatin modulation, and transcription upon 
cellular stress and is highly expressed in cells exposed to oxidative stress and 
thermal pressure (Luo and Kraus 2012). Its unregulated expression suggests laser 
exposure may increase ROS concentration in cells and possible genetic 
disruption, although again previous data supports the high viability of MG63 
spheroid control samples. Hsp90, as previously described in chapter 1 (section 
1.3.1) is an integral member of the heat shock protein family, Hsp90 is involved in 
cellular homeostasis, transcriptional regulation, chromatin remodeling, and DNA 
repair (Pennisi et al. 2015). The expression of both Hsp90 and PARP-1 suggest 
DNA damage via increased ROS production. Hsp90 may also be critical in 
regulating apoptosis by supporting Protein kinase B (PKB) activation, which in turn 
prevents cytochrome c release, and also by negatively regulating the association 
of Apaf-1 with caspase 9	(Workman and Powers 2007).  
 
However, MCF-7 spheroids displayed similar results to their monolayer 
counterparts, although a >2 fold change increase was observed in caspase 8, 
cytochrome c, and survivin. Survivin is a member of the IAP family and can inhibit 
apoptosis and promote cell proliferation (S. Cho et al. 2010b). Survivin has 
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previously been shown to inhibit SMAC/DIABLO while also stabilising XIAP – a 
protein capable of inhibiting caspase 3,7 and 9 (S. B. Bratton et al. 2002; Y.-F. Lin 
et al. 2013b; Pavlyukov et al. 2011). 
 
In summary, the bone cancer cell line (MG63) appears to be more susceptible to 
laser treatment than the breast cancer cells (MCF-7). Furthermore, cells respond 
more acutely to the laser when cultured as 3D spheroids rather than in monolayer 
cultures. This may be due to the tighter cell-cell interactions within spheroid culture 
allowing for a greater number of cells to be activated, or it may point towards an 
issue in heat dissipation in 3D compared to 2D, which has not been previously 
observed (Khoei et al. 2004; A. S. Song et al. 2014; Yamamoto et al. 2015). In 
both cases cellular stress appears to be linked to an increase in ROS within the 
cells, which is supported by the occasional ROS/mitochondria staining in figure 4-
22. 
 
4.5.2.2	Laser	Treatment	of	GNP	Labelled	Cells	Activates	Apoptosis	
 
The screening of 42 apoptotic genes has provided a widespread analysis of the 
molecular events that occur following hyperthermia via photothermal laser 
treatment of samples labelled with GNPs. Fluidigm analysis confirmed cell death 
occurred via apoptosis, in both 2D monolayers and 3D multicellular tumour 
spheroids when cells were labelled with GNPs and laser treated. The results are 
summarised in table 4-6 detailing the genes that were increased and the apoptosis 
pathway they are lined to (table 4-6.). When considering all samples, it appears 
the predominant pathway to induce apoptosis within cells is the intrinsic 
(mitochondrial) pathway (Z.-G. Cui et al. 2014e; Pérez-Hernández et al. 2015; J.-f. 
Zhang et al. 2016). However the high expression of caspase 8, BID and caspase 3 
in some samples may suggest that apoptosis occurring via the extrinsic pathway 
(Nagarsekar et al. 2008).  
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Table 4-6. A
 table indicating the genes expressed and the related apoptosis pathw
ay follow
ing laser treatm
ent of unlabelled M
G
63 
(bone) and M
C
F-7 (breast) cancer cell lines in 2D
 and 3D
 culture containing G
N
Ps. (* = fold change >5, ♯ = fold change >10). 
 C
ell 
Type 
C
ulture  
G
N
P
  
G
enes E
xpression 
A
poptosis 
P
athw
ay 
Therm
o- 
Tolerance 
M
G
63 
m
onolayer 
prism
s 
C
athepsin B
* C
athepsin S
*, C
athepsin D
♯, 
  S
urvivin* B
A
D
* B
A
X
* P
M
A
IP
 1* B
A
K
* B
ID
♯ caspase 9
♯ caspase 3
♯ 
C
ytochrom
e C
♯ D
IA
B
LO
/S
M
A
C
♯ B
C
L-X
L
♯ ♯ caspase 7
♯ 
  caspase 8
♯ 
Lysosom
e 
   Intrinsic 
  E
xtrinsic 
 
    H
sp70  
H
sp90 
   
M
G
63 
m
onolayer 
rods 
B
A
D
*, B
A
K
*, B
C
L-X
L*, B
B
C
3 (P
U
M
A
)*, B
O
K
* B
ID
♯ capsase 3*, 
A
P
A
F-1* B
C
L2L15
♯ C
aspase 9
♯, 
  TN
FS
F10
♯, S
E
R
P
IN
 B
10
♯, Fas-L
♯  C
aspase 8
♯  
 Intrinsic  
  E
xtrinsic  
  H
sp70* 
H
sp90
♯ 
M
C
F-7 
m
onolayer 
prism
s 
cytochrom
e c*, caspase 9
♯, A
P
A
F-1
♯, D
IA
B
LO
♯, caspase 7* caspase 
3* 
 caspase 8 (>21 fold change) 
Intrinsic  
 E
xtrinsic 
 H
sp70
♯ 
H
sp90* 
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M
C
F-7 
m
onolayer 
R
ods 
B
M
F*, B
IM
*, B
A
K
*, caspase 9* C
ytochrom
e c* caspase 7* 
 S
E
R
P
IN
 B
10*, C
FLA
R
* 
 C
athepsin B
*, C
athepsin K
* C
athepsin S
* 
Intrinsic 
 N
ecrotoposis 
A
utophagy 
 Lysosom
e 
  H
sp70
♯ 
H
sp90
♯ 
M
G
63 
S
pheroid 
P
rism
 
B
A
X
*,B
A
D
*,B
ID
*,C
ytochrom
e C
*, A
P
A
F-1*,C
aspase 3 (F.C
 ~20), 
D
IA
B
LO
* 
 FA
S
*B
C
L-2*,M
C
L-1
♯, S
E
R
P
IN
 B
3* 
 C
athepsin K
*, C
athepsin S
*, C
athepsin B
* 
Intrinsic  
  E
xtrinsic 
 Lysosom
e 
   H
sp70
♯ 
H
sp90
♯ 
 
M
G
63 
S
pheroid 
R
od 
B
ID
♯ B
IK
 B
A
K
*, B
C
L-2*, C
ytochrom
e C
 (~30 F.C
), C
aspase 3
♯ 
C
aspase 7
♯  (~23 F.C
), C
aspase 8 (~27 F.C
), C
aspase 9*, P
A
R
P
* 
 S
E
R
P
IN
 B
3*,S
E
R
P
IN
 B
10*, M
C
L-1* 
 C
athepsin K
* 
 
Intrinsic 
 E
xtrinsic  
  Lysosom
e  
 H
sp70 
(~15 FC
) 
H
sp90 
(~18FC
) 
M
C
F-7 
S
pheroid 
P
rism
 
B
A
X
♯, B
IM
*, B
C
l-2
♯, B
A
K
*, A
P
A
F-1*, C
aspase 3
♯, C
aspase 7* 
C
aspase 9
♯ 
 B
ID
 (F.C
 ~21),C
aspase 8
♯,M
C
L-1*,C
FLA
R
*, FA
S
-l*, P
A
R
P
* 
Intrinsic  
  E
xtrinsic  
 H
sp70* 
H
sp90
♯ 
M
C
F-7 
S
pheroid 
R
ods 
C
aspase 8
♯, P
A
R
P
♯ 
 B
C
L-2
♯, 
B
A
K
♯, 
B
IK
♯, 
C
aspase 
7*, 
C
aspase 
9*, 
C
ytochrom
e 
c
♯ 
D
IA
B
LO
♯ 
 C
athepsin K
*, C
athepsin S
♯ 
 
E
xtrinsic  
 Intrinsic  
  lysosom
e 
 H
sp70
♯ 
H
sp90
♯ 
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Monolayer MG63 Cells: Gold Nanoprisms and Nanorods 
 
MG63 monolayers labelled with gold nanoprisms showed an increased gene 
expression in the majority of apoptotic markers, with >5 fold change expression 
measured in survivin, BAD, BAX, PMAIP 1, BAK and cathepsin S. While a >10 
fold change expression was measured in caspase 8, cathepsin B, caspase 3, BID, 
caspase 7, caspase 9, DIABLO/SMAC, BCL-XL and Hsp70 and Hsp90. The 
majority of these markers indicate the intrinsic apoptotic pathway, as seen by the 
increased expression of BID, cytochrome c, DIABLO/SMAC and caspase -3, -7 
and -9, however the expression of caspase 8 also supports the activation of the 
extrinsic pathway. 
 
The up regulation of cathepsin has been linked to activating caspase 3 and 7, as 
well as BID activation	 (Leist and Jaattela 2001). Cathepsins are proteases which 
mainly located within lysosomes and capable of protein degradation; they were 
originally believed to cause degradation during necrotic and autophagic death (V. 
Turk et al. 2012). Their functions have been extensively explored and shown to 
promote apoptosis by degrading anti-apoptotic proteins such as Bcl-2, Bcl-xL, Mcl-
1 and XIAP, thereby tipping the scale towards apoptosis (V. Turk et al. 2012).
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Figure 4-24: Schematic depicting the permeabilization of a lysosome 
membrane by a variety of external stimuli, DNA damage or via intracellular 
signalling leading to the release of cathepsin from the lysosome and the 
simultaneous degredation of pro-survival proteins and subsequent 
activation of pro-apoptotic proteins. 
 
Cathepsin S is a cellular cysteine protease, with the over-expression of this 
protease, associated with cell survival	 (K.-L. Chen et al. 2012). However the 
increased expression is also linked to autophagy - a highly conserved metabolic 
process that permits the degradation and recycling of cellular constituents, in 
response to cell stress	 (Mariño et al. 2014). Cathepsin B is released upon 
lysosomal disruption and has been shown to degrade Bcl-xL proteins, thus 
promoting apoptosis and shifting the intracellular events away from necrotic 
activity (de Castro et al. 2016).  Cathepsin D activity is more controversial, and has 
shown both anti- and pro- apoptotic properties and has unfortunately not been fully 
characterised, although its activation appears similar to cathepsin B, released into 
the cytosol upon lysosome disruption (Minarowska et al. 2007). Oxidative stress 
again appears as a marker, as the increased expression of PMAIP (Noxa) was 
observed in increasing ROS concentrations (Eno et al. 2013). PMAIP expression 
has been shown to elevate in response to increased ROS concentration, in 
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particular hydrogen peroxide (h2O2)	 (Eno et al. 2013). H2O2 has also shown to 
cause lysosomal membrane permeabilisation, which may explain the increased 
expression of cathepesin observed.  
The increase in NOXA expression is also associated with a decrease in Bcl-2 and 
Bcl-xl and may explain the more modest expression values seen in Bcl-2 
expression (Barkinge et al. 2009). BAD is a pro-apoptotic marker, that contributes 
to the intrinsic pathway and is integral at lowering the threshold at which tBID and 
BAX/BAK are instigated and inhibiting Bcl-2 and Bcl-xl, although results show a 
minor fold change in Bcl-2, Bcl-xl expression remains unaffected by its increased 
expression (Howells et al. 2011). Survivin, is a unique inhibitor of apoptosis, that 
also showed >5 fold change, and although its function has not been entirely 
characterised, it has been shown that survivin can inhibit caspase 9 activation, 
although our results do not reflect this (Y. Lin et al. 2016; McKenzie and Grossman 
2012). Bcl-xl is an anti-apoptotic protein, found localised in the cytosol, 
surrounding the outer mitochondrial membrane, although its definitive role still 
remains controversial, Bcl-xl has been shown to inhibit pro-apoptotic members 
such as BAX/BAK tBID, BIM and PUMA (Janet H. Zheng et al. 2016; Zhou et al. 
2011). These results show a heavy influence of both the intrinsic pathway and 
ROS induced-apoptosis pathway, which has been explored and supported in 
isolation by previous groups. 
 
When MG63 monolayers were labelled with gold nanorods a similar large increase 
(>10 fold) was observed in genes including BID, Hsp90, caspase 9, SERPIN B10, 
and Fas-L, whilst BAD, BAK, BBC3 (PUMA), capsase 3, Hsp70 and APAF-1 
targets were also increased (>5 fold). As with the MG63 cells labelled with gold 
nanoprisms, many genes were linked to the intrinsic pathway, however there were 
some key genes in this pathway that differed from the MG63 cells labelled with 
nanoprisms, such as BBC3 (commonly referred to as PUMA). This is a pro-
apoptotic complex and has been discussed for its role in directly activating Bax 
and Bak activation proteins leading the subsequent release of cytochrome c from 
mitochondria and caspase 3 activation. This in turn leads to the proteolysis of key 
cellular substrates, including PUMA itself (Ramírez-Labrada et al. 2015). 
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Monolayer MCF-7 Cells: Gold Nanoprisms and Nanorods 
 
MCF-7 monolayers labelled with gold nanoprisms displayed potent intrinsic 
markers such as cytochrome c caspase 9, APAF-1, DIABLO, caspase 7 and 
caspase 3, suggesting hyperthermia contributed to the direct disruption of the 
outer membrane mitochondrial potential via ROS production and/or rupture by the 
persistent opening of the permeability transition pore due to mitochondrial calcium 
overload during heat stress (Belhadj Slimen et al. 2014). This would explain the 
more modest fold change expression of BAX and BAK, which are the notable 
proteins that instigate the intrinsic pathway. 
 
With regards to the extrinsic pathway, caspase 8, which chiefly coordinates the 
pathway, demonstrated a large increase (>21 fold change). No notable expression 
changes were observed in FAS or TNFSF10 gene expression, but the caspase 8 
fold change coincided with increased expression of BID and the subsequent 
release of cytochrome c. With regards to thermotolerance, as seen previously, in 
MG63 monolayers labelled with gold nanoprisms, in hyperthermic conditions, both 
Hsp70 (> 10 fold) and Hsp90 (>5 fold) were expressed. 
 
When MCF-7 cells were labelled with gold nanorods, as with the MG63 cells, the 
majority of genes were linked with the intrinsic pathway, with a >5 fold change in 
BMF, BIM, BAK, caspase 9, cytochrome c and caspase 7.  BIM, a pro-apoptotic 
Bcl-2 family member and is believed to facilitate BAX/BAK activation (Bean et al. 
2013; Koenig et al. 2014). Unlike MG63 cells, there were little/no changes in the 
extrinsic pathway, however interestingly the lysosome pathway was strongly 
implicated, with large increased noted in cathepsins -B, -K and -S. In addition, a 
>5 fold was noted in CFLAR (c-FLIP), CFLAR is a protein that can inhibit the 
extrinsic pathway by blocking the activation of FAS and TRAIL receptors thus 
preventing the activation of caspase 8, however it has been suggested CFLAR 
expression may potentiate necrotoposis (Safa 2013; Tsuchiya et al. 2015). The 
potent expression of Hsp70 and Hsp90 (>10 fold change) suggest a high 
concentration of denatured proteins via hyperthermia, while the overexpression of 
XIAP (>10 fold change) is associated with anti-apoptotic features as previously 
described (Hamacher-Brady and Brady 2015).  
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Figure 4-25: Apoptosis signaling pathways and roles of c-FLIP in preventing 
apoptosis. Interaction of TRAIL with its receptors DR4 and DR5 or binding of 
Fas ligand to Fas receptor initiates the death receptor (extrinsic) and 
subsequently mitochondrial apoptosis signaling pathways through FADD-
dependent autocatalytic activation of caspases -8 and -10 and Bid cleavage. 
c-FLIP inhibits caspase-8 and -10 activation, preventing the downstream 
apoptosis cascade. (Taken from(Safa 2013)).  
 
In summary, when referring to table 4-6 to identify and compare changes in 
monolayer MG63 and MCF-7 cultures following GNP induced photothermal 
hyperthermia, similarities and differences are noted between cell types. Both bone 
and breast cancer cell lines respond strongly to hyperthermic treatment, with large 
increases noted in apoptotic genes. Gold nanoprisms activate apoptosis mainly 
through the intrinsic pathway, involving mitochondria, in both cell types. However 
MG63 cells also engage the lysosomal pathway (figure 4-24). Meanwhile, when 
apoptosis was activated by gold nanorods, MG63 cells initiated both the intrinsic 
and extrinsic pathways, whilst MCF-7 cells responded differently, utilising the 
intrinsic and lysosomal pathways and necrotoposis/autophagy.  
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3D Spheroid MG63 Cells: Gold Nanoprisms and Nanorods 
 
MG63 spheroids labelled with gold nanoprisms demonstrated a large increase in 
markers associated with both the intrinsic and extrinsic pathway and the lysosomal 
pathway.  Similar to their corresponding monolayer results, which heavily relied on 
the intrinsic pathway, a >5/>10 fold change expression was observed in BAX, 
BAD, BID, cytochrome c, APF-1 and caspase 3. However when MG63 cells were 
cultured as 3D spheroids and labeled with nanoprisms, several new genes were 
highly expressed (>5/>10 fold) including FAS, Bcl-2 and MCL-1; all involved in the 
extrinsic pathway. In addition, spheroid culture further activated apoptosis via the 
lysosomal pathway, with >5 fold changes in cathepsins -K, -S and -B.  
Thermotolerance was again noted, with >10 fold change in Hsp90 and Hsp70. 
Therefore, results suggest that MG63 cells in 3D culture undergo apopotosis via 
the conventional intrinsic and extrinsic pathway, but also via more novel caspase-
independent pathway orchestrated by cellular oxidative stress. 
 
As the majority of these molecules have been discussed, focus will be drawn to 
the lesser-known apoptotic markers. MCL-1 showed ~13.8 fold change 
expression. Although known as a potent anti-apoptotic Bcl-2 family member, 
precisely how it functions to promote survival of normal and malignant cells is 
poorly understood although it has been shown to interact with BAK, tBID, BIM and 
PUMA (Gelinas and White 2005; Perciavalle et al. 2012; Thomas et al. 2010).  In 
addition, SERPIN B3 displayed ~12.4 fold change. SERPIN B3 (Squamous Cell 
Carcinoma Antigen, SCCA1) is a member of the ov-serpins, a serine protease 
inhibitors family and is an important modulator in apoptosis, serving to protect cells 
from apoptotic stimuli, such as TNF-α signaling. While its role in inhibiting 
cytochrome c has been observed (Thomas et al. 2010). Importantly, however, 
SERPIN B3 protects against oxidative damage caused through the increased 
intracellular ROS concentration and interestingly, is upregulated under hypoxic 
conditions, a feature associated with 3D multicellular tumour spheroids (Cannito et 
al. 2015; Ciscato et al. 2014; Vidalino et al. 2009). 
 
When MG63 spheroids labelled with gold nanorods were laser treated, as with the 
nanoprism labelled spheroid MG63 cells, apoptosis was activated through a range 
of pathways, including the intrinsic, extrinsic and lysosomal. Genes involved in the 
intrinsic pathway were similar to monolayer cultures and nanorod spheroids, they 
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included a >5 fold change in BID, BIK, BAK, Bcl-2, BCL2L15, caspases 3, 7 and 9, 
with a > 20 fold increase in BAD, and a >30 fold increase in cytochrome c.  Whilst 
these are similar genes to monolayer samples, the increases in 3D culture are 
much higher. 
 
The extrinsic pathway was again activated when MG63 cells were laser treated in 
3D culture with a >10 fold change in TNFSF10, FAS-L and a >27 fold increase in 
caspase 8 observed. TNFSF10 (also referred to as tumour- necrosis-factor-related 
apoptosis-inducing ligand -TRAIL) once activated by appropriate complexes can 
aggregate, leading to the oligomerisation of TRAIL receptors and the initiation of 
adapter molecules such as FADD as well as signalling molecules such as caspase 
8 to form the death-inducing signalling complex (DISC), eventually leading to the 
activation of caspase 8 and thus, the extrinsic pathway, as previously described	
(Ramírez-Labrada et al. 2015). This would validate the greatly increased 
expression observed in caspase 8 (>27Fc), while Fas-L (fas ligand), upon binding 
to FAS receptors, can initiate the same pathway. However as compared to the 
prism spheroid cultures a >5 fold change was noted in SERPIN B3. Survivin, a 
member of the family of inhibitor of apoptosis proteins, capable of inhibiting active 
caspase 9, also showed > 5 fold increase (Y. Lin et al. 2016; Alain C. Mita et al. 
2008b), while thermotolerance was again induced with increases noted in Hsp90 
and Hsp70, indicative of hyperthermia-induced apoptosis	 (Reihaneh Haghniaz et 
al. 2015b).  
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Figure 4-26: Extrinsic Apoptosis Signaling Network. The extrinsic apoptosis 
pathway is activated upon ligand binding to death receptors (TNFR1, 
Fas/CD95, DR4/5) leading to the assembly of FADD/TRADD and caspase 8 to 
form the death-inducing signaling complex (DISC), leading to caspase 8 
activation and downstream effects. TNFR1 may promote survival signaling 
through activation of NFκB (from(Krakstad and Chekenya 2010)).  
 
3D Spheroid MCF-7 Cells: Gold Nanoprisms and Nanorods 
 
Whilst apoptosis was activated mainly via the intrinsic pathway in nanoprism 
monolayer cultures, the 3D MCF-7 spheroids labelled with gold nanoprisms 
employed both intrinsic and extrinsic pathways. Increases of >5 fold were noted in 
BIM, BAK, caspase 7 and >10 fold in BID, BAX, caspase -3 -8 and -9, Bcl-2 and 
cytochrome c for the intrinsic pathway. However >5 fold changes were recorded 
for PARP, FAS-L, and MCL-1 in the extrinsic pathway, suggesting accumulation of 
ROS concentration and oxidative stress within MCF-7 spheroids (Luanpitpong et 
al. 2013; Luo and Kraus 2012). The denaturing effect of hyperthermia was again 
apparent with the increased expression of Hsp90 and Hsp70.  
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The MCF-7 spheroids labelled with gold nanorods indicated that apoptosis was 
activated mainly by the intrinsic and lysosome pathways, similar to the 
corresonding monolayer cultures.  Fold changes (>5) in APAF-1, caspase 9, 
cathepsin K, DIABLO/SMAC, caspase 7, while a > 10 fold change was detected in 
cytochrome c. These results suggest that apoptosis was mainly orchestrated by 
the intrinsic pathway, owing to the increased expression of caspase 9 and APAF-1 
expression, although preceding markers (e.g. BAX/BAK) expression was low, 
which may indicate that hyperthermic treatment with nanorods disrupted the outer 
membrane potential, independently from these complexes, as has been 
hypothesised elsewhere (White et al. 2012). The lysosomal pathway was also 
implicated, up to a lesser extent, with increased expression of cathepsin -B, -L, 
and -K, which is released upon lysosomal disruption and has been shown to 
degrade Bcl-xL proteins and promote apoptosis (de Castro et al. 2016). 
 
In summary, when considering the apoptosis response of 3D spheroid cultures at 
the gene expression level, both bone and breast cancer spheroid cultures commit 
to apoptosis following GNP-induced hyperthermia using a combination of 
pathways. MG63 spheroids differed from their corresponding monlayer culture 
results by utilising a wider range of pathways and demonstrating higher levels of 
gene changes, whilst response between prisms and rods in 3D were similar. 
Meanwhile MCF-7 spheroids also differed from their corresponding monolayer 
results with the nanoprism results, as this time the extrinsic pathway was also 
involved, whilst nanorods induced a similar response in monolayer and spheroid. 
 
Apoptotic Gene Expression: Apoptosis Pathways and Thermotolerance  
 
The quantification of various apoptotic gene markers was conducted via fluidigm 
analysis. Overall, these results suggested that laser treatment alone can induce 
mild cellular stress within samples. Cellular stress was believed to be to due to an 
increase in ROS accumulation within cells, as indicated by the increase in markers 
up-regulated in response to ROS such as PARP-1	(Rodríguez-Vargas et al. 2012), 
PMAIP	 (Tonino et al. 2011) and caspase 3	 (D. Y. Shin et al. 2009). ROS 
generation in cells has been directly linked to laser exposure	 (Mohanty et al. 
2006). Mohanty and Gupta studied the effects of a continuous wave 5W laser 
laser on HeLa cells and observed mitochondrial membrane potential changes, with 
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the subsequent leakage of electrons from the respiratory chain, resulting in the 
increased generation of ROS in the cytosol (Mohanty et al. 2006). However, whilst 
these intracellular events also occurred in our control samples (with no GNPs), 
they did not translate to cell death, as shown in previous viability staining (section 
3.4.7).  
 
As expected, cells labelled with GNPs and laser irradiated displayed a far larger 
fold change in apoptotic markers, resulting in cell death (viability staining, section 
3.4.7) (Lucian Mocan et al. 2015b). The activation of the intrinsic pathway was 
expected	 as several previous reports had demonstrated activation of intrinsic 
pathway markers in response to hyperthermic temperature profiles	 (C.-H. Hou et 
al. 2014b; Klostergaard et al. 2006; Tu et al. 2006).	 In this study, caspase 3, 9, 
APAF-1, and BAX/BAK expression was particularly highlighted. However, the 
extrinsic pathway was also activated within this study, in particular with the 
spheroid cultures (Nagarsekar et al. 2008), as demonstrated by the increased 
expression of caspase 8, BID, FAS, and FAS-L; indeed, MG63 spheroid samples 
incubated with gold nanorods resulted in a >25 fold change in caspase 8.  
 
The expression of cathepsins was also an interesting observation, which was 
particularly notable in MG63 monolayers and spheroid cultures when labelled with 
nanoprisms, and MCF-7 monolayer and spheroid cultures when labelled with 
nanorods. As previously explained, (figure 4-24) cathepsins are proteases that are 
located primarily within lysosomes, known as ‘suicide bags’. The loss of the 
lysosomal integrity, and the subsequent release of cathepsin into the cytosol, has 
been implicated in various forms of cell death including necrosis (de Castro et al. 
2016). Due to their broad spectrum of protein degradation, cathepsin up-regulation 
can lead to necrotic cell death due to loss of cellular functions, such as energy 
production and osmotic balance, as well as loss of cell structural integrity.  
However, cathepsin release has also been associated with caspase-dependent 
apoptosis via BID activation and mitochondrial membrane permeability (de Castro 
et al. 2016). Cathepsin (B) expression is also a feature during hypoxia, which may 
likely occur in tumour spheroids, and may therefore explain its dramatic up-
regulation in spheroid samples rather than monolayer samples that appear to have 
elevated basal cathepsin B expression (Wickramasinghe et al. 2005). 
Nonetheless, the increased expression of cathepsin measured in nanoprism 
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labelled MG63 monolayers may suggest cell death via necrosis or be indicative of 
the process of autophagy.  
Autophagy has been reported in response to hyperthermia, though it has been 
argued that it’s role may be more protective than destructive, by degrading 
misfolded proteins and preserving protein homeostasis (Dokladny et al. 2015). 
This has been further validated by previous studies in which Hsp70 inhibitors 
prevented the activation of autophagy (Budina-Kolomets et al. 2014). The 
exponential expression of caspase 8 in nanoprism labelled MCF-7 
monolayer/spheroid cultures, as well as nanorod labelled MCF-7 spheroids, and 
nanoprism/nanorod labelled MG63 monolayers was difficult to explain, as the 
majority of these samples did not show an increased expression in preceding 
extrinsic factors (Fas, Fas-L, TNFSF10), although isolated studies have shown 
that the activation of caspase 8 may occur during hypoxia and ROS generation 
(Byeong Mo Kim and Chung 2007). Caspase 3 has also shown to increase the 
expression of caspase 8, which then activates BID and the activation of BAX/BAK 
to further permeate the mitochondrial membrane, thus feeding a positive loop of 
caspase-depenent apoptosis (Karine Sá Ferreira et al. 2012b). Gonzalvez et al, 
(2008) also challenged the activation of caspase 8, describing caspase 8 
integration into Cardiolipin (CL)-rich domains of the outer mitochondrial membrane 
results in full activation of caspase 8 which can then directly access and cleave its 
substrate Bid (Schug and Gottlieb 2009). The quantification of caspase 8 from our 
samples suggests caspase 8 up-regulation occurs predominantly via the caspase 
3 positive feedback loop and activation by Cardiolipin at the outer mitochondrial 
membrane, as well as the conventional extrinsic pathway involving death receptor 
aggregation and DISC formation (figure 4-23).  
 
With regards to thermotolerance, in all hyperthermic cell cultures both Hsp70 and 
Hsp90 were upregulated owing to their chaperon functioning upon disruption to 
protein homeostasis as previously described in section 1.3. While Hsp27 is a 
potent chaperon, Hsp90 and Hsp70 are primarily investigated during heat shock 
response (Zunino et al. 2016). Miyagawa and co-workers validated this by 
demonstrating that the inhibition of Hsp90 and Hsp70 increased the sensitivity of 
magnetic nanoparticle-mediated hyperthermia in melanoma cells (Tomoyuki 
Miyagawa et al. 2014b). In a similar set up to our own, Ali et al demonstrated that 
Hsp70 inhibition produced an increased level of cells undergoing apoptosis and a 
reduction in MCF-7 cell viability after photothermal treatments using gold nanorods 
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(Ali et al. 2016). Hsp70 functions in the transportation of precursor proteins into 
cellular compartments and is vital for protein homeostasis, including protein folding 
and degradation of unstable proteins (Sanjay Kumar et al. 2016). However, during 
cellular stress human cells produce high levels of Hsp70, constitutively expressed 
as Hsp70, mitochondrial Hsp75, and GRP78, which are found in the endoplasmic 
reticulum and act as molecular chaperones, assisting proper folding/refolding 
(Sanjay Kumar et al. 2016). While its chaperon activity has been established, 
Hsp70 has also been shown to participate as an anti-apoptotic protein, capable of 
inhibiting both strands of the extrinsic and intrinsic pathway. In the intrinsic 
pathway Hsp70 has been shown to inhibit BAX translocation, inhibiting the 
formation of the apoptosome (caspase 9, APAF-1, cytochrome c, complex)	
(Shawn B. Bratton and Salvesen 2010). In the extrinsic pathway, Hsp70 has been 
shown to inhibit BID activation (to tBID) (Lanneau et al. 2008a). These events are 
summarised in figure 4-26. Hsp90 has also demonstrated similar inhibitory 
mechanisms, inhibiting BID and indirectly inhibiting caspase 8, as shown in figure 
4-26 (Lanneau et al. 2008a).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-27. Heat shock proteins: essential proteins for apoptosis regulation 
(Lanneau et al. 2008). 
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4.5.3 Photothermal Changes in Apoptotic Protein Expression  
 
Following on from the gene expression studies, the expression of 43 protein 
apoptotic markers were evaluated in bone cell (MG63) and breast cell (MCF-7) 
monolayer cultures to (i) determine the key molecules involved in apoptosis and 
(ii) verify the apoptosis pathways highlighted in the gene expression studies.  All 
monolayer cultures were labelled with either gold nanoprisms or nanorods (0.1 
mg.ml-1) and intracellular protein levels were assessed by cell lysis and antibody 
arrays.  
 
4.5.3.1	Laser	Treatment	Alone	Induced	Cellular	Stress	Response	
 
The results (figures 4-16 and figure 4-17), of laser treatment on control cell culture 
(with no GNPs) indicated an increase in several apoptotic markers in the presence 
of laser treatment alone compared to control groups (no laser treatment), however 
these peak mean intensity fold changes were small, with a large standard 
deviation leading to lack of statistical validity, therefore suggesting that the effect 
of laser treatment may not be as prominent as first assumed.  
 
With regards to MG63 cells, the markers that were increased included proteins 
involved in the extrinsic pathway (DR6), those involved in both the intrinsic and 
extrinsic pathway (BID, caspase 3), with apoptosis promoters (p53) and a range of 
apoptosis inhibitors (p27, IGF-I and in particular IGF-II). Both p27 and p53 have 
been widely explored for their roles in apoptosis and cell cycle arrest	(L. Fan et al. 
2014). The tumour suppressor p53 protein has important functions within cells, 
regulating cell senescence, metabolism, DNA repair and, importantly, cell cycle 
and apoptosis	 (J.-P. Kruse and Gu 2009). It is believed that an increased 
expression of p53 can encourage cell cycle arrest or apoptotic initiation upon 
cellular stress, however levels of p53 expression can activate p27 and p21 
expression (L. Fan et al. 2014). This may explain the proportional increase in p27 
expression observed, although only a small increase in expression was detected 
in p21. This may somewhat be explained as p21 can be activated by, and act as, a 
substrate for caspase 3 (Chiappara et al.), therefore an increase caspase-3 
concentration may reduce p21 levels in cells, this collaboration leads to pro-
apoptotic signalling, encouraging cells to undergo apoptosis. 
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The increase in BID expression has been previously linked to hyperthermia via 
caspase-2 activation	(Bonzon et al. 2006). However the increase in BID, caspase-
8 and caspase-3 is closely associated with the intrinsic pathway cumulating to 
apoptosis -	 although it is noted that this pathway is associated with increased 
cytochrome c expression, as shown in figure 4-23, which our results do not 
indicate (K. S. Ferreira et al. 2012a). As previously explained, cytochrome c is 
released from the mitochondria upon the destabilisation of the mitochondrial 
membrane potential (figure 4-25). Once released into the cytosol, cytochrome c 
can trigger the intrinsic apoptotic pathway via caspase cascade or amplify extrinsic 
apoptotic signalling (Kulikov et al. 2012). Interesting, caspase 3 and 8 are also 
integral players in the extrinsic pathway	 (Westphal et al. 2011). Caspase 8 
activation is believed to activate both caspase 3 and BID activation leading to 
either apoptosis or stimulating the intrinsic pathway. Caspase 8 activation however 
is predominantly orchestrated by ligands such as FasL, tumour-necrosis factor α 
(TNFα), or TNF-related apoptosis inducing ligand (TRAIL) which did not appear to 
show significant changes (Kulikov et al. 2012). 
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Figure 4-28: Oxidative stress: the mitochondria-dependent and 
mitochondria-independent pathways of apoptosis, (Sinha et al. 2013). 
Multiple pathways to apoptosis. The mitochondrial (or intrinsic) pathway is 
induced as a response to cellular stress and results in the activation of the 
pro-apoptotic BH3-only proteins. BH3-only proteins may directly bind and 
activate Bax and Bak (I, dashed lines), and may also bind to the prosurvival 
Bcl-2-like proteins to indirectly activate Bax and Bak (II). Once activated, Bax 
and Bak oligomerise to form pores in the mitochondrial outer membrane that 
release cytochrome c. Cytosolic cytochrome c leads to caspase activation 
and subsequent cell death. The death receptor (extrinsic) pathway is 
initiated by death ligands such as FasL, tumour-necrosis factor α (TNFα), or 
TNF-related apoptosis inducing ligand (TRAIL) binding to cell surface 
receptors, resulting in the activation of caspase-8. Active caspase-8 can 
either activate downstream caspases directly (in type I cells) or engage the 
intrinsic pathway via a cleaved form of the BH3-only protein Bid (tBid) (in 
type II cells) (Kulikov et al. 2012; Westphal et al. 2011). 
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One of the most notable fold changes in MG63 laser irradiated control sample was 
observed in the DR6 protein. DR6, conversely known as TNFRSF21, is a fairly 
new member of the death receptor family and only in the last few years has been 
confirmed for over expression to induce apoptosis (Sessler et al. 2013; Zeng et al. 
2012).  Zeng and co-workers demonstrated the unusual characteristics of DR6 
with their results suggesting that DR6 functions independently from the 
conventional type I and II signal transduction pathways via death receptor-
mediated death signals, with the inhibition of caspase-8 and knockdown of BID 
having no effect on DR6-induced apoptosis (Zeng et al. 2012). The authors 
suggest that DR6-induced apoptosis occurs through a novel, BAX dependent 
pathway (Zeng et al. 2012). This would suggest that the large increase in DR6 
expression could promote cells to commit to apoptosis via BAX activation, 
however the modest increase in BAX expression suggests minimal  apoptotic 
activation within the sample and would support the notion of only a small quantity 
of cells undergoing apoptosis during laser exposure.  
 
MCF-7 control cells (figure 4-17) displayed fairly innocuous results; only a few 
markers were increased, FAS (extrinsic pathway), caspase 8, which is involved in 
both the intrinsic/extrinsic pathway, IGFBP5 which propmots apoptosis (through 
caspase action) and heat shock proteins (Hsp27 and Hsp60).  IGFBP5 (Insulin-like 
growth factor-binding protein 5) is one of six members of the insulin-like growth 
factor-binding protein family, which are integral modules of the IGF (insulin-like 
growth factor) axis	 (Beattie et al. 2006). Of the six members, IGFBP5 has been 
heavily researched for its role in cancer progression and cancer development, 
whilst also being touted as a therapeutic target for human melanoma (Junyun 
Wang et al. 2015). IGFBP5 overexpression has been recently shown to promote 
apoptosis and cell cycle arrest (Su et al. 2011), and can induce a caspase-
dependent apoptotic pathway in human breast cancer cells via activation of 
caspase 8 (Butt et al. 2005). This was also observed in our results however the 
intrinsic activation  (i.e. of cytochrome c and BID) was not, observed in comparison 
to the previous study using human breast cancer cells (Butt et al. 2005).   
 
FAS, is a cell-surface receptor, commonly known as Cd95, and is the most well-
characterised member of the tumour necrosis factor (TNF) superfamily of 
receptors (Peter and Krammer 2003). The association of FAS and FASL has 
demonstrated pro-apoptotic signaling, as highlighted in figure 4-28 (Punsawad et 
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al. 2015). Thermotolerance was induced following laser treatment, with increases 
noted in Hsp27 and Hsp60. While the ubiquitous nature of Hsps as ‘molecular 
chaperones’ has been highlighted and illustrated in figure 4-27 (Hsp -27, -70 and -
90), the mechanism of action for Hsp60 has been poorly characterised. Hsp60 has 
been recognised for its protective function in cells (Ortega-Ortega et al. 2011), but 
does provide difficulty in characterising as studies have suggested an additional 
role in actually promoting apoptosis and subsequent phagocytosis of dying cells	
(Goh et al. 2011; S. Gupta and Knowlton 2005). Hsp60 is believed to have a 
protective quality, inhibiting apoptosis in stressed cells. This is further supported 
by Zhang and co-workers, who demonstrated bacterial GroEL-like Hsp60 
protected epithelial cells from UV radiated stress-induced death through activation 
of ERK and inhibition of caspase 3 (L. Zhang et al. 2004).  
 
Interestingly, unlike MG63 cells, there was no increase in DR6 as an apoptosis-
inducing receptor. The may reflect that DR6 is cell-type dependent, as exogenous 
expression of DR6 was found previously to induce apoptosis in HeLa cells 
(cervical carcinoma cell line) but not in MCF-7 cells	(Kasof et al. 2001). 
 
In summary, while we know that cell viability was not compromised, the results 
here show that, as with the RNA markers, laser treatment of control cell monolayer 
culture (ie. no GNPs) did indicate mild cellular stress. As with the RNA gene 
expression results, the bone cancer cell line (MG63) appeared to respond to laser 
treatment more that the breast cancer cell line (MCF-7), with a higher number of 
protein markers increased in response to treatment. 
	
4.5.3.2	Gold	Nanoprisms	Activate	Apoptosis	Following	Photothermal	Treatment	
 
When considering the effect of labelling cells with gold nanoprisms, the first results 
of note reflects the RNA apoptotic targets; with an immediate cell response of cells 
when labelled with gold nanoprisms (without laser treatments). An increase in fold 
change of ~1 to ~1.5 for the majority of apoptotic protein markers was recorded 
when compared to non-labelled control cells. This increased expression of both 
pro-apoptotic and anti-apoptotic markers indicated that the internalisation of gold 
nanoprisms caused cell stress, an observation corresponding to previous MTT 
results. Of these proteins, cIAP2 (cellular inhibitor of apoptosis proteins 2) 
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increased around 2 fold in the presence of gold nanoprisms.  CIAP2 is one of 8 
members of a family of factors called inhibitor of apoptosis (IAP) proteins. This 
family has been found to play a major role in a multitude of cellular processes, 
while cIAP2 remains one of the most characterised members (Kocab and Duckett 
2016). As their name suggests, IAPs are capable of inhibiting apoptosis in 
response to both extrinsic (death receptors-mediated) and intrinsic (cell stress-
mediated) signalling pathways	 (Guicciardi et al. 2014). CIAP2 in particular has 
shown cytoprotective features by inhibiting TNF-α-induced apoptosis	(S. Guo et al. 
2014). CIAP2 contain unique features such as a conserved RING domain at their 
C-terminal end, allowing these proteins to mimic E3 ubiquitin ligase, allowing for 
the ubiquitination and proteasomal degradation of caspases (casapse 3 and 7), 
TRAF2, and several other partner molecules (K. Wang and Lin 2013). CIAP has 
been shown to also bind to caspase 9, and XIAP that can additionally stimulate 
downstream signalling pathways such as the Akt survival cascade and/or NF-κB 
activation, which can counteract apoptosis (K. Wang and Lin 2013).  
 
When analysing the protein marker increases in nanoprism labelled cells following 
laser treatment, apoptosis was very clearly activated, with large increases in 
almost every single marker studied (figure 4-18). Large increases in particular 
were noted for protein markers linked to the intrinsic pathway (cytochrome c, BAD, 
BAX, BIM, SMAC), the extrinsic pathway (CIAP2, FAS, caspase 8) and those 
linked to both (BID, caspase 3), supporting wide scale apoptosis activation. The 
apoptosis promoter p53 was increased, but inhibitors of apoptosis were also 
activated, in particular IGFBP-1 and p27, indicating cell protection mechanisms 
were activated, along with Hsp70.  Interestingly, DR6, which was highly expressed 
in control cells (figure 4-16) following laser treatment, was not particularly affected 
with nanoprism labelled cells following laser treatment.   
 
A large increase was noted in Hsp70. Hsp70 has been extensively researched as 
an anti-apoptotic protein, preserving cells against environmental insults, including 
protecting cells from both chemotherapy, radiotherapy and ROS production whilst 
also being expressed during cell proliferation and differentiation (Multhoff et al. 
2015). Hsp70 has a multitude of functions within the cell, including protein 
homeostasis via protein folding, refolding, and assembly of nascent polypeptides. 
During cellular stress, Hsp70 is involved in preventing protein aggregation, and 
assisting the transport of other proteins across membranes (Multhoff et al. 2015). 
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It has also been noted as a potent inhibitor of apoptosis. Our results also suggests 
FAS, FAS-L and caspase expression was uninhibited by the elevated Hsp70 
expression. This was also a similar trend in BAX expression, whose activation is 
usually inhibited by Hsp70 expression therefore preventing mitochondrial 
membrane permeabilization and the release of pro-apoptotic factors such as the 
aforementioned cytochrome c as well as caspase 3 (Radons 2016; Xiaokui Yang 
et al. 2012b). However our results suggest these pro-apoptotic markers are 
unaffected even in the presence of the high Hsp70 expression.  
 
As with MG63 cells, when MCF-7 cells were labelled with gold nanoprisms (non-
laser treated), an increase in apoptotic markers was noted (as compared to non-
labelled cells), indicating cellular stress. However, as previously stated, this did not 
influence cell viability. A substantial increase in all apoptotic markers was noted, 
across a range of apoptosis pathways. The results were very similar to the MG63 
protein markers although the difference between laser and non-laser treated were 
more pronounced.  Again, DR6 was not affected, reinforcing the hypothesis of its 
cell specific role.    
 
The larger noted fold change expressions (compared to non-laser treated cells) 
were for TRAIL-R4 and BAX proteins. TRAIL-R4 (TNF-related apoptosis-inducing 
ligand- receptor 4) is a member of the TNF-receptor superfamily, alluded to in 
figure 4-28. The debate over its role in apoptosis still remains elusive, as TRAIL-
R4 does not contain a functional death domain and thus, upon activation via 
TRAIL, does not appear to induce the apoptotic pathway commonly associated 
with other TRAIL-R members (TRAIL R 1 and 2) (Lalaoui et al. 2011). Instead 
TRAIL-R4 has been considered an anti-apoptotic complex, with a number of 
studies showing the expression of TRAIL-R3 or TRAIL-R4 providing resistance to 
TRAIL-induced apoptosis in tumours (Lalaoui et al. 2011). 
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Figure 4-29:  Human TRAIL receptors and intracellular signal cascade. TRAIL 
binds to two death-mediating receptors, TRAIL-R1 and TRAIL-R2, and to two 
non-death receptors (“decoy receptors”), TRAIL-R3 and TRAIL-R4. TRAIL-
mediated apoptosis occurs upon binding of the trimerized ligand to the 
receptor, which instigates the recruitment of the signaling protein, FADD 
(Fas-associated death domain) and pro-caspase 8 (pro-FLICE). Activation of 
pro-caspase 8 leads to the generation of caspase 8 and subsequent 
activation of caspase 3, which mediates caspase-activated DNase and 
apoptotic demise of the cell. Moreover, TRAIL signaling may modulate 
mitochondrial apoptosis routes via induction of JNK and regulation of the 
bcl-2 family members bcl-2, BIM and BAX (taken from (Aktas et al. 2007)).  
 
TRAIL-R4 expression had been shown to inhibit TRAIL-mediated apoptosis in 
various tumours, while also binding to the pro-apoptotic complex, TRAIL-R2 
(Koschny et al. 2015). Typical TRAIL activation involves the clustering of receptor 
complexes and the activation of the death-inducing signalling complex (DISC) and 
the eventual activation of caspase 8 and 3	 (Bertsch et al. 2014). The inhibition of 
this pathway via TRAIL-R4 interaction may explain the increased expression of 
TRAIL-R4, and indeed TRAIL-3, which has also shown pro-apoptotic potential, 
leading to a modest increase of TRAIL-R1, TRAIL-R2, caspase 8 and caspase 3 
expression. (Degli-Esposti et al. 1997) when comparing non-laser treated and 
laser treated samples.  
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In summary, gold nanoprisms activated apoptosis following laser treatment, with 
large increases observed across the intrinsic and extrinsic pathways, as well as 
instigating cell protective mechanisms and thermotolerance. Whilst the pattern of 
protein marker expressions were similar for both cell types, the difference between 
non-laser treated and laser treated nanoprism labelled cells were greater in bone 
cancer cells (MG63 cells).  
 
4.5.3.3	Gold	Nanorods	Activate	Apoptosis	Following	Photothermal	Treatment	
 
As with the nanoprisms, the internalisation of gold nanorods also initiated cell 
stress, although again there was no compromise in cell viability. In the untreated 
nanorod labelled MG63 cells, Hsp27 displayed a near 4-fold increase in 
expression. The overexpression of Hsp27 has been shown to increase the 
resistance of cell to various apoptotic stimuli (Takayama et al. 2003). Although, 
conversely, the overexpression of Hsp27 can actually lead to the increased 
expression of caspase -3, -8 and -9, as well BIM activation, which were all highly 
expressed in our results	 (Y. Guo et al. 2015). Guo and co-workers also noted the 
pro-apoptotic role of Hsp27 in both the intrinsic and possibly extrinsic pathway via 
TRAIL in pancreatic cancer cells (Y. Guo et al. 2015).  
 
Nanorod labelled MG63 cells that were subsequently laser treated demonstrated 
increased apoptotic markers, resulting in the cell death observed in chapter 3. The 
makers were across a range of apoptosis pathways including the intrinsic 
(cytochrome c, BAD, SMAC), extrinsic (FAS, FASL, TRAILR2) and lysosome 
(CD40, TNFB) (figure 4.23). In addition, promoters of apoptosis were increased 
(p53) as well as apoptosis inhibitors (p21, p27, surviving, livin) and indicators of 
thermotolerance (Hsp -27, -60 and -70).   
 
Livin is a novel member of the inhibitor of apoptosis (IAP) protein family and highly 
expressed in many types of human malignancies, preserving the cell against 
apoptotic stress through the inhibition of the caspase signaling cascade, as well as 
inhibiting the cell death receptor tumour necrosis factor receptor-mediated 
apoptosis signaling pathway (Zhuang et al. 2015).  Livin is believed to function by 
inhibiting the caspase-3, -7, and -9, as well as promoting SMAC degradation (B. 
Yan 2011). Our results, however, show SMAC expression was increased 
compared to controls, suggesting SMAC was not degraded by livin. 
		176	
SMAC (second mitochondria-derived activator of caspases) is a pro-apoptotic 
factor, found within mitochondria. Upon mitochondria damage, SMAC, along with 
cytochrome c, is released from the mitochondria, into the cytosol (figure 4-27). 
SMAC interacts with apoptosis inhibitor proteins, such as XIAP, cIAP1 and cIAP2, 
allowing for the release of caspase 3 and 9, causing apoptosis (G. Martinez-Ruiz 
et al. 2008a).  
 
Survivin is a member of the family of inhibitor of apoptosis proteins and 
predominantly functions in the regulation of mitosis progression and apoptosis 
inhibition (Y. Lin et al. 2016). Survivin activity is inhibited by increased expression 
of SMAC and interesting, p53, another key apoptotic marker that showed 
increased expression. Although survivin is known to inhibit apoptosis by inhibiting 
active caspase-9, it showed no inhibition towards caspase-3 and caspase-7 while 
its functionality seems dependent on association with X-linked IAP	 (A. C. Mita et 
al. 2008a). 
 
HTRA (high temperature requirement A) showed a five-fold increase in expression 
compared to untreated samples. HTRA is a protective protease complex involved 
in protein quality control pathways and is crucially up-regulated under protein 
folding stresses, to prevent accumulation and aggregation of misfolded proteins 
that induce cellular stress and apoptosis (Tennstaedt et al. 2012). This 5-fold 
increase in HTRA strongly suggests a potent accumulation of unfolded and 
aggregated, denatured proteins, a hallmark of hyperthermic treatment (Yanting Cui 
et al. 2014b). 
 
As with the MG63 cells, non-laser treated MCF-7 cells showed an increase in most 
apoptotic markers following gold nanorod internalisation, inducing mild cell stress. 
However, following laser treatment, these marker levels were again highly 
increased, demonstrating cell apoptosis. The protein markers that were highly 
increased following laser treatment were again across a range of apoptotic 
pathways, including the intrinsic pathway (cytochrome c, Bcl-2, BAD), the extrinsic 
pathway (TRAILR1) and proteins linked to both pathways (caspases 3 and 8, BID) 
as well as lysosome stress (CD40) and cathepsin activation (figure 4.23).  Several 
pro-apoptotic proteins were also highlighted, such as IGFBP-3 (via promotion of 
p53) and IGFBP-4 (via involvement in the intrinsic pathway). In addition, numerous 
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anti-apoptotic proteins were also induced, including p21, p27 and IGFBP-5 
(through caspase interactions), as well as thermotolerance (Hsp -27, -60 and -70). 
 
The results from this experiment therefore seem to suggest laser treated MCF-7 
cells containing gold nanorods are led to apoptosis via the intrinsic, extrinsic and 
lysosomal pathways. In summary, gold nanorods, as with nanoprisms, strongly 
activate apoptosis in both cell lines.  In particular the JNK pathway was activated 
with both cell types (only observed in bone – MG63 – cells with the nanoprisms), 
supporting caspase-independent cell death.   
 
4.5.4 Hyperthermia-Induced Apoptosis via Increased ROS Production 
 
The RNA and protein apoptosis marker studies suggest that one of the main 
triggers of apoptosis may be due to the increase generation and accumulation of 
intracellular ROS concentration	 (Bettaieb and Averill-Bates 2008; F. Chen et al. 
2008a). Much focus within the hyperthermia literature to date has been 
hyperthermia leading to protein denaturation, indicated by increased expression 
Hsp family	 members	 (Glory et al. 2014; Kalamida et al. 2015; I. S. Singh and 
Hasday 2013; Y. Zhang and Calderwood 2011).	While our results do support this 
(both RNA and protein analysis), the strong association of ROS production 
indicated in the fluorescent staining (figure 4-22) during onset of apoptosis in cells 
may reflect ROS-induced cellular stress	 (Kanwal Ahmed et al. 2015b). 
Hyperthermia has been shown in a number of studies to increase ROS production 
in various cell lines, including MG63 and MCF-7 cells (Bohara et al. 2015; Z.-G. 
Cui et al. 2014f; C.-H. Hou et al. 2014b; Q.-L. Zhao et al. 2006). For example, 
hyperthermia-induced increases in ROS generation were noted by decreasing the 
expression of superoxide dismutase 1 (SOD-1), a potent antioxidant enzyme at 
both the mRNA and protein level (El-Orabi et al. 2011). This can lead to the 
overexpression and accumulation of ROS such as superoxide anion (El-Orabi et 
al. 2011), which can dismute to form hydrogen peroxide or react with other 
radicals such as NO to produce potent oxidant species (Q.-L. Zhao et al. 2006). 
 
The increased expression of ROS leads to nonspecific modifications of lipids, 
proteins, and nucleic acids, resulting in global, cellular dysfunction (Kanwal Ahmed 
et al. 2015b). ROS accumulation can also lead to mitochondrial damage and the 
activation of the intrinsic pathway, while also linked to the extrinsic pathway by 
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directly activating death receptors (TNFα, FASL, and TRAIL) and thus apoptotic 
induction through ROS-induced receptor clustering (Circu and Aw 2010). ROS 
accumulation can also stimulate apoptosis through independent signalling which 
can induce both the intrinsic and extrinsic pathways (Circu and Aw 2010).  
 
Hyperthermia has also been shown to induce endoplasmic reticulum (ER)- 
triggered apoptosis in numerous cancers; the ER is responsible for protein folding, 
modification and synthesis as well as lipid synthesis (C.-H. Hou et al. 2014b; 
Shellman et al. 2008). Cellular stress can be caused via heat and oxidative stress, 
that can disrupt ER homeostasis and thus lead to the accumulation of unfolded or 
misfolded proteins (C.-H. Hou et al. 2014b). Our results confirm hyperthermia 
increased ROS concentration, while laser treatment on control cells did yield some 
ROS accumulation, this is expected to occur as laser irradiation has been 
demonstrated to disrupt cellular organelles, including the mitochondria, leading to 
the disruption of ROS homeostasis and thus a small increase of ROS was 
observed in control samples exposed to laser treatment	(Minai et al. 2013).  
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4.6 General Conclusion  
 
4.6.1 GNP internalisation causes mild cell stress  
 
The results obtained from the apoptotic marker analysis confirmed that the 
labelling of both MG63 and MCF-7 cells with either gold nanorods or gold 
nanoprisms elicited mild cellular stress as indicated by the increased expression of 
apoptotic markers. Although this global increase in apoptotic markers revealed 
cellular stress, it did not translate to a decrease in cell viability as confirmed in 
chapter 3 (section 3.4.3).  
 
4.6.2 Laser treatment causes mild cell stress, but no cell death. 
 
Laser treatment alone appeared to cause minor cellular stress in both cell types 
but again this did lead to a compromise in cell viability (section 3.4.7). The 
increased expression of Hsp members (Hsp -26, -60, -70) also demonstrated the 
protective characteristics of Hsps in response to environmental insults such as 
laser exposure.  While previous studies have shown intense laser exposure can 
induce mitochondrial damage and ROS generation, our moderate laser exposure 
showed minor ROS production upon laser irradiation (figure 4-22) (M. J. Jou et al. 
2002; M.-J. Jou et al. 2004).  
 
4.6.3 Nanoprisms & Nanorods caused cell death by a range of apoptotic 
pathways  
 
Our results suggest that GNP-assisted photothermal treatment of MG63 and MCF-
7 cells, both in monolayer and multicellular tumour spheroids leads to the 
activation of both the intrinsic and extrinsic pathway as indicated by the increased 
expression of pro-apoptotic Bcl-2 family members and caspases. As previously 
alluded to, many groups attempt to confirm apoptosis after photothermal treatment 
by quantifying a handful of effector caspases such as caspase 3, 6 and 7 
(Abadeer and Murphy 2016; Espinosa et al. 2016; L. Mocan et al. 2015a). 
Although the increase in expression of these markers confirms cell death via 
apoptosis, the actual pathways are often overlooked. In this project, we 
determined cell death predominantly occurs via the intrinsic and extrinsic pathway, 
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although we have also observed the more novel and less characterised, lysosomal 
apoptotic pathway, which was continuously observed in photothermal treated 
samples and is associated with an increase in ROS generation. This was an 
important discovery as lysosomal degradation, cathepsin release and ROS 
generation have also been linked to autophagy, necrotopsis and necrosis (Boya 
and Kroemer 2008a; Brojatsch et al. 2015; Eskelinen and Saftig 2009; 
Vandenabeele et al. 2010).	 While thermotolerance was induced by samples, as 
indicated by the increased expression of Hsp members, the process appeared 
unsuccessful at preventing apoptosis as observed in chapter in 3 (section 3.4.7).  
 
4.6.4 Correlation between RNA & protein targets 
 
In this project, we attempted to characterise cell death using a range of apoptotic 
markers and attempted to quantify their expression at the genomic and proteomic 
level to better understand the molecular events leading to cell death upon 
exposure to photothermal treatment. The targets that were quantified at both the 
genomic and proteomic level are shown in figure 4-2. For RNA expression, the 
results presented here were transformed (log2) due to the large disparity between 
targets and to provide a more symmetrical data and thus any value below 0, 
although indicating positive fold change is insignificant. The notoriously genome-
wide correlation between expression levels of mRNA and protein having ~40% 
explanatory power across has been shown in numerous studies	 (Abreu et al. 
2009; Koussounadis et al. 2015; Vogel and Marcotte 2012a). Despite this, our 
results indicate strong correlation between both gene and protein markers in 
monolayer samples with only BID and Bcl-2 markers showing particularly high 
disparities between data sets. Both data sets however, are in an agreement that 
multiple apoptotic pathways appear to be activated simultaneously upon 
photothermal treatment while a photothermal response (Hsp -60 and -70) was 
activated, regardless of cellular signalling to undergo apoptosis.  
 
4.6.5 Comparison of monolayer and Spheroid response to photothermal 
treatment 
 
The results from this project suggests 3D tumour spheroids were more susceptible 
to photothermal therapy compared to monolayer samples, although a thorough 
statistical analysis would be required to validate. The susceptibility of spheroids 
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may be due to the thermodynamic nature of heat. In monolayer, laser exposure 
occurred in the middle of the sample with heat dissipating across the sample 
however only those cells in the epicentre of the laser displayed cell death while 
peripheral cells remained viable, possibly due to hyperthermic temperature profiles 
not reached as heat dissipated away from the epicentre of the sample. With 
spheroid samples however, due to laser penetration, the spheroid could be heated 
not only on the peripheral cells on the outer rim of the spheroid, but those near the 
core of spheroid (figure 3-18), with heat radiating from near the core of the 
spheroid, superficially more cells were thus affected by higher temperature 
profiles, promoting cellular stress and apoptosis.  
 
4.6.6 Influence of cell type on photothermal treatment  
 
The effectiveness of photothermal therapy via GNPs was evident in both cell 
types, with both MG63 and MCF-7 cells displaying apoptotic tendencies however it 
appears MG63 cells are slightly more susceptible to photothermal treatment 
although again, a detailed statistical analysis would be required to confirm this 
observation however it is reasonable that different cell lines, owing to their 
physiological differences, detoxification pathways, thermotolerance and metabolic 
output may show slight variations during hyperthermic exposure.  
 
4.6.7 Gold nanoprisms and gold nanorods can successfully instigate 
apoptosis via laser irradiation  
 
Both GNPs successfully triggered apoptotic events upon exposure to laser 
irradiation in different cell types as well as within monolayer and spheroids. From 
our apoptotic protein analysis data (section 4.3.2) it appears that gold nanoprisms 
were particularly effective in both cell types and this may be due to the remarkable 
internalisation of gold nanoprisms into both cell types in comparison to gold 
nanorods that demonstrated poor internalisation even at a higher concentration 
(figure 3-13). This may explain why gold nanorods, although displaying a higher 
temperature profile than gold nanoprisms (figure 3-3) does not yield a significantly 
increased apoptotic response within samples. 
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5 Magnetic Nanoparticle Induced Hyperthermia  
 
5.1 Introduction  
 
5.1.1 Magnetic Nanoparticles and Hyperthermia 
 
Hyperthermia is not intrinsically cancer-specific, however hyperthermic techniques 
can capitalise on tumour physiology in order to deliver and concentrate toxic heat 
levels to cancer cells within a tumour	 (Kaddi et al. 2013). This is due to the 
heterogeneous tissue structure and unregulated growth which tumours exhibit, 
making them more prone to heat stress	(Vaupel and Kelleher 2010). Tumours are 
also distinguishable by their grossly disordered vascular architecture, high 
interstitial fluid pressure, and hypoxic regions, features that actually diminish the 
potency of conventional treatment such as chemotherapy and radiotherapy (C. L. 
Dennis and Ivkov 2013a). Hyperthermia has been seen to address these issues by 
increasing blood perfusion, oxygenating tumours and facilitating transport of 
compounds into the tumour	 (B. F. Jordan and Sonveaux 2012).  Magnetic 
nanoparticles (mNPs) are capable of producing heat when subjected to an 
alternating magnetic field and as tissue is weakly diamagnetic, it does not 
attenuate or scatter static or low frequency magnetic fields allowing for the easy 
transmission of an alternating magnetic field (AMF) through an entire tissue with 
relative ease and minimal toxicity issues (C. L. Dennis and Ivkov 2013a).   
 
As described in chapter 1, section 1.6, mNPs have demonstrated their potential in 
various biomedical applications including drug delivery (Unterweger et al. 2014), 
gene delivery (Majidi et al. 2016), magnetic resonance imaging (G. Wang et al. 
2014a) and  hyperthermia (Gruttner et al. 2013). The use of mNPs in hyperthermia 
has seen a dramatic rise in research interest over the last 20 years, as noted with 
a simple literature search in figure 5-1. There have been a number of successful 
applications in vitro	(Liao et al. 2015; Munoz de Escalona et al. 2016; Sabale et al. 
2015) and in vivo studies (Attaluri et al. 2015; Moros et al. 2015; Radovic et al. 
2015). As with GNPs, mNPs are being explored with the view to use in therapy as 
an adjunct to both radiotherapy	and chemotherapy (H. C. Kim et al. 2015; M. Lin et 
al. 2013a).  
 
		184	
 
 
 
 
 
 
 
Figure 5-1: Number of publication hits using ‘magnetic nanoparticle 
hyperthermia’ search term, from 2001 to 2015 (pubmed).   
 
The multifunctional capability of these particles with regards to hyperthermia have 
also been highlighted by Yallapu et al (2011), in which superparamagnetic NPs 
(SPIONs) were used for simultaneous imaging, heating and drug delivery	 on 
A2780CP (ovarian), MDA-MB-231 (breast), and PC3 (prostate) cancer cells 
(Yallapu et al. 2011). Interestingly, iron oxide NPs have recently shown bimodal 
capacity, being effectively used for magnetic and photothermal treatment, termed 
‘magnetophotothermal’ treatment, both in vitro and in vivo	(Espinosa et al. 2016).  
 
5.1.2 Magnetic Nanoparticle Heat Generation  
 
With regards to hyperthermia, mNPs are assessed for their intrinsic ability to 
generate heat upon exposure to an alternating magnetic field via Neel and 
Brownian Relaxation mechanisms. As alluded to previously (chapter 1, section 
1.6.2), mNP size influences their heating capability, as the superparamagnetic 
properties iron oxides exhibit is observed at around 1-20 nm. Parmar et al 
performed a series of experiments to characterise 13 nm and 20 nm SPIONs 
synthesised from co-precipitation and solvothermal reduction, respectively. 
Though the 20 nm mNPs displayed a higher magnetisation than their 13 nm 
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counterpart (due to higher crystallinity and phase purity), the smaller 13 nm mNP 
produced higher heating capacity when dispersed in a glycerol solution	(Parmar et 
al. 2015). This is directly related to size;  the Neel relaxation time is much greater 
than the Brownian relaxation time with smaller NPs (John Pearce et al. 2013b). 
Both Neel and Brownian times depend on the size of the particles, however the 
Brownian time is influenced in a linear fashion with the size of mNP, which means 
Brownian relaxation forces are the dominant force in heating larger mNPs (Reeves 
and Weaver 2012). This becomes problematic in more viscous mediums, with 
Brownian forces becoming severely reduced and only modest Neel relaxation 
mechanisms contributing to heat production, thus lowering the overall heating 
potential of larger mNPs. Therefore, the mNPs used in this project have been 
synthesised at ~11 nm diameter, so as not to be influenced by cellular viscosity 
(Kuimova et al. 2009).  
 
In this project, a device termed the magnetherm was employed to induce mNPs to 
generate heat (Nanothermics, Keele, UK). The magnetherm allows the 
measurement of thermal effects from mNPs by subjecting them to an alternating 
current magnetic field, of variable strength and frequency.  Aside from the mNP 
size, as described above, other parameters also dictate successful heating, 
including saturation magnetisation, magnetic susceptibility, magnetic anisotropy, 
particle distribution, field strength and frequency of the AC field.  Whilst NP 
synthesis allows us to control the NP physical characteristics, the magnetherm 
allows us to control the magnetic field strength and frequency.  
 
The sample loading chamber in the magnetherm was designed ideally for small 
animal use, therefore we needed to design and create a cell seeding substrate 
which could be adapted for use in the device. Cura, an online computer aided 
design (CAD) software was used to design and 3D print a novel cell seeding 
chamber which could be used with the magnetherm sample loading chamber, 
allowing us to carry out hyperthermic experiments.  
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5.1.3 Magnetic Nanoparticle Biocompatibility 
 
The toxicity of mNPs, in particular SPIONs has been discussed in several reviews 
and studies and remains controversial (Ghasempour et al. 2015; G. Liu et al. 
2013a; S. Naqvi et al. 2010a; Y. C. Park et al. 2014; L. Harivardhan Reddy et al. 
2012b). One of the major issues when working with mNP, in particular SPIONs, is 
the metabolism and subsequent degradation of iron oxide into free iron, which can 
subsequently lead to the increased generation of ROS, capable of damaging 
proteins, lipids, polysaccharides and DNA, ultimately leading to cellular apoptosis	
(N. Singh et al. 2010a).   
 
Previous studies have also shown that following cellular internalisation, mNPs can 
accumulate in mitochondria, vesicles and lysosomes, suggesting that any 
observed cytotoxicity is related to inflammatory response and oxidative stress 
(Hanini et al. 2011; Hussain et al. 2005; Xia et al. 2006).	 In addition, Soenen and 
co-workers reported how the intracellular trafficking of various SPIONs across two 
different cell lines ultimately led to a reduced efficiency of protein expression and 
disrupted the maturation of actin fibres	(S. J. H. Soenen et al. 2010). 
 
In this study, following synthesis and characterisation, mNPs were assessed in 
terms of their impact on cell metabolic activity, cytoskeleton and viability, as well 
as their ability to be internalised into cells and subsequently produce heat via 
exposure to an alternating magnetic field.  
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5.2 Chapter Aims and Objectives  
The previous two chapters have focused on the use of gold nanoparticles for 
photothermal hyperthermia in bone (MG63) and breast (MCF-7) cancer cell lines, 
this chapter will focus on the use of mNPs as potential hyperthermic agents to 
induce hyperthermia in bone cancer cells (MG63).  The mNPs used in this project 
were kindly donated by our collaborators in Spain and were characterised prior to 
use in cell culture, with a zeta-potential (mV) of -40, a core size of ~11 nm and a 
hydrodynamic size of 100 nm due to the biocompatible coating of dextran.  As with 
any NP platform, following successful synthesis and characterisation, mNPs 
should be internalised into cells without causing structural damage or invoking 
cellular stress.  Once biocompatibility is established, the mNPs should be able 
trigger apoptosis via hysteresis and Neel and Brownian relaxation mechanisms 
upon exposure to an alternating magnetic field.  
These objectives were achieved as follows:  
• Particle biocompatibility was assessed via MTT assay and fluorescent 
cell viability staining, labelling cells with a range of different mNP 
concentrations over time in culture.  
• Cell – particle interaction was studied using scanning electron 
microscopy (SEM).  
• The mNP internalisation was assessed by transmission electron 
microscopy (TEM).  
• The heating potential of the mNPs was determined using the 
magnetherm. 
• 3D printing software was used to design a cell culture chamber for use 
in monolayer cell studies using the magnetherm.  
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5.3 Materials and Methods  
 
5.3.1 Magnetic Nanoparticle Characterisation 
 
MNPs were synthesised and characterised by our collaborators at the Aragón 
Materials Science Institute, Spain.  
 
5.3.1.1	Cell	Metabolic	Activity	(MTT	Assay)	
 
The MTT assay was performed as described in chapter 2, section 2.3.1. Briefly, 
MG63 cells were seeded at 1 x 104 in a 96 well plate for 24 hours to allow 
attachment prior to mNP introduction. Cells were then incubated with mNPs at 
concentrations of 0.1 and 1.0 mg.ml-1 for 24, 48 and 72 hours (n=5). The  0.1 
mg.ml-1 concentration in particular was recommended by our collaborators as the 
lowest concentration that could be utlised for hyperthermic experiments and was 
used as the standard for future experiments, while the 1.0 mg.ml-1  concentation 
was evaluated for its potential biocompatibility for future cell work. The MTT assay 
was run at the time points stated, whereby cells were further incubated with MTT 
for 1 hour before the solution was solubilised with DMSO.  The absorbance of 
each well was read on a microplate reader (Dynatech MR7000 instruments) at 550 
nm. 
 
5.3.1.2	Cell	Viability	
 
The cell viability assay was carried out as described in chapter 2, section 2.3.2. 
MG63 cells were seeded at 1 x 104 in a 24 well plate for 24 hours before 
incubation with mNPs at concentrations of 0.1 and 1.0 mg.ml-1 for 24, 48 and 72 
hours (n=3). The cell viability was assessed by simultaneous incubation with 
calcein AM and ethidium homodimer for 1 hour followed by washing with fresh 
warm growth media and immediate imaging.  
 
From the cell viability and cell metabolic activity results; it appeared only 0.1 
mg.ml-1 mNP concentration would be applicable for future cellular experiements 
and thus only was the only concentration selected for  downstream experiments 
including cell-NP interaction and in vitro hyperthermia experiments.  
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5.3.1.3	Cell	–	Nanoparticle	Interactions		
 
SEM 
 
The MG63 cells were seeded at 1 x 104 in a 24 well plate, left for 24 hours, then 
incubated with 0.1 mg.ml-1 mNPs for 1 hour and 24 hours (n=2) prior to fixation 
and processing as stated in section 2.4.2. 
 
Fluorescent Cytoskeleton Staining 
 
The MG63 cells were seeded at 1 x 104 in a 24 well plate, left for 24 hours, then 
incubated with 0.1 mg.ml-1 mNPs for 24, 48 and 72 hours (n=2) prior to 
fluorescently stained for F-actin and β-tubulin using the protocol described in 
section 2.4.3.  
 
 Nanoparticle Internalisation via TEM 
 
The MG63 cells at seeded at 1 x105 in a 24 well plate for 24 hour, then incubated 
with 0.1 mg.ml-1 mNPs for 1 hour and 24 hours (n=2) prior to fixation and 
processing as stated in section 2.4.3 
 
5.3.2 Magnetic Heating and Magnetherm Studies 
 
5.3.2.1	Heating	of	mNP	Samples	via	Magnetherm	Device		
 
Samples of mNP solutions were assessed for their heating potential using the 
magnetherm device (nanotherics, UK). Aliquots of 2 mL of various concentrations 
of mNPs were placed within a universal and located in the sample loading 
chamber in the magnetherm device, as illustrated in figure 5-2, producing an 
optimised characterised magnetic field (volt= 27.2, current= 9.3, frequency= 115 
kHz). Concentrations ranging from 0.01, 0.1, 1.0, and 5.0 mg.ml-1 were utilised to 
obtain a range of heating potentials. The temperature was measured via a 
thermocouple device and samples were recorded from baseline room 
temperature. The samples were left in the magnetherm device until a desired 
temperature profile was met, with a cut-off point of approximately 30 minutes if 
unsuccessful. 
		190	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-2: A photograph of the magnetherm set-up as used in experiment. 
The samples were loaded into the sample loading chamber, power applied 
and magnetic fields generated using the function generator (viewed on the 
oscilloscope).  The magnetic fields were governed by a capacitor / copper 
coil located within the maghetherm. 
 
5.3.2.2	3D	Printing	of	Culture	Chambers	for	the	Magnetherm	Experiment	
 
The magnetherm is not presently designed to allow  testing of monolayer cell 
culture samples, with the cylindrical sample loading chamber proving difficult to 
position petri dishes to allow simultaneous multi-well analysis of treated cell 
cultures. In order to pursue cell culture work within the magnetherm device and to 
compare samples, conditions and controls simultaneously, a 3D cell seeding 
chamber was constructed onto a polycarbonate substrate using acrylonitrile 
butadiene styrene (ABS). This 3D device was constructed onto a 2 cm2 
polycarbonate platform via a 3D printer (Ultimaker2) to create four identical culture 
chambers (1.25 X 104 cells per chamber). The final dimension of the device was 2 
cm2 with each of the four chambers measuring 9 mm2, as shown in figure 5.3. 
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Figure 5-3: Schematic of the 3D printed cell seeding chambers, printed onto 
a polycarbonate substrate using ABS.  
 
Prior to use with cells, the 3D chambers were initially rinsed with 70% ethanol and 
02 plasma treated (to ensure hydrophilicity) for 1 minute. The chambers were 
subsequently sterilised with 70% ethanol and allowed to dry within a laminar flow 
hood for 30 minutes. The chambers were finally washed thoroughly with HEPES 
saline and air dried within a laminar flow hood ready for cell culturing  
 
5.3.2.3	In	Vitro	heating	of	MG63	Cell	via	Magnetherm	using	3D	Printed	Culture	
Chambers		
 
The MG63 cells were seeded at a cell density of 1.25 x 104 per 200 µL in each 
chamber. The device was then carefully housed within a 35 mm petri dish and 
incubated for 24 hours (5% CO2; 37°C). After 24 hours, culture media was 
removed and cells were washed three times in PBS before incubation with mNPs 
in media, at a final concentration of 0.1 mg.ml-1 (200 µL per chamber), and 
incubated for a further 24 hours (5% CO2; 37°C). The device was then removed 
from the incubator and two of the four chambers were washed with PBS and re-
suspended with 200 µL of fresh media (this was to evaluate the performance of 
internalised mNPs only and not simply those within the media) before being placed 
into the sample loading chamber in the magnetherm. The magnetherm was then 
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tuned to an optimised magnetic field (volt= 27.2, current= 9.3, frequency= 115 
kHz) for 20 minutes. The potential effects from AMF exposure alone was 
determined by a control sample containing no mNPs.   
 
5.3.2.4	Cell	Staining	via	Coomassie	Blue		
 
Following hyperthmic treatment of MG63 cells, the 3D printed chambers were 
removed from the magnetherm and placed into an incubator (5% CO2; 37°C) for 3 
hours. The media was then removed from each chamber, the cells were fixed in 
4% formaldehyde for 15 minutes at 37°C washed in PBS and 200 µL coomassie 
blue stain was added for 2 minutes. The stain was washed well with PBS and 
subsequent light microscopy images were then taken on an inverted light 
microscope.  
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5.4 Results  
 
5.4.1 Magnetic Size and Morphology via TEM 
 
MNP size, morphology and aggregation state were determined by TEM (figure 5-
4). The image confirmed successful synthesis of mNPs that were well dispersed 
and with no indication of aggregation. MNPs displayed a low size distribution 
between 9 and 15 nm and an average size of 11 nm which has been previously 
shown to display optimal heating capactiy (Gonzales-Weimuller et al. 2009; 
Ganeshlenin Kandasamy and Maity 2015b). 
 
 
 
 
 
 
 
 
 
Figure 5-4: TEM of mNPs (A) and size distribution graph (B). 
 
5.4.2 Magnetic Nanoparticle Biocompatibility 
 
5.4.2.1	Cell	Metabolic	Activity	(MTT	Assay)	
 
The MTT assay provides an insight into the metabolic activity of cell cultures, 
providing an indicator of cell health. As may be expected, the metabolic activity 
was inversely proportional to mNP concentration, concluding that higher mNP 
concentrations invoked a negative cell response. However the lower 0.1 mg.ml-1 
mNP concentration did not substantially affect cell metabolic activity, although 
there was a time dependent effect noted with prolonged mNP exposure (Bellusci 
et al. 2014).  
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Figure 5-5: Metabolic activity of MG63 cells following incubation with 
magnetic nanoparticles. MTT analysis of MG63 cells treated with 0.1 and 1.0 
mg.ml-1 for 24, 48 and 72 hours (n = 5; error bars indicate SD).  
 
5.4.2.2	Cell	Viability			
 
While the MTT assay provides a quantitative assessment of the cell metabolic 
activity, limitations over the use of the assay have been highlighted (Kong et al. 
2011; S. Wang et al. 2011a) which could lead to false positive and false negative 
results. The cell viability fluorescent imaging allows the qualitative assessment of 
cell sample based on the integrity of cell membranes – a major indicator of 
apoptosis.  
 
The viability images are shown in figure 5-6 and show correlation with the MTT 
assay; cells exhibit an initial high viability at 24 hours, as observed by the high 
number of green (live cells) and low number of red (dead cells), however after 
prolonged exposure (48 and 72 hours) cell viability depreciates in comparison to 
control samples (containing no mNPs). In summary, cell viability appears 
compromised in correlation to the increased NP concentration (Saba Naqvi et al. 
2010b).
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Figure 5-6: MG63 cell viability following incubation with magnetic 
nanoparticles. Fluorescence images of MG63 cells treated with 0.01, 0.1 and 
1.0 mg.ml-1 mNPs for 24, 48 and 72 hours. Green and red fluorescence 
indicates living and dead cells, respectively (controls are cells containing no 
NPs, n=2). Scale bar = 100 µm. 
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5.4.2.3	Cell	–	Nanoparticle	Interactions		
 
SEM Imaging  
 
Figure 5-7 shows SEM images of MG63 cells after 1 and 24 hours incubation with 
mNPs.  Corresponding cells containing no mNPs were used as controls. Cells 
incubated with mNPs displayed an increased expression of filopodia, both as 
protrusions on the edges of the cell surface, with long protrusions extending from 
the cell edges as well as notable filopodia protrusions on the cell body	(P. Tseng et 
al. 2012). SEM images also indicated the aggregation of mNPs, both on the cell 
surface and also on the coverslip, which may have consequences for cell toxicity, 
internalisation and metabolism (Bae et al. 2011; Stefaan J. Soenen et al. 2011)
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Figure 5-7: SEM image of MG63 cells incubated with 0.1 mg.ml-1 mNPs at 1 
hour and 24. Subsequent control cells containing no NPs were used for 
comparison at 1 hour (A) and 24 hours (B). SEM images were taken at 3000 x 
magnification at 300kV voltage. 
 
Fluorescent Cytoskeleton Imaging 
 
Fluorescence microscopy, as shown in figure 5-8. was performed on MG63 cells 
incubated with 0.1 mg.ml-1 mNPs for 24, 48 and 72 hours to further investigate any 
adverse interactions with the cell cytoskeleton over time.  As time progressed, the 
mNP treated cells displayed smaller, more condensed cell bodies. The β-tubulin 
microtubules appeared denser, with less elongation throughout the cell body, 
whilst F-actin filaments also appeared denser, with punctate areas, which may 
indicate exocytosis processing (Gasman et al. 2004). 
 
		198	
	
Figure 5-8: Cytoskeletal imaging of MG63 cells following incubation with 
magnetic nanoparticles. Fluorescent images of MG63 cells incubated with 
mNPs at 0.1 mg.ml-1 for 24, 48 and 72 hours (control cells contained no 
mNPs). F-actin (red), β-tubulin (green), counterstained with DAPI to visualise 
the cell nucleus (blue).  Scale bar 10 µm. 
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Particle Internalisation via TEM Imaging  
 
TEM images in figure 5-9 confirmed the successful internalisation, distribution and 
compartmentalisation of mNPs (0.1 mg.ml-1) at 1 and 24 hours, into endosome-like 
structures. TEM images appeared to show large quantities of mNPs internalised 
into cells after just 1 hour of mNP incubation (figure 5-9 A,B). Figure 5-9 B in 
particular appears to show the invagination of the cell membrane around the 
mNPs, indicative of a form of receptor mediated endocytosis involving invagination 
and formation of intracellular vesicles	(Zhenjia Wang et al. 2011b). No mNPs were 
observed free within the cytoplasm, suggesting that the NPs entered cells via 
endocytosis rather than passive diffusion. At 24 hours, mNPs were observed 
densely populated within endosome-like structures Figure 5-9 C,D) however a 
high concentration of mNPs were also apparent outside the cell, which may 
indicate slow uptake or exocytosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-9: The internalisation of magnetic nanoparticles into MG63 cells. 
TEM images of MG63 cells incubated with 0.1 mg.ml-1 mNPs confirming mNP 
internalisation after just 1 hour with early signs of cell membrane 
invagination and endocytosis driven uptake (A and B). At 24 hours large 
concentrations of mNPs were seen grouped and packaged within large 
endosome like structures however, large concentration of mNPs were also 
observed outside the cells (C and D). Images were taken at 10000x 
magnification at 120 kV voltage. 
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5.4.3 Magnetic Heating and Magnetherm Studies 
 
5.4.3.1	Heating	of	mNP	Samples	via	Magnetherm	Device		
 
Magnetic samples of various concentrations were located in universals and placed 
into the magnetherm sample loading chamber. Samples were heated for 30 
minutes or until hyperthermic profiles were attained (42-45°C) as shown in figure 
5-10. The higher concentrations (1.0 and 5 mg.ml-1) heated rapidly, reaching the 
desired temperature profiles in less than 5 minutes. The mid-range concentration 
(0.1 mg.ml-1) achieved the profile in under 20 minutes, however the lowest 
concentration (0.01 mg.ml-1) failed to achieve a hyperthermic temperature profile, 
with a modest increase of temperature after 30 minutes (~12°C).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-10: Temperature profiles of various concentrations of magnetic 
nanoparticles stimulated in the magnetherm. The heating potential of 2 mL 
aliquots of mNPs at concentrations of 0.01, 0.1, 1.0, and 5.0 mg.ml-1 within a 
magnetherm producing a characterized magnetic field (volt= 27.2, current= 
9.3, frequency= 115 kHz, nanotherics, UK). The magnetherm device was 
switched off after 30 minutes or after hyperthermic profiles (42-45°C) were 
achieved, indicated by the black dash. 		
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5.4.3.2	In	Vitro	heating	of	MG63	Cells	via	Magnetherm	using	3D	Printed	Culture	
Chambers		
 
Initial hyperthermic experiments were carried out; the MG63 cells were seeded in 
the 3D printed culture chambers, labelled with 0.1 mg.ml-1 mNPs and located with 
the magnetherm	 for 30 minutes. Coomassie blue staining was used to assess the 
cell morphology following treatment, as shown in figure 5-11. Control cells 
exhibited typical stellate adhered cell morphology, however an immediate 
alteration in morphology was observed in samples containing mNPs; cells were 
notably smaller and displayed decreased cell-cell adhesion. At the higher 20 x 
magnification, the mNP labelled cell bodies appear condensed, with areas of cell 
debris, suggesting cell death.  
 
Figure 5-11: Coomassie stain of mNP labeled MG63 cells following 
hyperthermic treatment within a magnetherm. Cells were labeled with 0.1 
mg.ml-1 mNPs, +/- PBS washed and located within the magnetherm for 30 
minutes, prior to coomassie blue staining.  
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5.5 Discussion  
 
5.5.1 MNP Synthesis: Size and Morphlogy  
 
MNPs used in this study were successfully synthesised and imaged via TEM and 
a size distribution graph was generated. MNPs synthesised,  showed a narrow 
size distribution predominantly  between 9 and 13 nm with an average core size of 
~11 nm, a crucial attribute for SPION heating capcity (Gonzales-Weimuller et al. 
2009; Ganeshlenin Kandasamy and Maity 2015b). MNPs displayed a consistent 
sphere morphology and importantly, did not show signs of aggregation, which has 
been shown to alter NP internalisation rate into cells (Alexandre Albanese and 
Chan 2011b). Aggregation to mNPs and in particular, SPIONs has also been 
shown to decrease their heating capacity (SAR), while a further reduction in 
heating capactiy has been observed for SPIONs in suspensions containing cells, 
but the origin of this further reduction is still elusive (Jeon et al. 2016).  
 
5.5.2 Magnetic Nanoparticle Biocompatibility 
 
The mNPs used in this study had a magnetic core size of ~ 11 nm, with a 
hydrodynamic radius of 100 nm following stabilisation with dextran. It is well known 
that both the size and shape of NPs can influence their biocompatibility and 
internalisation into cells (Arami et al. 2015; Forest et al. 2017; Neenu Singh et al. 
2010b; Vanessa Valdiglesias et al. 2016; Yameen et al. 2014a). Therefore this 
chapter aimed to characterise the mNPs prior to use as agents for in vitro 
hyperthermia.  
There are many methods employed to assess particle toxicity.  The MTT assay is 
a well established technique for in vitro cellular toxicity evaluation and is 
extensively used (Watanabe et al. 2013). The results indicated that lower 
concentrations were favourable, as cell metabolic activity decreased with an 
increase in mNP concentration. This is somewhat in agreement with the general 
consensus of the literature concerning functionalised mNPs (Khot et al. 2013; Y. 
Liu et al. 2011; Mejias et al. 2013; Mojica Pisciotti et al. 2014). Dextran is a widely 
used biocompatible coating for many mNPs, including those used for in vivo 
imaging, due to its inert, biocompatible characteristics; indeed many of the FDA 
approved SPIONs are coated with dextran molecules (L. Harivardhan Reddy et al. 
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2012b).  The difficulty with comparing the toxicological affect of dextran coated 
SPIONs with those studies in the literature is due, not only by the variance of 
concentrations used by respective groups, but also the use of different cell lines 
tested and the physical, chemical and structural characteristics of SPIONs (S. 
Laurent et al. 2012a). 
Recently, the concept of ‘nanotoxicity’ has evolved as a distinct research area.  
Nanotoxicity does not only connote cell death in response to nanomaterial 
exposure, but has broadly extended into identifying other markers associated to 
cell stress. This includes oxidative stress, genotoxicity, cell cycle disruption and 
morphological changes, which have all been previously explored in dextran-coated 
mNPs	 (Remya et al. 2016; V. Valdiglesias et al. 2015a). A great deal of difficulty 
therefore exists in forming a cohesive opinion on the toxicity of SPIONs. As well as 
the various characteristics of NPs that can influence cytotoxicity, it also appears 
that the response of identical NPs differ among various organs and cell types 
(Sophie Laurent et al. 2012b). SPIONs in particular appear to demonstrate large 
variance within cell lines due to various cell types responding differently towards 
the uptake of SPIONS, and follow different detoxification mechanisms to overcome 
the toxicity induced by SPIONs (N. Singh et al. 2010a).  
The results in this chapter suggest that dextran-coated mNPs over a prolonged 
period of time (> 24hours) are mildly toxic to bone cancer cells (MG63). The 
increased cytotoxicity at 1.0 mg.ml-1 may be due to an increased accumulation of 
mNP concentration internalised within cells that can be readily metabolised 
(Buyukhatipoglu and Clyne 2011).  The metabolised free iron can be transported 
and stored (via ferritin proteins), however too much free iron that cannot be 
continually stored in ferritin and similar proteins may lead to the breakdown of iron 
oxide into free iron ions within lysosomes	 (Vanessa Valdiglesias et al. 2015b).  
This ‘free iron’ has the capacity to cross mitochondrial membranes, and react with 
hydrogen peroxide and oxygen produced naturally by mitochondria leading to the 
formation of highly reactive hydroxyl radicals and ferric ions (Fe3) via the Fenton 
reaction	 (Malvindi et al. 2014; N. Singh et al. 2010a). ROS have been shown to 
interfere with and cause DNA damage as well as proteins and lipid peroxidation	
leading to the eventual induction of apoptosis (N. Singh et al. 2010a). Several 
studies have also drawn concerns of using iron oxide NPs at high concentrations, 
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including compromises to the cytoskeleton (as shown in this chapter), 
mitochondria and DNA (Calero et al. 2014; Sadeghi et al. 2015).  
5.5.3 Magnetic Nanoparticle Internalisation 
The SEM imaging confirmed the interaction of the mNPs on the cell surface, with 
resultant increased expression and exension of filopodia (Pauksch et al. 2014). 
Flopodia have been previously described as 'antennae' or 'tentacles' that are 
capable of probing their microenvironment, although their function has not been 
fully characterized, filopodia and are capable of creating 'sticky fingers' along the 
leading edge promoting cell adhesion, migration and guidance towards 
chemoattractants (Mattila and Lappalainen 2008). Although the cytoskeleton 
imaging demonstrated reduced cell  size and morphology, both the SEM and TEM 
images suggest that the mNPs do not alter the general morphology of cells too 
drastically, or compromise the integrity of plasma membrane or affect cellular 
aherence which has been noted in previous studies (Berry et al. 2003; Calero et 
al. 2014; Rivet et al. 2012). SEM images however did demonstrate the 
aggregation of mNPs, which may influence mNP toxicity and uptake. 
The mNPs were clearly internalised as shown in the TEM images. Endocytosis is 
the major route of NP transport across the membrane and broadly categorised into 
either phagocytosis or pinocytosis.  There are several different mechanisms 
known to be involved in the uptake of NPs, these include clathrin-dependent 
endocytosis and clathrin-independent endocytosis, which includes caveolae-
mediated endocytosis, micropinocytosis and phagocytosis, as shown in figure 5-12 
(Kou et al. 2013).  The images taken during this chapter support both endocytosis 
and pinocytosis, with SEM imaging supporting the former, whilst TEM and 
condensed/punctate F-actin supporting the latter. 
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Figure 5-12: Schematic depicting the main routes of nanoparticle 
internalisation into cells. Nanoparticles (green dots) are taken up by 
endocytosis and enclosed within early endosomes (EE), which mature to 
become multivesicular bodies / late endosomes (MVB),which fuse to form 
lysosomes (Lys).  Nanoparticles can also be recycled back to the cell 
surface through recycling endosomes (RE) (image adapted from ‘Cellular 
Toxicity of Nanoparticles’, Seallab wordpress). 
 
These mechanisms of entry are intrinsically dependent on several factors including 
NP shape, size, surface area, morphology, chemistry and functionalization and 
could subsequently influence NPs toxicology, exocytosis and metabolism (Kettler 
et al. 2014; Kou et al. 2013; Sara Salatin et al. 2015b). Although it has been 
observed that mNP can cause cytotoxic effects without being internalised within 
cells, most effects are uptake-dependent, with corresponding toxicity dependent 
on NP fate within the cell	 (Nel et al. 2009). Thus, an increased uptake of mNPs 
may lead to a decrease in viability and may account for the decreased metabolic 
activity observed in higher mNP concentrations.  
Invaginations of cell membrane with bound mNPs was observed after 1 hour of 
mNP incubation, with mNPs contained in large vesicles (Wilhelm and Gazeau 
2008). Research groups that have used dextran coated mNPs similar to our own 
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have also reported mNP uptake via an endocytosis pathway. This was confirmed 
via endocytosis inhibition that subsequently blocked mNP uptake into cells, and 
upon restoration, mNPs were successfully internalised into Hela cells	(Wilhelm and 
Gazeau 2008) and A549 cells	(J.-S. Kim et al. 2006). Rofe’s group also confirmed 
final destination of dextran-coated mNPs into lysosomes using lysosome-specific 
staining which validate our TEM images after 24 hours (figure 5-9. C and D), in 
which mNPs are clearly observed packaged within vesicles	(Rofe and Pryor 2016).  
F-Actin is a protein producing linear filaments that facilitates the formation of 
microfilaments within the cytoskeleton; these microfilaments are integral for cell 
mobility and intracellular transport, cell-cell and cell-substrate interactions, and 
signal transduction (Calero et al. 2014). Actin filaments are  also involved in 
cellular processes, including apoptosis and mitosis, through integrin-mediated 
signaling, as integrins are mechanically linked to the actin cytoskeleton in so-
called focal adhesion complexes (FACs)	 (S. J. H. Soenen et al. 2010). β-tubulin 
subunits meanwhile, form microtubules, which have fundamental functions similar 
to that of microfilaments including motility and vesicle transport, however play an 
essential role in apoptosis and the separation of chromosomes into daughter cells 
during interphase	 (Kettler et al. 2014; Mundra et al. 2015; Y. Song and Brady 
2015). Potential damage to either of these components would suggest acute 
toxicity of NPs. The results from previous cell metabolic and cell viability results 
suggest a time-dependent affect on cell cultures exposed to mNPs, which is in an 
agreement with the F-actin and β-tubulin staining, where filaments and tubules 
appear to be compromised with notable morphological changes at 24, 48 and 72 
hours. Actin filament disruption has also been shown to increase in a dose 
dependent manner upon mNP incubation (A. K. Gupta and Gupta 2005). At 72 
hours, both F- actin and β-tubulin filaments showed clear alterations, indicating 
potential long term effects of mNPs on cellular structure and function, although it 
has been suggested that this reorganisation or remodelling of the cytoskeleton 
maybe linked to different mechanisms involved in NP internalisation, as shown in 
figure 5-12, rather than as a direct response to the mNPs (A. K. Gupta and Gupta 
2005). 
 
As previously mentioned, the high intracellular concentration of nondegradable 
and solid nanoparticles, such as mNPs, may provoke the synthesis of large 
endosomes to compartmentalise internalised mNPs and it may be these 
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organelles that may actually, sterically hinder and deform the cytoskeletal 
architecture	 (Stefaan J. Soenen et al. 2012). The same observation was noted 
with the MG63 cells exposed to GNPs in chapter 3, with β-tubulin disruption, which 
further supports that NP internalisation disrupts β-tubulin networks (Diptiman 
Choudhury et al. 2013b).  Regardless of the effects noted with longer term 
incubation with the mNPs, there was little/no compromise in overall cell viability, as 
shown in figure 5-6. 
 
5.5.4 Hyperthermia using Magnetic Nanoparticles 
 
SPIONs have been shown to cause hyperthermia both in vitro (Reihaneh 
Haghniaz et al. 2015b) and in vivo (C. L. Dennis et al. 2009). To first evaluate the 
mNP heating potential, samples of various concentrations were assessed as to 
their heating potential using the magnetherm (figure 5-10). As expected, the 
heating capacity increased in a dose dependent manner; the mid-range 
concentration of 0.1 mg.ml-1 was selected as the most suitable candidate for cell 
studies, as this concentration was considered a reasonable threshold between cell 
tolerance and heating capacity.  
 
In general, mNP-heating capacity is proportional to the applied MF amplitude, with 
studies showing an increase in field strength corresponding to an increase in 
mNP-heating capacity	(Deatsch and Evans 2014; Mehdaoui et al. 2010). However 
this approach is not clinically relevant due to the physiological difficulties high 
frequency magnetic fields may inflict, such as induced local heating in non-
magnetic tissue due to induced eddy currents (Deatsch and Evans 2014). 
Therefore many studies use fairly narrow frequencies between 100 to 150 kHz for 
medical considerations (André C. Silva et al. 2011b). The characterised MF 
produced in this chapter for hyperthermic experiments was optimised at 115 kHz 
and therefore seems towards the upper limit of clinically relevant parameters and 
the strength was considered the maximum threshold. The mNP diameter/size also 
plays a role in its heating capacity, with smaller particles often releasing heat 
predominantly via Neel relaxation (< 15 nm), therefore our mNPs are expected to 
generate heat in this fashion, which is considered ideal as it is not influenced by 
the viscosity of its environment (Smolkova et al. 2015).  
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The magnetherm is not ideal for cell culture experiments, and in-house 
measurements were used to attempt to locate our 3D printed cell chambers in the 
centre of the applied field, where the force will be strongest, as shown in figure 5-
13. If cells are located at the optimal position, the mNP should cluster within the 
cell upon stimulation, causing maximum cell disruption. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-13: Magnetic nanoparticle heating within an alternating magnetic 
field. Magnetic nanoparticles generate their maximum potential heat, 
identified as an increase in temperature (ΔT), when located within the centre 
of an alternating magnetic field (image adapted from  Piñeiro-Redondo et al, 
2011). 
 
Due to time restraints, only initial gross cell morphology results were obtained. The 
results suggest MF alone does not contribute to cell death nor does it appear to 
affect cellular morphology. Cells exposed to mNPs and MF (and thus 
hyperthermia) showed striking, morphological changes indicative of cell stress 
such as loss of cell extensions, rounding up morphologies and cell detachment 
(Reihaneh Haghniaz et al. 2015b). The shrunken morphology and blebbing in cells 
exposed to hyperthermia may also indicate cells in the latter stages of apoptosis 
while the loss of the organisation of the cell layer and cell-to-cell contact and a 
significant decrease in the number of attached cells demonstrate the global effect 
of hyperthermia on cell monolayers (P. Garcia et al. 2012). 
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5.6 Conclusion 	
 
The aim of this chapter was to evaluate mNPs as potential hyperthermic agents. 
The ideal candidate must be biocompatible, internalised into cells and able to 
produce hyperthermic temperature profiles (42-45°C) upon exposure to an 
external alternating magnetic field (Bañobre-López et al. 2013).  
 
The mNPs used in this study showed great potential when used at 0.1 mg.ml-1, 
demonstrating cell viability, mNP internalisation and hyperthermic temperature 
profiles in under 20 minutes	 (M. Gong et al. 2015; S. Naqvi et al. 2010a). 
(Orynbayeva et al. 2015; Alice Panariti et al. 2012b; M. Yu et al. 2012a). The 
imaging (SEM, cytoskeleton and TEM) confirmed the interaction and subsequent 
internalisation of mNPs via endocytosis pathways, in particular clathrin-mediated 
endocytosis and pinocytosis appearing the most dominant processes, with mNPs 
packaged within lysosome structures within the cell body (no NPs were observed 
free within the cytoplasm)	(Yameen et al. 2014b).  
 
A 3D printed cell culture chamber was designed to adapt our in vitro studies to the 
magnetherm device used and MG63 cells were successfully cultured and exposed 
to a characterised magnetic field (H. S. Huang and Hainfeld 2013).  Subsequent 
coomassie staining confirmed that exposure to an applied magnetic field (AMF) 
alone did not affect cells, whilst mNP labelled cells exposed to an AMF showed a 
considerable decrease in cell attachment, morphology and size, representative of 
apoptotic/necrotic features. If time had allowed, I had planned a series of 
experiments to further analyse the effects of the AMF on the MG63 cells; initial cell 
viability staining would be carried out to confirm cell death, followed by annexin V 
staining to identify apoptosis. Further TEM imaging could be applied to further 
identify the mechanism of cell death. As shown in figure 5-14, the application of an 
AMF is known to result in the release of lysosome contents, therefore TEM 
analysis post hyperthermic treatment could identify mNP location within cells and 
verify if any particles were free in the cytoplasm, indicative of lysosomal bursting.  
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Figure 5-14: Iron oxide nanoparticles induce cell death by release from 
lysosomes following excitation by an alternating magnetic field (AMF) 
(image adapted from Domenech et al, 2013). 
 
The vast majority of studies perform hyperthermic experiments at room 
temperature, however Glover et al recently carried out mNP hyperthermic 
experiments with a starting temperature of 37°C to mimic in vivo like conditions. 
The temperature was then raised by just 5°C by mNP-induced hyperthermia to 
42°C in just 30 seconds. If time permitted, I would be keen to try and replicate this 
process of culturing cells at a baseline of 37°C before hyperthermic treatment.  
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5.7 Supplementary Data  
 
During the course of this final chapter, several other magnetic nanoparticles were 
assessed for their biocompatibility and heating potential via the magnetherm, 
however to date no others qualified for future study. The magnetic field parameters 
was investigated previously by a postdoctoral researcher to optimise the 
magnetherm device for hyperthermic experiments however the frequency range 
and magnetic field strength was curtailed towards more biological and clinically 
relevant conditions (Deatsch and Evans 2014; A. C. Silva et al. 2011a). 
 
A commercially available SPION formulation were acquired from collaborators in 
Liquids Research Limited (LRL, UK). These SPIONs had a ~ 13 nm core and  a 
DMSA (dimercaptosuccinic acid) biocompatible layer. They were evaluated in 
terms of biocompatibility and heating potential using the protocols within this 
chapter. Although not conventionally used, DMSA is a well-known molecule, 
considered non-toxicand orally administrated as a chelating agent to remove 
heavy metals from an organism representing its biocompatibility (M. P. Garcia et 
al. 2005; Miller 1998). DMSA has also verified its biocompatibility in vivo with 
mouse studies (M. P. Garcia et al. 2005) as well as non-human primates (Monge-
Fuentes et al. 2011). Silva et al assessed the biocompatibility and uptake of both 
magnetic and gold NPs decorated with DMSA on mesenchymal stem cells; both 
types of NPs showed excellent viability but only mNPs were proficient for magnetic 
targeting in vivo (L. H. Silva et al. 2016).  Unfortunately, the compromise between 
the biocompatibility/toxicity of these particular SPIONs and the concentration 
required to produce hyperthermic temperature profiles was unattainable, as shown 
in figures 5-15 and 5-16 respectively. Whilst a mNP concentration of 0.01 mg.ml-1 
was deemed the most biocompatible for biological experiments (figure 5-15), this 
concentration only permitted a modest change in temperature was observed that 
did not reach hyperthermic temperature profiles (figure 5-16). Interestingly, it has 
been previously reported that dispersed single magnetic nanoparticles were able 
to increase the temperature of their immediate surroundings within a magnetic 
field, in an amplitude dependent manner, without increasing the temperature of the 
bulk solution (Creixell et al. 2011; Krpetić et al. 2010). Perhaps further 
investigations using these mNPs may identify whether this could occur. Figure 5-
17 and 5-18 show the temperature elevation during magnetherm experiements of 
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both DMSA and PEG coated mNPs at 0.1 mg.ml-1 concentration at various 
characterised frequencies. No strong correlation was observed with an increased 
frequency on temperature between 100-130 kHz however a frequency of 200kHz 
showed a notable increase in temperature although this frequency is not 
considered biologically applicable. A frequency of 115 kHz provided the most 
biologically  appropriate condition as well as consistent and high heating 
temperature without compromising cell viabilty and was subsequently selected for 
experiments conducted within this study.  
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Figure 5-15: Metabolic activity of MG63 cells following incubation with LRL 
magnetic nanoparticles. MTT analysis of MG63 cells treated with 0.01, 0.1 
and 1.0 mg.ml-1 mNPs for 24, 48 and 72 hours (n = 5; error bars indicate SD). 
 
 
 
 
 
 
 
 
 
 
Figure 5-16: Temperature profiles of LRL mNPs stimulated in the 
magnetherm. Concentration used were 0.01, 0.1, 1.0, and 5.0 mg.ml-1, with a 
characterised magnetic field (volt= 27.2, current= 9.3, frequency= 115kHz, 
nanotherics, UK). The magnetherm device was switched off after 30 minutes 
or once a hyperthermic profile (42-45°C) was achieved, indicated by the 
black dash. 
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Figure 5-17: Temperature profiles of LRL mNPs at 0.1 mg.ml-1  stimulated by 
the magnetherm device at a range of frequencies. Magnetic field strength 
was maintained (volt= 27.2, current= 9.3) after 20 minutes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-18: Temperature profiles of PEG coated mNPs used throughout this 
study, at 0.1 mg.ml-1  stimulated by the magnetherm device at a range of 
frequencies. Magnetic field strength was maintained (volt= 27.2, current= 
9.3) after 20 minutes. 
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6 Final Discussion 
 
6.1 Nanoparticles in Hyperthermic Cancer Treatment 
 
Although nanomedicine is considered a promising field with exciting prospects for 
the diagnostics and clinical treatment of human disease, important parameters 
such as the biodistribution, biological interaction and toxicological effects of new 
nanomaterials must be carefully assessed before actual clinical use (Nikolai 
Khlebstov et al, 2010; Ruchi Roy et al, 2014).  Many nanoparticles (NPs) have the 
ability to absorb energy (magnetic pulse, laser light, ultrasound etc) and turn it into 
heat.  The use of nanothermal therapy as a viable future option for cancer 
treatment has been recently discussed (Chatterjee et al. 2011; Krishnan et al. 
2010).  It is noted that researchers have to focus their attention not only on the NP 
heating efficacy, but also on parameters such as NP blood half-life, toxicity, organ 
distribution and renal clearance. To date a number of studies have made the 
successful leap from in vitro to in vivo with encouraging results	 (G. Kandasamy 
and Maity 2015a; Muldoon et al. 2005). The following discussion sections will 
detail the key in vitro and in vivo studies for both gold and magnetic naonparticles 
that have been carried out to date, including those that have achieved clinical trial 
status. The ultimate goal of this field of research looks forward towards using gold 
or magnetic nanoparticles as successful, practical thermal agents in cancer 
treatment. One consideration when using NPs in vivo is the route of 
administration. For NP intravenous administration - which is the standard to date 
for accessing tumours, researchers have exploited the phenomenon of the 
enhanced permeability and retention effect (EPR), which allows the natural 
‘passive’ accumulation of NPs into tumours	(Nichols and Bae 2014). This is due to 
the increased leakiness of tumour blood vessels allowing for NPs to seep into the 
disorganised vascular architect and accumulate, as shown in figure 6-1 (Nichols 
and Bae 2014). Accumulation is further amplified through the lack of functional 
lymphatic drainage in tumours that inhibits the removal of extravasated NPs 
leading to increased retention times	 (Baetke et al. 2015). The EPR effect can be 
further increased through ‘active’ targeting with nanosystems designed to increase 
the targeting, uptake and retention of NPs to specifically targeted sites (Cherukuri 
et al. 2010; Cole et al. 2011b).  
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Figure 6-1: Nanoparticle transport to cancerous tissues via the enhanced 
permeability and retention (EPR) effect. Nanoparticles of various sizes 
accumulate more in cancerous tissues (right) than normal tissues (left) due 
to disorganised vasculature and impaired lymphatic drainage (Sun et al, 
2014).   
 
The interaction, consequences and fate of NPs within a biological system remain 
complex and it is important for researches to understand the cell-nanoparticle 
interactions in order to predict potential toxicity issues	(Verma and Stellacci 2010).  
In this regard, a further consideration for NP use in vivo is NP interaction with 
proteins within a biological fluid, such as growth media in vitro or blood in vivo, 
which are able to adhere to and essentially coat NPs, thereby influencing the 
overall NP performance. The type and amount of these proteins that attach onto 
NPs, termed “protein corona”, could lead to a very different cellular responses as 
compared to uncoated NPs, by altering the ‘cell vision’ (i.e. how a cell type views a 
particular NP) (Mahmoudi et al. 2012; Saptarshi et al. 2013). Both the NP protein 
corona and the cell vision of different cell types could holistically lead to restricted 
clinical use of NPs and should therefore be considered, or negated, when 
designing a NP-based platform for bioapplications.  
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6.2 Gold Nanoparticles as Photothermal Agents 
 
6.2.1 Gold Nanoparticle Biocompatibility In Vitro  
 
Bulk gold is well known to be chemically inert and gold-based compounds have 
been used in clinic, such as anti-inflammatory agents to treat rheumatoid arthritis.  
The chemical reactivity for nanoscale gold particles, however, is different to bulk 
gold. The debate over the biocompatibility and potential toxicity of GNPs has been 
extensively discussed within the literature (Ellen E. Connor, 2005; Pratap C. Naha, 
2015; Hirak K. Patra, 2007; Show-Mei Chuang, 2013). However only a modest 
consensus has suggested that GNPs themselves may be inherently toxic 
(Ahamed et al. 2016; A. M. Alkilany and Murphy 2010; A. M. Alkilany et al. 2012; 
Karakoçak et al. 2016). With GNPs being explored as prospective drug delivery 
agents (Coelho et al. 2015), contrasting agents (Q. Wu et al. 2015), gene delivery 
agents (Bishop et al. 2015) and, in this case, hyperthermic agents (Hainfeld et al. 
2014), the potential short-term and long-term toxicity must be fully realised in order 
to safely and reliably translate for clinical application. 
 
6.2.1.1	Cytotoxicity	is	Dictated	by	Size	and	Shape:	Nanorods	and	Nanoprisms	
 
GNP toxicity has been directly linked to their size and shape.  There have been 
numerous studies in this regards, table 6-1 summarises some of those studies, 
indicating the cell culture model used and the size and shape of the GNP. As the 
table shows, the response is varied. 
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Table 6-1 Sum
m
ary of Studies show
ing G
N
P toxicty observations (adapted from
 C
larence S. Yah et al, 2013). 
Type 
exposed 
organism
 
S
ize of 
G
N
P
s 
R
oute of 
E
xposure 
D
ose 
S
urface 
C
oating 
Test 
B
iological E
ffect 
R
ef 
M
ale W
U
 
W
istar-
derived rats 
10, 50, 
100 
and 
250 nm
 
Intravenously 
1 m
L 
S
pherical 
G
N
P
s 
O
rgan index 
The G
N
P
s w
ere found in the liver and spleen. 10 nm
 w
as 
presnt in all blood, liver and spleen. G
N
P
s found in the 
liver and m
acrophages 
[53] 
Fem
ale m
ice 
2, 40 
and 
100 nm
 
Intratracheal  
1.4-1.6 
m
g/kg 
N
egatively 
charged 
m
onodisperse 
and spherical 
G
N
P
s 
O
rgan index 
(liver) 
G
N
P
s found in liver and m
acrophages 
[88] 
M
ice 
13.5 
nm
  
O
ral, 
Intraperitoneal 
routes and tail 
vein 
intravenous 
injection 
137.5-
2200 
µg/kg 
S
pherically 
citrate-coated 
A
nim
al survival, 
w
eight, 
heam
otology, 
organ index 
H
igh G
N
P
 induced decrease in body w
eight, red blood 
cells. N
o effect at low
 level. O
ral adm
in caused a 
significant decrease in body w
eight, spleen index and red 
blood cells 
[14] 
B
A
C
B
/C
 
M
ice 
3-100 
nm
 
Intraperitoneal 
8 mg/k/w
eek 
N
one 
P
hysical and 
behavioural 
exam
ination  
G
N
P
s of 8, 12, 17, 37 nm
 induced fatigue, loss of 
appetite, change of fur colour and w
eight loss. M
ost died 
w
ithin 21 days. 3-5 nm
 did not induce sickness 
[68] 
M
ale W
istar 
rats 
20 nm
 
Tail-vein, 
intravenous 
injection 
0.2 m
L 
(0.01 
m
g/kg) 
G
N
P
s 
O
rgan index 
G
N
P
s accum
ulated and persisted in the liver and spleen 
and other organs. M
any up and dow
n regulated gene 
w
ere expressed.  
[37] 
M
ale m
ice 
C
57/B
L6 
~12.5 
nm
 
Intraperitoneal 
40-400 
µg/kg/day  
C
olloids citrate 
coated G
N
P
s 
A
nim
al survival, 
w
eight, 
heam
otology 
m
orphology and 
organ index 
G
N
P
s w
ere able to cross the vrain barrier and 
accum
ulate in neural tissues but no toxicity evident but 
there w
as uptake in the spleen, kidney and liver.  
[87] 
		220	
  Rat 
5 nm
 
Tail vein 
intravenous 
and 
Intratracheal 
570-870 
µg/kg  
P
E
G
 coated 
G
N
P
s 
O
rgan index 
P
E
G
 coated G
N
P
s accum
ulated m
ostly in liver and 
spleen  
[90] 
M
ale m
ice 
~15 nm
 
Tail vein 
intravenous 
and 
Intratracheal 
150-200 
µL   
H
um
an serum
 
album
in, G
N
P
s 
O
rgan index 
Functionalised G
N
P
s accum
ulated in the hippocam
pus, 
thalam
us, hypothalam
us and the cerebral cortex 
[91] 
B
A
LB
c/c 
A
nN
H
sd 
fem
ale m
ice 
~2.5 
nm
 
S
ubcutaneous 
injection 
200 µL 
P
E
G
-TM
P
C
 
coated 
O
rgan index 
100%
 survial at all the different concentrations of P
E
G
-
TM
P
C
 and TM
P
C
. P
articles present in the organs but 
TM
P
C
 is not suitable for in vivo studies 
[92] 
		 221	
Smaller GNPs were reported to elicit greater toxicity than larger GNPs, where 
particles <3 nm were observed to intercalate in DNA  (Hung-Jen Yen, 2009). A 
study by Goodman et al also demonstrated cytotoxicity of cationic 2 nm diameter 
gold nanospheres (Goodman et al, 2004). However control experiments, 
assessing the same GNPs with a negatively charged surface, tested in the same 
cell line with the same dose were not found to be toxic, as the cationic GNPs 
interacted with the negatively charged cell membrane and caused disruption. 
Therefore, such studies should always be thorough, to determine the correct 
parameter influencing toxicity.  
 
The perspective of smaller particle sizes conferring cytotoxicity has been 
challenged recently by Mingfei Yao et al, who demonstrated that an increase in 
particle diameter promoted the depolarisation of mitochondrial membrane 
potential, an early indicator of apoptosis (Yao et al. 2015). Therefore size is not 
always a clear determinant for cell response.  
 
Synthesised GNPs come in a variety of shapes, including rods, spheres, tubes, 
wires, cubic, hexagonal triangular and tetrapods. GNP shape is known to influence 
cytotoxicity, with more sophisticated geometries associated with a higher cytotoxic 
effect	 (Carnovale et al. 2016). For example gold nanorods are often cited as a 
more toxic geometry as compared to nanospheres (Yinan Zhang et al, 2012), 
nanocages (Y. Wang et al. 2013b) and nanohexapods (Y. Wang et al. 2013b). The 
in vitro cytotoxicity of gold nanorods in a human lung adenocarcinoma cell line was 
recently published (Ying Tang, 2015). The study confirmed membrane damage 
within 4 hours of gold nanorod exposure while ROS production correlated to 
increased GNP concentration. In another study, gold nanorods with three varying 
aspect ratios were also evaluated for their cytotoxic potential across 6 cell lines 
(Show-Mei Chuang, 2013). All three nanorods induced a dose-dependent 
suppression on cell growth to varying degrees, with ROS induced apoptosis and 
cell cycle inhibition considered the main route of GNP cytotoxicity. Conversely, the 
nanorods used in this project exhibited low cytotoxicity even at high concentrations 
and produced similar biocompatible features as their gold nanoprism counterparts.
 
		 222	
The associated toxicity of gold nanorods in particular may be due to the synthesis 
process rather than the actual geometry, as previously highlighted by Alkilany and 
co-workers (Alaaldin M. Alkilany et al. 2009). As previously highlighted in chapter 
3, section 3.5.4, CTAB is a cationic surfactant conventionally used by groups to 
“grow” gold nanoseeds into nanorods, could indeed be the the primary source of 
toxicity. CTAB is typically removed via purification or desorption techniques, 
however these processes are often inadequate at removing all CTAB molecules 
and thus free CTAB molecules can remain within the nanorod solution leading to 
toxicity (A. M. Alkilany and Murphy 2010). Alkilany and Murphy (2009) validated 
this claim when they centrifuged GNP solutions and removed and analysed the 
supernatant (containing free CTAB molecules). They observed the concentration 
of CTAB in the supernatant was able to cause cytotoxicity and a reduction in cell 
viability. The study may explain the associated toxicity of gold nanorods and other 
geometries both in vitro and in vivo (A. M. Alkilany and Murphy 2010).  In addition, 
gold nanorods synthesized in the presence of CTAB conjugates have been shown 
to lead to toxicity in both cells and in animals (Akiyama et al. 2009; Wan et al. 
2015), with CTAB shown to damage mitochondria and increase the activation of 
intracellular ROS, inducing cell apoptosis and autophagy (Wan et al. 2015). 
However, despite its use in the production of the gold nanorods used in this 
project, our collaborators have taken measures to remove as much CTAB as 
possible from the gold nanorod solution (chapter 3, section 3.3.1), which may 
clarify the low toxicity levels observed throughout the project.  
 
6.2.1.2	Variation	in	Cell	Response	Between	Different	Cell	Lines	
 
The general outcomes drawn from various studies are unfortunately, inconclusive 
due to the inherent variations in how the different research groups carry out 
experiments, including using different cell lines, different NP sizes, different 
surface coatings, different concentrations/doses and different time points. For 
example, with regards to cell lines, GNPs have been shown to lead to cell death in 
A549 cells (human hepatocellular liver carcinoma) in a dose dependent manner, 
but not in HepG3 (human hepatocellular) or BHK21 (baby hamster kidney) (H. K. 
Patra et al. 2007a). The study confirmed cell death occurred through Poly ADP-
ribose polymerase (PARP) activation, a protein which can be cleaved and leads to 
the downstream activation of caspases and cell death (H. K. Patra et al. 2007a) 
		 223	
while oxidative stress and increased lactacte dehydrogenase leakage was also 
induced in A549 cells, again in a dose dependent manner (Ying Tang, 2015).  
 
The results in chapter 3 confirmed the relative inert nature of both gold nanorods 
and nanoprisms (without heating) in the two cell lines, with no differences noted 
between MG63 and MCF-7 cells in either monolayer or spheroid culture. This was 
surprising, given that the gold nanorods that were synthesized in the conventional 
“see-mediated” method utilizing the CTAB surfactant. Gold nanoprisms were 
synthesised without the use of CTAB and thus no toxicity was anticipated.  
The results in chapter 3 did highlight variation in GNP internalization based on 
geometry, with nanoprisms being internalized with far greater efficiency than 
nanorods.  The size of GNPS is known to influence both the rate and extent of 
cellular uptake, with smaller particle sizes proving more efficient (Chithrani et al, 
2006). A study by Gao et al adopted a mathematical approach to identify an 
optimum particle size of 27-30 nm to permit the most efficient internalisation	 (H. 
Gao et al. 2005). However, whilst there were no practical experiments to support 
this claim, the gold nanoprisms used in this project were much larger and quickly 
internalized by both cell lines. 
 
6.2.1.3	GNP	Coating	and	Cytotoxicity	
 
The biocompatibility of the gold nanoprisms and nanorods may be attributed to 
their functionalization with 5 kDa PEG chains. The PEGylation of NPs has been 
shown to improve systemic performance, decreasing inflammatory responses in a 
PEG dose-dependent manner and increasing endocytosis into lung alveolar 
endothelial cells (Ibricevic et al. 2013). PEGylated NPs have also been shown to 
increase cancer cell uptake, reducing nonspecific accumulation and prolonging 
blood circulation by decreasing the rate of opsonisation and thus RES clearance	
(Hongwei Chen et al. 2013; J. Liu et al. 2013c). 
 
The PEGylation of NPs has also been demonstrated to increase the accumulation 
and residence time within tumours while also enhancing the affect of photothermal 
treatment in vivo as compared to bare GNPs, possibly due to the increased uptake 
and tumour accumulation of PEGylated GNPs	(J. Bai et al. 2014a; Huiyu Liu et al. 
2013b). The pharmacokinetics of PEGylated GNPs illustrated the passive 
accumulation of both gold nanoshells and nanorods in tumourss within mice, while 
		 224	
PEG functionalisation preserves GNP stability against agglomeration at 
physiological conditions during systemic circulation (Constantin et al. 2013; 
Terentyuk et al. 2013). 
 
One of the major advantages to the use of GNPs over other NPs is their ‘active’ 
surface chemistry (Pissuwan et al. 2006). GNPs can be functionalised with ease 
by a wide range of thiolated molecules with very high affinity (Beatriz Pelaz and 
del Pino 2012) and can be easily functionalised with various ligands (Constantin et 
al. 2013), antibodies	(Di Pasqua et al. 2009) and proteins	(Di Pasqua et al. 2009). 
Although geometry (Chithrani et al. 2006), size (Freese et al. 2012) and 
functionalisation	(Y. Jiang et al. 2015)  can all affect the GNP uptake, it seems the 
most conventional route is receptor-mediated endocytosis (Dykman and Khlebtsov 
2014; N. Oh and Park 2014). Our results support a combination of endocytosis 
and pinocytosis for nanoprism and nanorod cellular uptake.  
 
The intracellular distribution of GNPs has been previously studied, with consensus 
supporting storage in vesicles, howvever GNPs are also reported to leave the cell 
via exocytosis. Chithrani and Chan (2007) detailed the elimination of GNPs from 
cells, which was size dependent, with smaller GNPs removed faster than large 
GNPs in a practically linear pattern (14, 30, 50, 74, 100 nm), while gold nanorods 
seem to be removed from cells at a greater rate than spheres. Chan et al group 
also observed a similar pattern on the uptake rate of sphere and rods, with 
spheres showing more efficient uptake into cells than rods, with a higher aspect 
ratio of rods also correlating to a lower uptake rate (Chithrani et al. 2006; Chithrani 
and Chan 2007; E. C. Cho et al. 2010a). 
 
6.2.2 Gold Nanoparticle biocompatibility in 3D Culture  
 
Traditional in vitro studies are performed in 2D, with cells cultured on plastic or 
glass substrates which provide a lack of relevance to the in vivo environment, 
while the behaviour, intracellular fate and toxicity of NPs in in vitro studies often 
exhibit poor consistency when scaling to in vivo models (Joris et al. 2013). Testing 
NP platforms immediately within animal models does present unique challenges, 
including ethical issues, while animal models do not correlate to human systems. 
The economical issues, practicality and feasibility of in vivo studies also limit their 
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use. To bridge the gap between in vitro and in vivo, with the aim to produce more 
clinically relevant data, 3D cell culture models are instrumental.  
 
In this project multicellular tumours spheroids were employed alongside 
corresponding monolayer cell cultures. The standard biocompatibility assessment 
in chapter 3 did not reveal discriminate differences between the 2D and 3D 
models, as reported by previous studies that detail 3D models as more resistant to 
toxicological affects than their 2D counterparts (Jungwoo Lee et al. 2009; H. 
Tseng et al. 2015; Wills et al. 2016). Recent studies have challenged the 
hypothesis of 3D cultures being more resistant to toxicity than 2D models, often 
citing difficulties with colorimetric dye-based cytotoxic assays (such as MTT 
assays) in 3D cultures (Bonnier et al. 2015). In addition, other groups have 
observed 3D models as more susceptible to nanotoxicity when compared to 2D 
models, with different cytotoxic mechanisms occuring in either 2D or 3D culture 
upon NP exposure (Sambale et al. 2015; Theumer et al. 2015; Miao Yu et al. 
2012b). 
 
6.2.3 Gold Nanoparticle Induced Hyperthermia via Photothermal Treatment  
 
6.2.3.1	Modest	Screening	Provides	Ambiguous	Results	
 
The results from chapters 3 and chapter 4 confirm the that both cell lines labelled 
with either gold nanoprisms or nanorods and laser treated resulted in hyperthermic 
temperature profiles, leading to cell death	 (Raji et al. 2011a).  The cell death was 
apparent in both 2D and 3D cultures, confirming that the laser was capable of 
penetrating the spheroids, which were approximately 200 µm (Madsen et al. 
2015).  
 
Many other groups carried out experiments detailing photothermal treatment on a 
plethora of monolayer cancer cell cultures using various GNP platforms with 
success	 (C.S et al. 2012; Chiu et al. 2015; Gobin et al. 2010; L. Mocan et al. 
2015a; Raji et al. 2011b; L. Yang et al. 2015).	 	The majority of studies confirm a 
decrease in cell viability and increase in apoptosis using standard viability assays 
and focusing on a single apoptosis pathway (Alfranca et al. 2016; Gobin et al. 
2010; Y. Guo et al. 2013; X. Huang et al. 2006b). Unfortunately these studies do 
		 226	
not clearly distinguish if cell death occurred via apoptosis or necrosis and of the 
two, which appeared the more dominant process.  There are no studies which 
have screened both 2D and 3D cultures for a wide range of RNA and protein 
targets to identify the various pathways activated during cell death, as was carried 
out during this project. 
 
To somewhat answer these apparent shortcomings, groups have focused on 
speficic markers, for example evaluating the intracellular events after photothermal 
treatment by identifying increases in heat shock protein expression (Ali et al. 2016; 
Leung et al. 2013; L. Yang et al. 2015) and/or apoptosis via caspase 3 expression 
(C.S et al. 2012; Raji et al. 2011a). Although caspase 3 is a good indicator of cell 
death via apoptosis, caspase 3 is actually an effector caspase mediating apoptosis 
once activated by either the intrinsic, extrinsic pathway, while also playing a role in 
lysosome degradation, providing ambiguous results (Oberle et al. 2010). To the 
best of our knowledge only a few groups have attempted to decipher the more 
intrinsic intracellular events and pathways of apoptosis upon photothermal laser 
irradiation, including the analysis of Bcl-2 family members and proteins associated 
with mitochondria (Abadeer and Murphy 2016; Perez-Hernandez et al. 2015; 
Shiwen Zhang et al. 2014).  
 
6.2.3.2	Identifying	the	Intracellular	Events	of	Photothermal	Treatment		
 
In this project, we attempted to characterise photothermal-induced apoptosis, by 
screening a variety of apoptotic markers both at the genetic and proteomic level. 
Experiments were carried out using two cell lines, two GNP types and two cell 
culture models, with a view to clarifying any differences observed. Although the 
intrinsic pathway appeared the dominant protagonist for apoptosis, our results also 
showed a more broad activation of both the extrinsic pathway and cathepsin 
mediated apoptosis upon photothermal treatment (K. Ahmed et al. 2015a; 
Shellman et al. 2008). These more novel pathways are orchestrated by cellular 
oxidative stress as well as autophagy (Shellman et al. 2008).  Our results further 
suggested that hyperthermia-induced apoptosis was activated primarily via ROS 
accumulation as well as protein degradation and activation of pro-apoptotic 
markers.  
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6.2.4 Gold Nanoparticle Hyperthermia In Vivo and the Clinic  
 
The in vivo performance and associated toxicities of GNPs has been discussed 
(Nikolai Khlebtsov, 2010; Carrie A. Simpson et al, 2015; Xiao-Dong Zhang, 2011; 
Nikhat J Siddiqi, 2012; Mayara Klimuk Uchiyama, 2012). GNPs have been seen to 
accumulate at different rates within different tumour models, where the 
accumulation of GNPs was 5 times higher in breast cancer tumours compared to 
fibrosarcoma tumours, suggesting tumour type is influential on GNP accumulation 
(Dam et al. 2015). Interestingly, this group also noted discrepancies in the GNP 
half-life in males and females, although no hypothesis was put forward.  Aside 
from tumour accumulation, GNPs also accumulate in the spleen and liver (Black et 
al, 2013). The particle shape appears to be a factor in determining the half-blood 
life and clearance of NPs, with nanospheres retained for longer in circulation as 
compared to disks, rods and cages (Black et al, 2013). As with toxicity studies, 
comparisons are often difficult due to variation in experimental design, including 
the administration route, passive/active targeting, concentration, exposure time as 
well as individual particle features (shape, size charge etc).  However, in summary 
most groups showed no significant permanent toxicity associated damage when 
using in vivo animal models (Sung Gu Han et al, 2015; Samuel A. Jensen, 2009), 
even up to 120 days after exposure (Goel et al, 2009).  
 
The use of GNPs for the thermal tumour therapy was first documented in mice in 
2003 by Hirsch et al (Hirsch et al. 2003). Histological samples confirmed the 
irreversible tissue damage of irradiated tumourss containing gold nanoshells. 
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Figure 6-2: Effects of GNP photothermal treatment.  a) Gross pathology after 
in vivo treatment with nanoshells and NIR laser reveal hemorrhaging and 
loss of tissue birefringence beneath the apical tissue surface. (b) Silver 
staining of a tissue section reveals the region of localized nanoshells 
(outlined in red). (c) Hematoxylin/eosin staining within the same plane 
clearly shows tissue damage within the area occupied by nanoshells. (d) 
Likewise, MRTI calculations reveal an area of irreversible thermal damage of 
similar dimension to a, b, and c. (taken (Hirsch et al. 2003)). 
 
Since this report, many other in vivo animal studies have been conducted with 
promising results (Bogdanov et al. 2015; Dickerson et al. 2008; Melancon et al. 
2008; D. P. O'Neal et al. 2004a; Rengan et al. 2015). Systemic studies focused on 
GNP biodistribution, has shown that smaller GNPs result in a more widespread 
distribution in both rat (De Jong et al. 2008) and mouse organs	 (Hillyer and 
Albrecht 2001) via intravenous injection and oral intake, respectively. A 
comprehensive systemic review by Mohan Singh et al in 2015 detailed the use of 
GNP thermal therapy solely for gastrointestinal cancers with eleven studies that 
were conducted using rodents and demonstrated excellent therapeutic outcomes. 
However, in another animal trial, more severe effects have been reported by Chen 
and co workers, where GNPs within a size range (8-37 nm) led to various side-
effects including fatigue, loss of appetite, change of fur colour, and weight loss, 
while more stark characteristics such as crooked spines and loss of lung structural 
integrity were also noted	 (Y.-S. Chen et al. 2009). While Zhang and co-
workers(2011) demonstrated an increase in alanine transaminase and aspartate 
transaminase levels, clinical markers signifying liver damage upon the introduction 
of PEGylated GNPs at 10 nm and 60 nm, within mice (Xiao-Dong Zhang, 2011). 
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Despite this, GNP thermotherapy has shown more promising potential in a number 
of studies including treatment for prostate cancer (Terentyuk et al. 2013), 
pancreatic cancer	 (C. R. Patra et al. 2010) and breast cancer (Jihyoun Lee et al. 
2014b). 
 
The success of in vitro and in vivo studies has lead to clinical trials. In 2011, a 
Phase I clinical trial confirmed GNP biocompatibility while a predicted yet 
controlled fever occurred in patients due to immune activation and inflammation	
(Elsabahy and Wooley 2013; Libutti et al. 2010). The study not only showed how 
the use of PEGylated 27 nm colloidal gold nanospheres, even at previously 
believed toxic concentrations, can be tolerated by the body, but also demonstrated 
the efficacy of targeting systems to traffic GNPs to tumour tissue (Libutti SK, 
2010).  
 
Currently, only one GNP photothermal treatment system has progressed to clinical 
trials produced by Nanospectra Biosciences, Inc., founded in 2002. The company 
focuses on commercialising photothermal therapeutics for the destruction of solid 
tumours (Abadeer and Murphy 2016). While a US Food and Drug Administration 
(FDA) approved	AuroLase® pilot study using silica-gold nanoshells  (AuroShells) 
has been completed, for the photothermal treatment of patients with primary and 
metastatic lung tumours. AuroLase Therapy involves the use 150 nm PEGylated 
gold nanoshells. The nanoshells are injected intravenously, while the PEGylation 
allows GNPs to circulate in the blood long enough to accumulate in tumours via 
the EPR effect (Abadeer and Murphy 2016). As NIR laser penetration is ~10 cm, 
deep seated tumours may not be adequately treated and therefore fibre optic NIR 
lasers will be inserted into the body to alleviate this fundamental issue (Abadeer 
and Murphy 2016; Ralph Weissleder 2001b). The use of a fibre optic NIR laser 
has been proved effective by Schwartz and co-workers (2009) who successfully 
utilised photothermal therapy in a venereal tumour in a canine brain model 
(Schwartz et al. 2009). A second AuroLase® pilot study has also been completed 
using AuroShells for the treatment of neck and head tumours. Although both 
studies have been completed, the results have not yet been publicised (Pedro 
Pedrosa, 2015). A schematic of the GNP core is shown in figure 6-3. 
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Figure 6-3: The AuroShell GNPs currently being used in the AuroLase 
clinical trial program. While information is limited; the image on the left 
shows the particle and its mode of action, whilst the image on the right 
illustrated an IV bag of AuroShells. (Image adapted from Nanospectra 
Biosciences;http://nanospectra.com/our-technology/products/aurolase-
therapy).  
 
6.2.5 GNPs as an Adjunct to Established Cancer Therapies  
While GNP photothermal therapy has been highlighted as a viable, alternative 
therapy for cancer treatment, GNPs have also recently been investigated as an 
adjunct to established cancer therapies (J. Lee et al. 2014a; Lucian Mocan et al. 
2016). For example, photothermal heating has been synergistically used to reduce 
the amount of radiation dose required during radiotherapy (James F. Hainfeld, 
2014) and for the dual modality of targeted chemotherapeutic delivery and 
hyperthermia to cells (Hussaina Banu, 2015). Jaesook Park et al, (2015) showed 
the effectiveness and range of uses of hollow GNPs for triple combination therapy 
and CT imaging, with the hollow core housing chemotherapeutic payloads. The 
GNPs also featured a high x-ray absorption capability, which increased the effect 
of radiotherapy while its own heating capability contributed to hyperthermic 
profiles. The combination of hyperthermia, radiotherapy and chemotherapy 
dramatically delayed tumour growth (by a factor of 4.3) and reduced tumour 
weight (6.8-fold) compared to control tumourss, while the ability of GNPs as 
contrast agents for CT scans were in accordance with previous literature (Ahn et 
al. 2013). This extensive study highlights the huge potential of GNPs as 
contrasting agents and as nanoscale heaters.  
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6.3 Magnetic Nanoparticles as Hyperthermia Agents  
 
6.3.1 Magnetic Nanoparticle Biocompatibility 
 
As with GNPs, the toxicity of mNPs, in particular SPIONs, have been well 
documented in several comprehensive reviews (Sophie Laurent et al. 2012b; G. 
Liu et al. 2013a; Mahmoudi et al. 2011; L. H. Reddy et al. 2012a).  The importance 
of a biocompatible coating surrounding mNPs has been well established, with 
Miao Yu et al demonstrating the potentially cytotoxic nature of bare SPIONs, while 
SPIONs coated with PEG or dextran showed little toxicity in both 2D and 3D 
models	 (Miao Yu et al. 2012b).  Morteza Mahmoudi’s group further confirmed the 
uptake and cytotoxicity at both the cellular and molecular level with thirteen cell 
lines exposed to the same SPION at various concentrations (Mahmoudi et al. 
2012). Not only did the study demonstrate that the toxicity levels of different cell 
types to SPION exposure varied, it also probed the potential detoxification 
pathways different cell types use to remove ROS and remain viable.  
 
A number of studies have demonstrated, DNA damage (Mahmoudi et al. 2011), 
oxidative stress (Ivask et al. 2015; U. A. Reddy et al. 2015), mitochondrial damage 
(Unfried et al. 2009) and protein denaturation (Vanessa Valdiglesias et al. 2015b) 
of cells in the presence of mNPs. These toxicity issues are believed to occur upon 
internalisation of SPIONs, where iron oxide can be metabolised by heme 
oxygenease-1 to form haemoglobin and hence maintain iron cell homeostasis 
(Kumar and Faruq, 2011). However the increase concentration of iron within the 
body can lead to the production of free radicals that can lead to oxidative stress 
and eventual death of cells (Santhosh and Ulrih 2013). 
 
Despite these potential pitfalls, the FDA and the European Medicines Agency 
(EMA) have both approved the medical use of selected iron oxide nanoparticles, 
which have been applied to human clinical trials for the treatment of brain cancer, 
glioblastoma (Bayazitoglu et al. 2013; Tombacz et al. 2015). For future medical 
applications, mNPs must show efficacy in biocompatibility and long-term stability in 
vivo for use in thermotherapy treatment  of cancer cells	 (Gobbo et al. 2015; C. S. 
Kumar and Mohammad 2011).  
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Our short study, in chapter 5, confirmed the low toxicity of dextran-coated mNPs, 
even at a relatively high concentration (0.1 mg.ml-1), which was required for 
adequate hyperthemic temperature profiles (42-45°C)	 (Toraya-Brown and Fiering 
2014). Successful cellular uptake into monolayer MG63 cells was observed, most 
likely due to the biocompatible dextran, which has been shown to increase mNP 
internalisation and also reduce mNP toxicity compared to bare and PEG coated 
mNPs	 (Miao Yu et al. 2012b). Dextran coated mNPs also boast an advantage in 
biological systems where they have been shown to prolong blood duration time 
allowing access to macrophages located in tissues such as lymph nodes, kidney, 
brain	(Easo and Mohanan 2013).  	
6.3.2  Magnetic Hyperthermia In Vivo and the Clinic  
 
The mNPs used in this project were able to generate heat upon exposure to an 
external alternating magnetic field (volt= 27.2, current= 9.3, frequency= 115 kHz) 
within 20 minutes, leading to a decrease in cell viability and change in cellular 
morphology indicative of apoptosis (P. Garcia et al. 2012).  Although further 
analysis is certainly required, the experiments confirmed substantial cell death 
upon elevated temperature exposure, while cells exposed to AMF alone did not 
appear to show signs of cellular stress or apoptosis (Beik et al. 2016). 
 
In 2011, Alsayed A.M. Elsherbini’s group used mNPs to induce hyperthermia in 
mice implanted with subcutaneous Ehrlich carcinomas.  Although the experiment 
was not entirely successful at destroying the entire carcinoma, it did demonstrate 
the dual modality capability of mNPs as both nanoscale heaters for hyperthermia 
and contrast agents for MRI (Elsherbini et al. 2011; Yallapu et al. 2011).  Other in 
vivo studies of magnetic nanoparticles have shown more encouraging results with 
regards tumour destruction in animal models (Balivada et al. 2010; Espinosa et al. 
2016; Hayashi et al. 2013; Ingrid Hilger 2013; J. H. Lee et al. 2011). Studies 
include systems that use magnetic targeting, by locating a permanent magnet over 
the tumour to increase SPION concentration in cancer cells, thereby diluting the 
concentration of SPIONs found in the spleen, liver and tissue (Min et al. 2010; 
Prijic et al. 2010).  
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Other groups are taking this forward by designing mNPs which can actively target 
tumour cells by incorporating targeting systems onto the mNP surface, for 
example ligands that bind to overexpressed receptors on tumour cells such as 
transferrin receptor 1 (TfR1) (K. Fan et al. 2012).  MNPs have also been 
functionalised with Galactose-Carrying Polymers	(M. K. Yoo et al. 2007), folic acid	
(Q. L. Jiang et al. 2014), PEG modified, cross-linked starch (Cole et al. 2011a) and 
homing peptides (A. M. Kruse et al. 2014) to increase their proximity to target 
cells. The competency of active targeting was demonstrated in SPIONs 
functionalised with anti-human epidermal growth factor receptor-2 aptamers, with 
hyperthermia induced at a 90-fold lower concentration than untargeted SPIONs 
(Kaur et al. 2016). Although a valuable component, active targeting systems via 
ligands, antibodies and peptides are influenced by the complex relationship of 
mNP shape, size, ligand density, surface hydrophobicity and are compromised 
with issues of non-specific binding which can influence their overall in vivo 
performance (Bertrand et al. 2014).			
One of the first clinical trials using mNP based hyperthermia was conducted in 
1991.  In this clinical trial, mNP-mediated hyperthermia was performed in 23 brain 
tumour patients, while the results were still preliminary, an overall response of 
~35% was recorded	 ((response rate was the ratio of responded cases to the total 
treated cases) (Kobayashi et al. 1991).  A more recent brain tumour clinical trial 
was performed in 2006, in which patients with glioblastoma multiforme were 
treated with a combination of magnetic hyperthermia and radiotherapy. This 
showed promising results with no apparent toxicity, while the exposure of an 
external AMF was tolerated by the majority of patients with only minor side effects 
reported	 (Maier-Hauff et al. 2007). In 2001, Jordan and co-workers developed an 
alternating magnetic field heating (MFH) device that was made available for 
medical experiments and developed the world’s first MFH (R) 300F-type magnetic 
induction hyperthermia instrument available for clinical treatment	 (A. Jordan et al. 
2001). To date, clinical trials of mNP hyperthermia have been conducted for 
prostate cancer	 (Manfred Johannsen et al. 2007), recurrences of different tumour 
entities and deep regions of the human body	(Gneveckow et al. 2004; Sreenivasa 
et al. 2003; Thiesen and Jordan 2008; Wust et al. 2006). In no cases were several 
side effects reported whilst the effectiveness of mNP based hyperthermia proved a 
feasable alternate therapy prospect for both deep seated and superficial tumours.   
 
		 234	
6.3.3 Magnetic nanoparticles as an Adjunct to Established Cancer Therapies 
 
More recent and larger scale phase 3 clinical trials have been conducted on 341 
patients enrolled in either chemotherapy alone or chemotherapy and hyperthermia 
via mNP heating. Results showed the combinational impact of regional 
hyperthermia and chemotherapy as an effective future treatment strategy	 (Rolf D. 
Issels et al. 2010). Similarly, the combinational approach of radiotherapy and mNP 
hyperthermia was recently carried out in clinical trials, with the combined effect of 
hyperthermia and a reduced radiation dose leading to a safe and effective therapy 
for recurrent glioblastoma, increasing overall survival rates (Maier-Hauff et al. 
2011). 
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6.4 Conclusion  
 
The research involved in this PhD project primarily set out to identify whether gold 
nanoparticles, in the form of nanoprisms and nanorods, and magnetic 
nanoparticles could be used as nanoscale heaters in cancer cell cultures to induce 
toxic heat levels.  If successful, I then aimed to further investigate the molecular 
mechanisms behind the cell death (apoptosis), to establish the types of 
intracellular pathways involved. If we can understand the process and pathways 
involved, this can help future nanoparticle design. The first part of the project, 
chapter 3, characterised gold nanoprisms and nanorods in terms of their 
biocompatibitly and cellular uptake.  This was studied (i) in two cell lines, bone and 
breast cancer, to determine if tissue origin would influence nanoparticle 
performance, and (ii) in 2D and 3D cultures, to verify monolayer results were 
translated to the 3D environment. Both types of GNP proved to be highly 
biocompatible and rapidly internalised, with minimal disruption to cell morphology 
or structure. The GNPs demonstrated excellent heating profiles when excited with 
a 1 W continuous wave laser; 1 minute laser irradiation of labelled cells caused 
rapid cell death, in both 2D and 3D, demonstrating the potential depth of laser 
penetration at fairly modest laser intensity and duration.  
 
Following gold nanoparticle characterization and successful photothermal 
treatment, chapter 4 focused on assessing apoptotic markers at both the genomic 
and proteomic level with particular emphasis on large families such caspases, 
Hsps, bcl-2 and cathepsins, while influential molecular markers such as 
cytochrome C, DIABLO/SMAC, survivin, livin and TRAILR -1, -2, -3 and -4 were 
also evaluated. This analysis revealed a unique insight into the mechanisms of cell 
death attributed by elevated temperature profiles (42-45°), which to the best of our 
knowledge have not been explored in this depth previously.  Our results, although 
conforming to the majority of the literature of hyperthermia-induce apoptosis via 
the intrinsic pathway, also revealed the importance of both the extrinsic pathway 
and in particular autophagy, orchestrated by members of the cathepsin family. 
These results indicate that apoptosis can occur via more novel or less 
characterised pathways upon heat stress, while the main instigators of cell death 
upon hyperthermia exposure may be due to the generation and accumulation of 
ROS and endoplasmic stress.  
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The final chapter focused on the use of magnetic nanoparticles as hyperthermia 
agents. Several types of mNP were trialled during this section of work, however 
only one particle type was successful in balancing biocompatibility with the 
generation of hyperthermic temperature profiles. I employed a magnetherm device 
during this chapter, whereby 3D printed cell culture chambers were designed to be 
compatible with the device. Although these results were preliminary, the mNP 
labelled cells did appear to demonstrate a reduction in cell attachment and change 
in morphology akin to induction of apoptosis following exposure to an an external 
AMF, while cells exposed to the external AMF alone, did not appear affected.  
 
The NPs used in this project displayed various potential as viable future 
hyperthermic agents. The extensively studied GNPs used in this study displayed 
incredibly high heating potential within one minute at low concentrations                
(0.1 mg.ml-1). Although displaying excellent biocompatiblity and low toxicity at this 
concentration, the GNPs may be used at even lower concentrations (to futher 
decrease toxicity issues) while still reaching hyperthermic profiles albeit at an 
increase laser exposure time that would still be applicable for clinical application. 
Of the two GNP types, our data suggests that although nanorods show higher 
heating potential, the nanoprism; due to their enhanced biocompatibility and 
internalisation, may actually produce stronger photothermal effects upon laser 
treatment. When compared to mNPs, GNPs not only displayed lower toxicity and 
improved biocompatbility, they demonstrated stronger hyperthermic compatiblity at 
the same concentration within a minute of laser treatment as opposed to the 20 
minutes required during mNP heating via an external alternating magnetic field. 
The limiting factor for photothermal treatment would be the required laser 
exposure and depth penetration accessible within patients. This can present 
complications or slightly more invasive treatments in the case of deep seated 
tumours where a laser light source would be directed into the patient in such 
cases. In comparion, mNP heating involves magnetic fields that can easily 
penetrate the body and thus capable of stimulating mNPs located deep within the 
patients body and possibly in several sites without the need for any invasive 
procedures and thus maybe more desirable in a clinical application. However, of 
the two NP types used in this study, it appears GNPs are the stronger candidates 
for future application and put forward for future research. 
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6.5 Recommendation for future work 
 
One of the main focuses of the project was to attempt to better understand the 
elusive molecular events that occur upon hyperthermic exposure in cells, both in 
2D and 3D. While this was successful in terms of GNPs and has opened up further 
potential for future studies, particular areas of interest are described and 
summarised below.  
 
• Establishing cell death following mNP-mediated hyperthermia and 
evaluating the molecular events responsible (at the gene and protein level). 
 
• Investigating the effects of ROS generation (individual species) and RE 
stress upon hyperthermia exposure. 
 
• Further evaluating more novel cell stress/cell death pathways such as 
autophagy, necotoposis and necrosis after hyperthermia exposure. 
 
• Analysing cell death to quantify and discriminate between apoptosis and 
necrosis after photothermal and magnetic treatment, optimising laser 
power/duration to ensure safe treatment. 
 
• The functionalisation of the GNPs with chemotherapeutic payloads may be 
an attractive possibility for synergistic effect of drug payloads and 
hyperthermia; this could be assessed by standard monolayer and 3D 
testing platforms as used here. 
 
• Moving the GNP from successful current 3D in vitro studies to an in vivo 
small animal model to confirm the therapeutic effect of photothermal 
therapy.  
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